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WITNESS SEMINARS: 
MEETINGS AND PUBLICATIONS 1
In 1990 the Wellcome Trust created a History of Twentieth Century Medicine 
Group, associated with the Academic Unit of the Wellcome Institute for the 
History of Medicine, to bring together clinicians, scientists, historians and others 
interested in contemporary medical history. Among a number of other initiatives 
the format of Witness Seminars, used by the Institute of Contemporary British 
History to address issues of recent political history, was adopted, to promote 
interaction between these different groups, to emphasize the potential beneﬁts 
of working jointly, and to encourage the creation and deposit of archival sources 
for present and future use. In June 1999 the Governors of the Wellcome Trust 
decided that it would be appropriate for the Academic Unit to enjoy a more 
formal academic afﬁliation and turned the Unit into the Wellcome Trust Centre 
for the History of Medicine at UCL from 1 October 2000. The Wellcome 
Trust continues to fund the Witness Seminar programme via its support for 
the Centre.
The Witness Seminar is a particularly specialized form of oral history, where 
several people associated with a particular set of circumstances or events 
are invited to come together to discuss, debate, and agree or disagree about 
their memories. To date, the History of Twentieth Century Medicine Group 
has held 45 such meetings, most of which have been published, as listed on 
pages xv–xxiii.
Subjects are usually proposed by, or through, members of the Programme 
Committee of the Group, which includes professional historians of medicine, 
practicing scientists and clinicians, and once an appropriate topic has been 
agreed, suitable participants are identiﬁed and invited. This inevitably leads to 
further contacts, and more suggestions of people to invite. As the organization 
of the meeting progresses, a ﬂexible outline plan for the meeting is devised, 
usually with assistance from the meeting’s chairman, and some participants are 
invited to ‘set the ball rolling’ on particular themes, by speaking for a short 
period to initiate and stimulate further discussion.
1 The following text also appears in the ‘Introduction’ to recent volumes of Wellcome Witnesses to Twentieth 
Century Medicine published by the Wellcome Trust and the Wellcome Trust Centre for the History of 
Medicine at UCL.
xii
Members of the Programme Committee of the  
History of Twentieth Century Medicine Group, 2005–06
Dr Tilli Tansey – Reader in History of Modern Medical Sciences, Wellcome Trust Centre 
for the History of Medicine at UCL (WTCHM) and Chair
Sir Christopher Booth – WTCHM, former Director, Clinical Research Centre,  
Northwick Park Hospital, London
Dr Robert Bud – Principal Curator of Medicine and Manager of Electronic 
Content, Science Museum, London
Dr Daphne Christie – Senior Research Assistant, WTCHM, and Organizing Secretary
Dr John Ford – Retired General Practitioner, Tonbridge 
Professor Mark Jackson – Centre for Medical History, Exeter
Professor Ian McDonald
†
 – WTCHM, former Professor of Neurology, Institute of 
Neurology, London
Dr Helga Satzinger – Reader in History of Twentieth Century Biomedicine, WTCHM
Professor Lawrence Weaver – Professor of Child Health, University of Glasgow, and 
Consultant Paediatrician in the Royal Hospital for Sick Children, Glasgow
Each meeting is fully recorded, the tapes are transcribed and the unedited 
transcript is immediately sent to every participant. Each is asked to check his 
or her own contributions and to provide brief biographical details. The editors 
turn the transcript into readable text, and participants’ minor corrections and 
comments are incorporated into that text, while biographical and bibliographical 
details are added as footnotes, as are more substantial comments and additional 
material provided by participants. The ﬁnal scripts are then sent to every 
contributor, accompanied by forms assigning copyright to the Wellcome Trust. 
Copies of all additional correspondence received during the editorial process 
are deposited with the records of each meeting in Archives and Manuscripts, 
Wellcome Library, London. 
As with all our meetings, we hope that even if the precise details of some of the 
technical sections are not clear to the non-specialist, the sense and signiﬁcance 
of the events will be understandable. Our aim is for the volumes that emerge 
from these meetings to inform those with a general interest in the history of 
modern medicine and medical science; to provide historians with new insights, 
fresh material for study, and further themes for research; and to emphasize to 
the participants that events of the recent past, of their own working lives, are of 
proper and necessary concern to historians.
†Died 13 December 2006 
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INTRODUCTION
This Witness Seminar adds an important oral history study to the many 
accounts of medical innovation that have appeared over the past 15 years.2 
This interest in innovations among historians, economists, sociologists and the 
general public can be explained by both the remarkable successes and the rising 
costs of medical technologies and drugs. Many recent studies have focused 
on the political, social and economic contexts as much as on the technologies 
themselves. In reconstructing these contexts, the recollections of the pioneers 
are invaluable (if not always indubitable). In this Witness Seminar some of the 
surviving actors involved in the early development of total hip replacement 
(THR) assembled to discuss their contributions and recollections. The resulting 
transcript provides an insight into the creation of a new medical technology in 
mid-twentieth-century Britain.
The THR operation has been seen as a landmark in twentieth-century surgery. 
Since the early 1960s it has played an important role in alleviating pain and 
restoring mobility to millions of people suffering from arthritic joints. Today 
about 35 000 hips are replaced in England and Wales each year by the NHS and 
many more operations are carried out in private hospitals.3 THR has become 
one of the most commonly-performed elective surgical procedures worldwide. 
Its development was associated with innovation in materials, instruments, 
techniques and operative procedures, later adapted to treat other joints and 
applied across a range of surgical specialties. Hip replacement became a ﬂagship 
operation and helped to raise the status of British orthopaedic surgery.4 
The success of THR was not the result of one single breakthrough. Its origins 
lay in the interpositional- and hemi-arthroplasties developed between 1920 and 
1950 in Europe and the US. The evolution of procedures for putting materials 
between the articulating surfaces or for replacing one side of the hip joint led 
2 See Pickstone (ed.) (1992); Löwy (ed.) (1993); Lawrence (ed.) (1994); Stanton (ed.) (2002); Webster (ed.) 
(2006); Timmermann and Anderson (eds) (2006). 
3 National Audit Ofﬁce (2000). 
4 For a long-term analysis of what made orthopaedic surgery viable, from its foundation in the folk medicine 
traditions of bone setting in the eighteenth century to research-based practices and organized medical 
services in the twentieth century, see Pickstone (2006), 17–36.
xxvi
to materials, designs and surgical techniques that proved crucial to its success.5 
However, THR was primarily a British innovation, one that started to take 
off in the late 1950s, under the NHS, but mainly in district general hospitals 
rather than in teaching hospitals. It was created in hospital units at Norwich, 
Wrightington (near Wigan), Stanmore, Redhill and later Exeter.6 
The story begins with the pioneering operations of Philip Wiles at the Middlesex 
Hospital in the late 1930s;7 it continues through the later work of his registrar 
G Kenneth McKee at the Norfolk and Norwich Hospital, and includes the 
programmes at the other centres, led by John Charnley (Wrightington), John 
Scales and ‘Ginger’ Wilson (Stanmore), Peter Ring (Redhill) and Robin Ling 
and Clive Lee (Exeter).
The aim of the Witness Seminar was to reveal some of the personal stories 
and relationships behind the published accounts. Though many of the early 
innovators are no longer with us, their tales live on through the reminiscences 
of their trainees and some of the nurses, surgeons, engineers and manufacturers 
who were involved with the original centres and with later developments, who 
spoke at this meeting. The transcript shows early THR as classic British postwar 
science, characterized by improvisation, ingenuity, long hours and low budgets. 
But by the 1970s THRs were taken up across the Western world, and by the 
1990s the British companies had become attractive acquisitions for healthcare 
corporations. The global market is now dominated by a handful of multinational 
5 In the US, for instance, Dr Marius Smith-Petersen experimented with a number of materials in the 1930s 
(including glass and Pyrex) for his interpositional cup arthroplasty until he had some success with Vitallium® 
(a chrome–cobalt alloy) [see Figure 12 and Appendix 3]. This alloy was used by Drs Fred Thompson and 
Austin Moore for their hemi-arthroplasties to replace the head of the femur in the early 1950s. These 
prostheses had an advantage over earlier hemi-arthroplasties, ﬁxed with plates and screws on the outside 
of the femur, because their stems, which went down the medullary canal, were more stable. They were 
also much more reliable than the acrylic polyethylene hemi-arthroplasty developed by the Judet brothers in 
France in the late 1940s, which only had a small stem. See note 96 and Appendix 3, pages 101–06. 
6 For detailed histories of THR and its precursors from the point of view of the development of materials, 
see: Parsons (1972); and Walker (1977): 253–75. For a chronological history based around solutions, see 
Scales (1966–7). For a more recent historical overview, see Klenerman (2002): 13–23. 
7 Thermistokles Glück (1853–1942) replaced a number of tuberculosis-damaged joints with ivory prostheses, 
which were ﬁxed with a bone glue composed of colophony or rosin, pumice powder, and plaster of Paris 
in the 1880s. These may have included an ivory total hip replacement, but his work was discredited when 
he was forced to retract his results after an argument with Professor Ernst von Bergman (1836–1907), his 
boss and head of the Berlin surgical clinic. See Glück (1891). See also www.totaljoints.info/Prehistory_
GluckPean.htm (visited 2 November 2006). 
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companies, mostly based in the US, some of which are associated with the 
pharmaceutical giants.
The early development of THR was a ‘cottage industry’, in which surgeon–
inventors with a knowledge of engineering principles worked with craft-
based technicians, university departments and small surgical instrument 
manufacturers. For instance, in the late 1950s John Charnley employed the 
technician Harry Craven to work from the workshop at Charnley’s home, 
making Teﬂon® acetabular cups and ﬁnishing forged stainless steel femoral 
prostheses on a lathe. These would be sterilized in formaldehyde overnight 
ready for operating the next day.8 Charnley had liaised with the Engineering 
Department at UMIST over materials for the prosthesis and with the Victoria 
University of Manchester Dental School over the pink, acrylic dental cement 
that he used to ﬁx his prostheses in place (see pages 13 and 22). He worked 
with the Leeds-based surgical instrument company Chas F Thackray to forge 
his femoral prosthesis and by 1963 they were mass-producing his prosthesis at 
their factory.9 Throughout the 1960s Charnley also worked with another local 
company to develop a clean air operating theatre environment to reduce post-
operative infections, which were ruining nearly 10 per cent of his hip replacement 
operations. This Bolton-based company, Howorth Air Conditioning, had been 
developing clean air environments for cotton mills and breweries since the late 
nineteenth century and adapted their technologies to Charnley’s needs.10 
This use of local companies and expertise was a feature of all of the ﬁve early 
THR centres.11 But each leading surgeon used the particular surgical approach 
he had learned for earlier hip operations, including tumours, fractured necks 
of femur etc. [see Figure 24]. Their choice of materials also varied considerably 
(stainless steel, cobalt–chrome alloy, Teﬂon®, and high-density polyethylene), as 
did the prosthesis design (femoral head size and neck, stem and cup geometry) 
8 For an account of Charnley’s research including the early setup for manufacturing prostheses by hand, see 
Waugh (1990): 116–17. See also note 7, page 7. 
9 For the Thackray company’s relationship with Charnley, see Wainwright (1997): 73–105, especially 
Chapters 9 and 10.
10 See Howorth (2002); and Whyte (2001): 9–20, especially Chapter 2.
11 It is interesting to note their ingenuity in adapting materials and existing technologies from the aircraft, 
dental prosthetic and surgical-instrument industries to their purposes. For example, many of the early 
biomechanical engineers came from the aircraft industry, which was a rich source of research on corrosion-
resistant materials, and the use of chrome–cobalt alloys and acrylic cement was well established in dental 
prosthetics. See Professors Swanson on pages 26–28 and Dowson on pages 28–30. 
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and the methods of ﬁxation (screws or nails, acrylic cement and bone in-growth). 
These local variations led to a plethora of debates about the best mode of THR; 
the arguments continued at formal meetings and in more informal settings like 
the annual orthopaedic skiing trip to the Alps.12 
This transcript is also a testament to why these debates continue to the present 
day, and to the shifting concerns about the body’s reactions to materials and 
cement, which made certain combinations of materials and ﬁxation methods 
more attractive at particular stages in the development of THR. For instance, 
concerns about the effect of the debris produced by metal-on-metal articulations 
promoted a general shift in the early 1970s to cemented metal-on-plastic hips, 
especially after the very good early results with the Charnley prosthesis. But 
towards the end of that decade, new worries about the biocompatibility of 
the cement and the effect of polyethylene wear particles led to a resurgence of 
metal-on-metal combinations. Later problems with the ﬁxation of metal-on-
metal components, especially those using new bioactive coating methods (like 
hydroxyapatite), made metal-on-plastic attractive again, and in the 1990s more 
accurate machining techniques created the possibility of obtaining good results 
from metal-on-metal hip resurfacing.13 For over 50 years now, the debates have 
continued, partly because of continual novelties, but also because the results are 
hard to predict and can only be judged over 10–20 years. Short-term studies 
can only pick up serious failures, and records of long-term performance are less 
complete than they might have been. The transcript shows how proposals to 
create a British register of hip implants in the 1980s came to little.14 
The seminar participants also considered the attempts to impose standards on 
the design and manufacture of hip prostheses. The 1970s and 1980s saw little 
consensus in the committees set up in Britain and Europe. Standardization and 
regulation in Britain came much later than in the US: the Medical Devices 
12 For a description of the British Orthopaedic Ski Group, see Waugh (1990): 93; 130–1. Its name was later 
changed to Study Group (BSOG) and is used throughout the transcript. 
13 Hip resurfacing was attempted by Charnley in the late 1950s with a PTFE double cup (see Figure 4) 
and Freeman in the early 1970s with a metal-on-polyethylene combination (see Figure 18). There were 
early failures, but the Birmingham metal-on-metal hip resurfacing, developed in the 1990s (see Appendix 3, 
page 106) was widely copied and resurfacing is now a common operation for younger patients, see page 32.
14 For instance, the recommendations of the DoH Implant Advisory Group [see pages 39–41 and Sweetnam 
(1981)]. Although hip registers were set up in Scandinavia in the period, the Swedish National Hip Arthroplasty 
Register had begun collecting and analysing data about all primary total hip replacements and re-operations and 
revisions of hip implants in 1979, while the Norwegian Arthroplasty Register was started in 1987.
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Agency (MDA) was not formed until the 1990s and it was then merged with 
the Medicines Control Agency (MCA) in 2003 to form the Medicines and 
Healthcare products Regulatory Agency (MHRA).15 In the early period of THR 
in the UK, as covered by this seminar, single-centre follow-up studies were the 
best data available. Regional registers began to appear in Britain in the 1990s 
and in April 2003 the National Joint Registry for England and Wales (NJR) was 
set up.16 Recently, as in some other countries, the National Institute for Clinical 
Excellence (NICE) has produced studies of the cost effectiveness of prostheses 
based on long-term follow-up studies.17 These studies clearly show that the most 
common and most reliable of the models used in Britain are closely related to 
the Charnley designs of the 1960s. 
THR materials and techniques came to be adapted for a greater range of 
types of patient and for the replacement of other joints; they proved to be the 
basis of a huge global industry that now has many of the characteristics of 
the pharmaceutical business, including ‘me too’ models and huge amounts of 
money spent to secure ‘surgeon loyalty’. It is a far cry from the British pioneers 
of the 1950s and 1960s who worked in the NHS, led the collaborations with 
engineers and companies, and achieved long-lasting results with remarkable 
economy. To them, millions of older (and some younger) people now owe 
substantial enhancements in their quality of life. This transcript will serve as a 
permanent record of the early developments and we are most grateful to all who 
took part. 
Francis Neary and John Pickstone,  
Centre for the History of Science, Technology and Medicine,  
University of Manchester
15 See their website at www.mhra.gov.uk (visited 2 November 2006).
16 The latest NJR report for 2005/06 records 82 per cent of the hip and knee operations performed in 
England and Wales and can be viewed at www.njrcentre.org.uk/Public/PPEhomepage.htm (visited 
12 December 2006).
17 For instance, NICE (2000): 1–9. See www.nice.org.uk/page.aspx?o=510 for later guidelines to the NHS 
and for patients, freely available (visited 2 November 2006).
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Dr Daphne Christie: We are very grateful to our advisers, Ravi Kunzru and 
Francis Neary, for their help with the organization of the meeting and I am 
particularly grateful to Alan Lettin, who has kindly agreed to chair the meeting 
this afternoon. So, without further ado, I will pass you over to the Chairman.
Mr Alan Lettin:1 Thank you very much. These Witness Seminars have been 
going since 1993.2 It strikes me that perhaps it is about 20 years too late for one 
on total hip replacement [THR, also known as total hip arthroplasty, THA, see 
Figure 1], because if one had been held 20 years ago, the modern innovators 
would have been here in person. In fact, one or two are here, I am looking straight 
at Peter Ring. I think the concept of this meeting started with Ravi Kunzru, 
who has become very interested in medical history since retiring as a Consultant 
Orthopaedic Surgeon, and Francis Neary and his boss, John Pickstone, who is 
a professor of medical history at the University of Manchester.
I think most people would know that the idea of replacing diseased and damaged 
joints by artiﬁcial implants was not new in the 1950s when John Charnley and 
Ken McKee and others really put joint replacement on the map. People tried in 
the nineteenth century, in the great explosion of surgical knowledge and effort 
at the end of that century, but for all intents and purposes, we will be talking 
about the second half of the twentieth century, a period which began with 
John Charnley and Ken McKee and perhaps ended 20 years later with Michael 
Freeman and the double cup.3 Everything since then has been a variation on a 
theme and what we really want, in the absence of those early innovators, is for 
the people here, who have been asked to come because they worked with or for 
those pioneers, to reminisce and to tell us what happened.
Although I said that it really started with McKee and Charnley, I think perhaps 
we should pay some tribute to Philip Wiles [Figure 2], who, as I understand it, 
did the ﬁrst total hip replacement in 1938 [see Appendix 3, page 101].
Sir Rodney Sweetnam was Philip Wiles’ houseman, registrar, and succeeded 
him at the Middlesex Hospital, London. I thought it would be appropriate if 
Sir Rodney started the ball rolling. If everybody in this room speaks, they are 
1 Biographical notes appear on pages 133–45.
2 For the background to the Witness Seminar as an historical tool, see pages xi–xxiii.
3 The Imperial College London Hospital (ICLH) hip replacement, see Figure 18. See also Brigitte and Earl 
(2006); Padgett et al. (2006); Parker and Gurusamy (2006).
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Figure 1: The disarticulated hip joint, the site of a total hip replacement.  
L: the head of the femur; R: the acetabulum, part of the pelvis.
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only going to be able to do so for four minutes each, so we don’t really want 
anyone speaking for longer than four minutes at a time anyway. Of course, 
there shouldn’t be any undue constraints, but I do beg you not to take the ﬂoor 
for too long. Rodney, I am sure you will set a tremendous example to everyone 
by telling us about Philip Wiles’ contribution.
Sir Rodney Sweetnam: Yes, and I will do it in three and half minutes. Thank 
you very much and thank you for asking me. You made it sound as though there 
was a degree of nepotism, Chairman. Yes, I was Philip Wiles’ houseman, and I 
did indeed succeed him, although I wasn’t his registrar. 
I want to draw everybody’s attention to the pioneer work that my ex-chief and 
predecessor [see Figure 2] did, and, to that end, on your chairs, is a copy of a 
paper in the British Journal of Surgery that he wrote in 1958, describing his ﬁrst 
attempt at a total hip replacement arthroplasty. You will see that in the right-
hand column on the ﬁrst page, he describes what I believe to be the ﬁrst total 
hip replacement [in the UK] in 1938, at the Middlesex Hospital, replacing the 
socket and the femoral component.4
4 Wiles (1958). See Appendix 3, page 101. 
Figure 2: Mr Philip Wiles FRCS, c. 1950. 
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He describes animal experimentation, and later the insertion of six of these 
prostheses into patients. He also goes on to say that he had no adequate follow-
up, as the war intervened and, of the six patients, he only knew of one later. 
That one patient became my patient when I succeeded him in 1960. That 
patient had a painful, stiff, but slightly mobile hip, which was the site of one 
of Wiles’ six total joint replacements. I removed the artiﬁcial joint and, if I 
remember correctly, arthrodesed the hip – I may have done a Girdlestone, I can’t 
remember.5 But the prosthesis is now in the archives of the British Orthopaedic 
Association (BOA), on loan to the Hunterian Museum at the Royal College of 
Surgeons. This ﬁrst attempt at total hip replacement had some similarity to the 
present-day, so-called ‘surface’ replacement [see Appendix 3, page 106].
In my time Philip Wiles was a modest man, you’ll see that in his paper he makes 
relatively short reference to this major contribution in hip surgery worldwide 
– six cases, he dismisses it, goes on to describe all the other operations. 
5 A Girdlestone operation is a resection arthroplasty of the hip, removing the head and neck of the femur, 
which usually leaves the patient with a pain-free hip. The femur is left loose allowing some movement 
between it and the acetabulum (pelvis) – a ‘pseudoarthrosis’ or false joint. See the Glossary, page 148.
Figure 3: X-ray of Wiles’ hip, c. 1950s.
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Lettin: I suppose, having said that very few of the originators are left, Peter Ring 
is here. Peter, I don’t know whether you could perhaps tell us the sequence of 
events? Was it McKee who produced the ﬁrst total hip replacement, or was it 
John Charnley, or was it even you? I know it wasn’t the Stanmore.6
Mr Peter Ring: No, it certainly wasn’t me. I was a registrar at the time when 
John Charnley was working with PTFE [polytetraﬂuoroethylene (Teﬂon®, 
Fluon®)],7 and later I became a consultant at Redhill and went to a meeting 
two or three years later, at which both McKee and Charnley were present, one 
demonstrating the metal-on-plastic hip and the other the metal-on-metal.8 
6 McKee produced an all-metal prototype replacement joint in 1940, although his results were not published 
until 1951 [McKee (1951)], the Judet brothers inserted a perspex femoral head in 1946 [Judet and Judet 
(1950)], and the Charnley hip was the ﬁrst total hip replacement system to be adopted worldwide. Foreman-
Peck (1995): 109. See Appendix 3, pages 101–06, for illustrations of the cups and stems mentioned in this 
transcript and the materials used.
7 Teﬂon® is the trade name for a family of PTFE resins produced by DuPont, Wilmington, Delaware, 
USA. Charnley’s acetabular and femoral components were made from Fluon® resin produced by Imperial 
Chemical Industries (ICI) in the UK. Charnley (1974) describes the material illustrated in Figure 4 as 
polytef. Many participants called this Teﬂon® during the meeting, which has been replaced in the text with 
the more accurate term PTFE. See Li and Burstein (1994). 
8 See note 42.
Figure 4: Charnley PTFE double cup implant, c. 1960. 
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It occurred to me that they were both making a rather simple job difﬁcult by 
using bone cement,9 which was a relatively untried material at that time. And 
since we had a prosthesis at that time, Moore’s,10 which gave a reasonable result, 
certainly in the treatment of fractures of the hip joint, if one could match that 
to some sort of cup that was ﬁxed ﬁrmly, you might avoid the use of bone 
cement [see Figure 5]. I had spent two or three years demonstrating anatomy 
before that, and one of the areas that was quite obvious to an anatomist was the 
ileopubic bar of bone. And as an orthopaedic surgeon, I became familiar with 
this in doing arthrodesis, because one attempted to get the triﬁn nail up the 
9 Charnley describes the properties of polymethylmethacrylate (PMMA), the self-curing bone cement: 
‘PMMA for orthopaedic usage (for example, CMW [see Appendix 2]) is packaged as two components: 20ml 
of liquid and 40g of powder. The liquid contains the PMMA monomer, stabilizer and activator. The powder 
contains the polymer, a radio-opaque substance and polymerization initiators. When added together and 
mixed, polymerization occurs. At ﬁrst the cement is a relatively low viscosity glistening paste. The viscosity 
of the preparation steadily increases and the surface becomes dull. The rapid ﬁnal phase of polymerization 
is associated with an exothermic reaction. The material then becomes a solid resin. When used in large 
volumes, a bulk state, PMMA behaves in a different way from the thin mantle seen in prosthetic ﬁxation.’ 
McCaskie et al. (1998): 37. See also Charnley (1970) and note 37.
10 See Appendix 3, page 102.
Figure 5: The Ring total hip replacement: X-ray of THR in position, 1970.
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ileopubic bar of bone for secure ﬁxation. It seemed, therefore, that if you could 
locate a cup with a long screw thread up the ileopubic bar of the bone, you 
could hope for a reasonably sound method of ﬁxation. If you also got a cup that 
was orientated more or less directly, and certainly uniformly, and matched that 
to a femoral component and you had a total hip replacement [see Figure 5]. For 
the development of that, I am very indebted to Maurice Down,11 who put the 
resources of his ﬁrm at my disposal and helped me in its development, as he did 
for a number of orthopaedic surgeons. 
Lettin: Essentially, what you were developing was an uncemented implant, 
because you didn’t feel that cement was the way forward; was that the essence 
of your contribution? Now, obviously, we have asked one or two people along 
who were associated with the early development, including John Kirkup, who 
worked as a junior with McKee [Figure 6]. Perhaps you could tell us, John, what 
went on way back in the early days?
11 Mr Maurice Down OBE was Chairman and Managing Director of the small medical equipment ﬁrm, 
Downs Surgical Ltd, Mitcham, Surrey, that manufactured and marketed the Ring THR from 1964. Mr 
Peter Ring wrote: ‘Maurice Down remained until the ﬁrm was eventually taken over by Smith’s Industries 
in the mid-1980s, although it continued to manufacture my implants and continued the trading name of 
Downs for many years after that’. Letter to Mrs Lois Reynolds, 17 October 2006.
Figure 6: Ken McKee with his total hip replacement system.
Reproduced by permission of the ©Eastern Evening News. 
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Mr John Kirkup: I had the privilege of being there with Ken McKee from 1956 
to 1958, six months as a senior house ofﬁcer (SHO) and 18 months as a registrar, 
and the thing that struck me was that he was not just an orthopaedic surgeon 
of mechanical bent, but he was a general orthopaedist, with his clinics full of 
interesting material, a fact that converted me to orthopaedic surgery. But there 
was no doubt that he was interested in hips, perhaps because his clinics were full 
of farmers and farm workers, who were otherwise very ﬁt, except for an arthritic 
hip, or an arthritic knee, or both. And this was one of the things that motivated 
him towards that particular ﬁeld of surgery, which he started in 1951, you may 
remember. The ﬁrst hip in stainless steel was unsatisfactory, as was the second; 
the third, in the alloy of chrome and cobalt, lasted some three years.12 When I 
arrived in 1956, he was starting what he called Mark 3 hips, comprising metal-
to-metal chrome–cobalt, with a ﬂanged acetabulum, in the centre of which 
were three holes with three screws. I thought this was rather unsatisfactory, but 
anyway, the operation worked [for an X-ray of a later version, see Figure 7].
12 McKee (1953).
Figure 7: Post-operative X-ray of the McKee artiﬁcial joint, 1963. 
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It was interesting. One day he said, ‘We are replacing a hip tomorrow’, and as I 
was a bit late getting to the theatre that morning, I saw him going up the steps 
rubbing something on the back of his right buttock, and then saw this was a 
prosthesis. He said, ‘Yes, we must ensure that we have complete slipperiness, it’s 
very important that we reduce the friction’. It was the hip ball he had polished 
in his workshop the night before. Anyway, the fact is that this somewhat odd 
operation appeared to work. You had to have the patient on a Hawley table 
[Figure 8] and Frank, the orthopaedic technician, was called upon to move the 
leg as necessary at the relevant moment.13 The patient remained in bed for ten 
or 12 days, until the wound was healed, and stayed in hospital for maybe three 
or four weeks. 
For many patients this surgery succeeded; I saw them at follow-up and most 
were very pleased. However, McKee was only doing something like ten a year. 
And then in 1960, of course, he was converted to the use of cement.14
Lettin: That leads us on very nicely, I suppose, to John Read. There are several 
people here, not least Lady Charnley, who were associated with Sir John 
[Charnley]. Of course, John, you were working for him fairly early on. What 
are your recollections? I think it’s quite clear that Sir John introduced cement 
into the operation.
13 See Figure 8 for an example of a Hawley table.  
14 McKee and Watson-Farrar (1966). 
Figure 8: Hawley orthopaedic table showing a non-sterile assistant controlling the leg. 
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Mr John Read: I arrived at Wrightington16 in 1961, having previously done three 
years as a registrar at Sunderland Orthopaedic and Accident Hospital. Before 
my arrival, John Charnley [Figure 9] had been working on his artiﬁcial hip 
using a PTFE socket and a stainless steel femoral head. Actually, the ﬁrst one he 
produced was a double PTFE cup [see Figure 4], which was a failure, and after 
that he moved on to using a metal femoral head. And the initial results of that 
had been quite good, but there were several problems. One was that, within a 
year, PTFE was beginning to show signs of wear, and the other was that he had 
a high infection rate,17 because at his unit at Wrightington, he’d been allocated, I 
think, ten theatre hours altogether, but the theatre was very basic – it didn’t have 
a recognizable ventilating system, was used by all sorts of people, at all sorts of 
times, and it had a high infection rate, which I think was about 7 per cent.18 
15 Professor Mike Wroblewski wrote: ‘Charnley gave this photo, autographed, to his past Residents.’ Note 
on draft transcript, 24 October 2006.
16 The Centre for Hip Surgery at Wrightington Hospital, near Manchester.
17 Charnley and Eftekhar (1969); Charnley (1972).
18 Professor Mike Wroblewski wrote: ‘The infection rate before clean air enclosure was 8.9 per cent’. Note on 
draft transcript, 20 June 2006. See Charnley and Eftekhar (1969): 645; also Figures 12, 13 and 24.
Figure 9: Professor Sir John Charnley FRCS FRS
15
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Before I arrived he started designing his greenhouse, to produce his own fresh 
air inﬂow from outside, and Harry Craven [Figure 10], who is here today, built 
the enclosure in his workshop.19 My ﬁrst theatre list was with this greenhouse 
being used for the ﬁrst time, which was quite something. I am sure you have 
all seen pictures of it from time to time [Figures 12 and 13]. It only took the 
patient’s body. The anaesthetist was kept outside, because he was dirty anyway, 
but we had windows at the side so that other people could look in and see what 
was going on. 
Lettin: One of the topics that we want to get to is infection and the question of 
the greenhouse might be better discussed then. Was that your main recollection? 
What about the cement? Was that introduced in your time, or before?
Read: A little before, I think, and the cement that we used initially still had the 
pink dental dye in it, which was quite useful actually because you could see 
where it was going quite well.20 
Lettin: Mr Craven, would you like to comment on those early times?
19 Anonymous (1960); Lowbury and Lidwell (1978); Johnston (1981); Bintcliffe (1983).
20 Mr John Read wrote: ‘Dental acrylic with a pink dye to match the gums’. Note on draft transcript, 
4 July 2006.
Figure 10: Harry Craven, 1981. 
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Mr Harry Craven: Speaking of the cement, I think we started using it about 
1960. This was when we were still on with the PTFE and then we went on to 
other stuff called Fluorosint®21 – funny name, and funny mixture – and we 
didn’t do very many with that. But I designed another hip, which I thought was 
a three-dimensional hip, where you had a Smith-Petersen cup [Figure 11]22 and 
a plastic socket put inside it, cemented in with the acrylic cement, and then you 
got the main head of the prosthesis going into the main HDP socket. I thought 
if there’s any movement, you’d get three movements, which could help the life 
of the hip socket. 
Apparently this wasn’t so, although some of the chaps at Wrightington – Kirk 
Houston was one – loved doing these, after we had gone on to the high-density 
polyethylene (HDP). John Charnley said to him: ‘I don’t want you to do those, 
I want you to do research on them’. But Kirk Houston still insisted on doing 
them. 
21 Charnley used Fluorosint®, a mica-reinforced Teﬂon®, for the cups. The replacement UHMWPE 
[Hoechst, Oberhausen, Germany] had been used in the European textile industry in the 1950s for impact 
bearings of mechanical looms. Charnley’s ﬁrst UHMWPE socket, labelled RCH 1000, was implanted in 
November 1962. [Gomez and Morcuende (2005b): 33; Charnley (1979): 87–9, Figure 6.29.] Professor 
Mike Wroblewski wrote: ‘The Press-Fit cup was used from 1962/3 to 1965; 336 were implanted. It was 
not used after 1965. The longest surviving, well-functioning press-ﬁt is in a patient aged 44 at the time of 
surgery. He has now completed 42 years of clinical success. This is the longest surviving, well-functioning 
THA.’ Note on draft transcript, 24 October 2006. Freeman et al. (1985); Swanson and Evarts (1984). See 
also Semlitsch and Willert (1997): 73.
22 Smith-Petersen (1939); Berntsen and Bertelsen (1952). 
Figure 11: Stainless steel Smith-Petersen cup (4.5cm diameter x 4cm), c. 1938. 
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With regard to the greenhouse [see Figure 12], it was built in 1960, and this 
was done, as John [Read] said, because things weren’t sterile. I managed to 
get a little ventilation unit, which was put outside the enclosure and we had 
the greenhouse [see also Figure 13]. John Charnley used to come for me on 
a Sunday, and say: ‘Can you come down for half an hour?’, and it would last 
all day. We would do smoke tests in the theatre, all kinds of tests, to see where 
the air was going. And we ended up with two bags inside it, which were ﬁlters, 
but the unit I got had six ﬁlters inside it with two micron ﬁlters [see Figure 14] 
and, from then on, the infection rate seemed to drop.23 The people who had 
lent me the sterile unit, which was outside the ventilation plant, was the ﬁrm of 
Howorths.24 It was a friend of John Charnley who put me on to them. The chief 
engineer, a Mr Poulton, came out and I showed him what I wanted, and he lent 
me this ventilation plant, and then he phoned me and asked for Mr Howorth to 
come. And it was a bit of a laugh really. He came in an E-type Jag – you needed 
23 Charnley’s greenhouse succeeded in reducing the sepsis rate in THR operations from 8.9 per cent in 1960 
to 0.9 per cent in 1968. Lowbury and Lidwell (1978): 800. See also Anonymous (1976); Howorth (1985); 
Berg et al. (1991). 
24 Mr F N Howorth represented his air ﬁltration ﬁrm, Howorth Surgicair, from Bolton, Lancashire 
[established in 1854, known as Howorth Airtech Ltd in 1996] that had originally designed ﬁlters for brewers 
and pharmaceutical manufacturers to remove particles, or bacteria, from the air. See Scottish Society for 
Contamination Control (S2C2) (2004a and b), in particular (2004a): 4–5 for photographs of the 1962 
greenhouse and a later undated commercially-available model [s2c2@mech.gla.ac.uk]. See also page 80. 
Figure 12: Charnley’s original greenhouse clean air enclosure, 1960. 
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a shoe horn to get in – and he introduced himself to me, and I took him in 
theatre, got him gowned up, and said, ‘You can watch the operations through 
the windows’. He looked through the windows and collapsed on the ﬂoor: it 
took three of us to drag him out. 
And then the hip success rate improved and we, or rather I, got the HDP from 
West Germany through a sales technician who came. I asked if he could give 
me a piece – he was trying to sell things – as I wanted to put it under test. I had 
built a test rig for testing all the materials we could get on a ﬂat surface, and 
he sent me a piece. I got all the information on it as well from West Germany, 
and I tested it. John [Charnley] was going away to Zurich, I think it was, for 
about three weeks, and he came in and said, ‘What are you testing?’ I replied, 
‘Polyethylene’. ‘Throw the bloody stuff away,’ he said, ‘it’s no good’. Anyway, I 
carried on testing it, and when he came back he asked what I was testing and I 
said, ‘The stuff you told me to throw away’. He asked for my graph, because I 
did a graph of everything I did. ‘Well’, I said, ‘there’s your graph, a straight line 
all around the room and, from my ﬁgures, I have calculated that it would last 
70 years’.25 
I don’t know what the record is at the moment with regard to hip joints, but on 
a ﬂat surface, I got 70 years work out of it.26
Lettin: Lady Charnley, do you have any recollections, I am sure you have lots 
of recollections.
Lady Charnley: I certainly don’t want to hold the ﬂoor for any length of time, 
partly because I am having great difﬁculty in speaking today with a peculiar 
throat. But yes, of course, I have very many marvellous memories, and I must 
say that it was Harry Craven’s persistence in doing what he shouldn’t have done, 
to put this piece of high-density polyethylene on the wear-testing machine that 
he had made at the hospital, against John’s wishes, which of course eventually 
was the great breakthrough that John had been looking for.27 
25 Charnley (1974): 1028. 
26 See, for example, Wroblewski (1997). Professor Mike Wroblewski wrote: ‘I have an original specimen 
from 1962.’ Note on draft transcript, 20 June 2006.
27 For a remark on Mr Harry Craven’s testing of the HDP samples and a full discussion of the progression 
from a large-diameter 41mm Thompson or Austin Moore prosthesis to the Charnley low-friction 
arthroplasty using the 22.225mm head, see Charnley (1974):1027–8. Early prostheses were tested on hand-
made wear-test machines. Modern testing equipment can be seen at www.dur.ac.uk/cbme/facilities/ (visited 
21 September 2006).
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Figure 13: Filters and masks: cutting infection rates. From The Times (30 November 1965): 20. 
Provided and annotated by Mr John Read. 
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Figure 14: Looking down on to the greenhouse roof showing three cloth infuser bags inﬂated with 
clean air. 
Figure 15: The Charnley low-friction arthroplasty in use from November 1962, having a thick 
socket of UHMWPE with deep external serrations and a small femoral-head on the ﬂat-back 
prosthesis. 
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At that time, John was extremely despondent. He had a great many patients 
who initially had done incredibly well with the PTFE, and when the PTFE cups 
began to wear he had nightmares. In fact, I know it is well documented that he 
used to wake up at about 3 o’clock in the morning and I would see him with 
his head in his hands, saying, ‘I don’t know what I am going to do with all the 
patients that are going wrong’. But, of course, when HDP came and was proved 
to be a very hard-wearing material, he was able to operate on all the patients 
who had had PTFE and, of course, that was the start of the great breakthrough 
in hip replacement [Figure 15]. I could go on all afternoon, but I shall happily 
hand over to somebody else.
Lettin: Thank you very much for those recollections. Now I know that the 
Stanmore total hip replacement came a bit after the McKee and the Charnley. 
We haven’t really decided which came ﬁrst, but we’ve decided that Wiles really 
has precedence in the introduction of total hip replacement. I do know that 
Stanmore came a bit later.28 Unfortunately, ‘Ginger’ Wilson [Figure 16], who 
was due to talk about the early Stanmore experience, passed away a couple of 
weeks ago, but his daughter and son are both here. I don’t know if they would 
like to say anything.29 
Mrs Sheila Edwards: We can only tell you silly stories, having lived with 
the Stanmore through our formative years. I know nothing really practical 
about it, I think Phyllis [Hampson] will be able to tell you much more about 
it than I can. 
We do have recollections of mother’s tablespoons going missing from the 
kitchen drawer, to be used as some sort of reamer, or battered into some shape 
he needed. There was another ghastly story about something exploding in 
theatre and leaving ball bearings all over the theatre ﬂoor.30 We are not quite 
sure what that was. We are grateful that you have invited us here today to stand 
up for him.
28 Duff-Barclay et al. (1966); Scales and Wilson (1969); Wilson and Scales (1973).
29 See Owen (2006). Mr Michael Wilson wrote: ‘He inserted the ﬁrst Stanmore total hip on 25 April 1963 
with John Scales, and afterwards initiated the Bone Tumour Registry. He described Wilson’s operation for 
hallux valgus, but gained media attention from his descriptions of “Winkle-Picker’s Disease” and “The 
Battered Buttock”. I’ve just checked my Father’s diary for 25 April 1963. He wrote: “Did our ﬁrst Scales–
Wilson prosthesis. It went very well – took about three hours, but this was mainly because we went very 
slowly and took lots of photos. I can hardly believe it was so easy. Now it depends upon healing and rehab”.’ 
E-mail to Mrs Lois Reynolds, 17 October 2006. 
30 See note 86.  See also an example of a reamer in Figure 22, page 39.
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Lettin: I think we are probably coming to the end of this initial topic and, as I 
believe I said, we thought that perhaps the ﬁnal innovation, if you like, was the 
double cup. Everything since then has been a variation on a theme. 
The conventional total joint replacement has had, for example, hydroxyapatite 
surfaces and various other modiﬁcations, but essentially the basic design remains 
the same. But the double cup, I think, is obviously something quite different. 
Michael [Freeman], would you like to say why and how you came to do it, 
and why Derek McMinn’s resurfacing arthroplasty seemed to work and yours 
didn’t.31
Professor Michael Freeman: The concept of a two-part resurfacing arthroplasty, 
I dare say, came from a number of people, but the reason it came to me was 
made up of two things: one was that the early results of conventional THR, 
I won’t go into details, were not absolutely wonderful technically, and there 
were some particularly dramatic failures on the femoral side in the hands of 
both my colleagues and myself. It seemed a pity to treat a disease that was 
only a few millimetres thick on the femoral side, with an operation that ended 
with approximately one-third of the femur being severely damaged. That was 
one factor. The other was that one of my senior colleagues, Scottie Law, had 
a very large experience of single cup arthroplasty, having been in the US, in 
31 Derek McMinn reintroduced the double cup or ‘resurfacing arthroplasty’ with his own design at the Royal 
Orthopaedic Hospital, Birmingham, in 1991. McMinn et al. (1996). See also note 118 and Appendix 3, 
page 106.
Figure 16: Mr ‘Ginger’ Wilson, c. 2000.
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Boston, after the war, and it was a very small step to think that you could 
cement the metal component to the femur and a polyethylene socket to the 
acetabulum. The man who actually designed the [ICLH double cup] implant is 
Alan Swanson, who is sitting next to me.32 I was the surgical half, and together 
we were at Imperial College. The reason it failed, apart from the fact that I, like 
many others, didn’t know what we were doing surgically, was, as I now realize, 
that the polyethylene cup, articulating with a large head, as John Charnley said, 
was a particular risk. But in retrospect I think much more important was the 
fact that it was gamma-irradiated in air and thus although it started out as ultra-
high molecular weight polyethylene [UHMWPE], by the time it was implanted 
into the patient, the chain lengths had usually been reduced and the wear rate 
went up through the roof. I don’t know whether you want me to comment on 
cobalt–chrome-on-cobalt–chrome. I will do if you wish. 
Another piece of Professor Swanson’s work was the design – I don’t know 
whether it was the ﬁrst – of one of the earliest hip and knee simulators, in which 
he ran cobalt–chrome against cobalt–chrome and metal against polyethylene. 
In 1972 I put in my ﬁrst resurfacing arthroplasty. A man called Trentani at the 
32 The ICLH double cup was implanted using a thin layer of PMMA in 1972, following two years of 
laboratory investigation. The prosthesis used on the ﬁrst 16 hips had a HDP femoral component and a 
stainless-steel acetabular component. From 1974 the acetabular component was of HDP with a cobalt–
chrome femoral component, as in Figure 18 and Appendix 3, page 106. Freeman et al. (1975); Freeman 
(1978b); Freeman et al. (1978). 
Figure 17: Principal stages in the design and development of the Stanmore prosthesis, 1960–85. 
Note that the ﬁrst four models were double, with the base secured to the acetabulum and the 
inner cup rotating inside. 
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Rizzoli Institute in Bologna had put one in a few months earlier.33 About that 
time Alan [Swanson] was doing this work and we retained the debris from 
cobalt–chrome and that was implanted into rats. The results were published in 
the Journal [Journal of Bone and Joint Surgery].34 The fact is that cobalt–chrome-
on-cobalt–chrome is a perfectly satisfactory material mechanically, if properly 
manufactured. We now know how to do that. But whether it’s going to be 
biologically satisfactory, is a completely open question, and since Alan’s work 
with myself and a man called John Heath, on the implantation consequences of 
the debris,35 there’s been a lot of work to do with cobalt and chromium in the 
area of DNA and fertility, which is quite unknown to orthopaedic surgeons. So 
we await that with some interest.
Lettin: That leads very nicely on to what we are going to ask Professor Alan 
Swanson to speak about, but before we do that, is there anyone who wishes to 
make any comments about these implants, before we move away really from 
this very historical part? 
Mr Kevin Hardinge: Just to mention that the cement was introduced by John 
Charnley to ﬁx the Thompson prosthesis,36 and he found that with his exposure 
it would reduce the movement of the stem by some 300-fold, so it was a parallel 
development.37 When the double-cup PTFE failed, he then abandoned the 
33 Paltrinieri and Trentani (1971); Trentani and Olmi (1974); Trentani and Vaccarino (1978).
34 Swanson et al. (1973).
35 Freeman et al. (1969a and b). 
36 Thompson (1952). See Appendix 3, page 102.
37 Mr John Older wrote: ‘I am concerned about the precise detail of Charnley’s use of cement both in the 
comments made by Hardinge and others. The history of acrylic cement began with its ﬁrst synthesis in 
1843, but it was not used in the human body until 1937, and then only as a denture base material. In 
the early 1950s Sven Kiaer of Copenhagen [Kiaer (1951)] and Edward Haboush of New York [Haboush 
(1953)] used self-curing methylmethacrylate in hip surgery. They used, as did Ken McKee in Norwich and 
Maurice Müller in Switzerland later, small amounts as a seating compound beneath the collar of the femoral 
prosthesis to allow it to settle over a perfect surface area. Very little cement was placed down the medullary 
canal. In the late 1950s, Charnley was looking for a substance he could use to support the cup and femoral 
prosthesis in bone. He went to see Dennis Smith, a lecturer in dental materials in charge of the material 
laboratory of the Turner Dental School, Manchester, who took some pink self-curing acrylic off the shelf 
and suggested he use it as a ﬁller. Charnley’s great contribution as a result of this visit was the formulation 
and elucidation of the principle of using large amounts of acrylic as a ﬁller or grout. Charnley’s observations 
led to his third monograph, Acrylic Cement in Orthopaedic Surgery, a classic on the subject.’ Note on draft 
transcript, 10 July 2006. See Older (1986); Charnley (1970). See also note 9 and Appendix 3, page 102, 
which shows the Thompson prosthesis secured by cement. 
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plastic on the femur and switched to using a Thompson prosthesis with a PTFE 
cup and then he found that they were wearing out. The low-friction principle 
came about through serendipity, when he tried to increase the amount of plastic 
in the cup to extend the wear and he eventually ended up using a 7/8 inch 
stainless steel bar, which became the 22.225mm low-friction head. So the low-
friction concept was found as a result of observation in trying to prolong the 
life of the implant.38 
The other thing I would like to say is that John Charnley mentioned to me 
that he had done 300 of these hip replacements using PTFE, and they were all 
starting to fail and it was a very uncomfortable time for him. If he had been 
a surgeon working in the US, his back would have been nailed to the wall. 
Anyway, what he found was that the patients were still turning up at the clinic, 
38 Professor Mike Wroblewski wrote: ‘Low-frictional torque was not a question of “serendipity”; it is a 
well known and accepted engineering principle. From the property of materials to low-frictional torque, 
the principle of the design was Charnley’s application of mechanical factors to hip replacement. All this 
is well documented [Charnley (1961, 1974)]. Serendipity is certainly not the word to use in this context. 
Charnley did use the term in a broader sense.’ Notes on draft transcript, 20 June and 24 October 2006. 
See note 27 and for an example of cup wear, see also Figure 5. 
Figure 18: ICLH resurfacing arthroplasty done bilaterally, c. 1980.  
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saying, ‘We know the operation only lasts for three years, but we are having 
such bad pain, can you not do something?’, because John Charnley’s indication 
for a hip replacement was the patient’s overall condition would be improved by 
a pseudoarthrosis, a Girdlestone operation.39 So when they had all the implant 
material taken out, these patients were still better off than they had been pre-
operatively. I think that should be recorded. 
Miss Betty Lee:40 It was a pleasure and a privilege to work for the late Mr G K 
(Ken) McKee. As a staff nurse and ward sister on the male orthopaedic block of 
the Norfolk and Norwich Hospital from 1950 to 1967, I observed Mr McKee’s 
pioneering work on total hip replacement surgery, which he had commenced 
prior to 1950. He had frequent meetings with a Mr Hunton who owned a 
small engineering ﬁrm in Norwich. Together, they designed prototypes that 
surgical-instrument makers could then provide in the new inert metals. At that 
time, Mr McKee had treated arthritic hips surgically with lag-screw arthrodeses, 
whereas his colleagues, the late Mr H A Brittain and Mr R C Howard, favoured 
the V-type arthrodesis. However, in the early 1950s Mr Howard had treated 
two male patients suffering from ankylosing spondylitis with cup arthroplasties; 
later both the patients had total hip replacements. 
Despite receiving little encouragement from the establishment, Mr McKee 
self-funded all his early research; ofﬁcial funding came only later. By the late 
1950s a number of total hip replacements had been carried out successfully. 
After removing the head of the femur, a curved stem prosthesis was inserted 
into the medullary cavity above the trochanters, the cup being ﬁxed into the 
acetabulum with a screw. Subsequently a new (metal) cup was used, with 
small projections on the outer side of the cup, which would ﬁx into the dental 
cement then used to line the acetabulum. Mr McKee was very particular about 
the positioning of patients and relied upon the late Frank Baker, then theatre 
orderly (and, later, technician) to do this. In fact, he was reluctant to operate if 
Frank was unavailable. In the 1960s, Mr John Watson-Farrar joined Mr McKee 
as his registrar, later becoming the fourth consultant. Together they devised 
the McKee–Farrar hip joint. As a committed Christian, Mr McKee saw the 
alleviation of pain and suffering in others as his mission in life. It was to this end 
that he was a pioneer in total hip replacement surgery.
39 See note 5.
40 A memoir, prepared by Miss Lee in July 2006, ‘Postwar development of the Orthopaedic Department 
of the Norfolk and Norwich Hospital’, will be deposited, along with the tapes and other records of the 
meeting, in Archives and Manuscripts, Wellcome Library, London.
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Freeman: This is a question to the group – is it true that there was a BOA meeting 
in Manchester or somewhere thereabouts, at a time when John [Charnley] was 
doing arthrodesis, and, so this story goes, Ken McKee came with some of his 
patients,41 John [Charnley] saw the patients, and said, ‘That’s the way forward’; 
thus started replacement instead of arthrodesis. Is that true or is that rubbish?
Hardinge: The BOA meeting was in Manchester in 1960. I think the truth is 
that John Charnley was showing his cement ﬁxation of the stem of a Thompson 
prosthesis in a fracture of the femur and that was the ﬁrst time that Ken McKee 
had seen the use of cement in Manchester in 1960.42
Lettin: I can certainly remember Ken McKee showing his patients at the BOA 
meeting in Norwich when, in those days, we had a clinical meeting on Friday 
afternoon. He produced these elderly ladies with their dresses tucked in their 
knickers, and I think that was the last time there was ever a clinical meeting at 
the BOA. That was about 1963 or 1964.43 
Kirkup: May I make a point about cement? We have forgotten Edward Haboush. 
I am talking about cement and total hips; in 1951, 1952, 1953, Haboush was 
using cement, methylmethacrylate. But, of course, he was applying it as a collar 
around the bone to support the prosthesis and this failed. The other point 
raised was ‘who was doing total hips ﬁrst?’ I think McKee and Haboush are 
the signiﬁcant pioneers, in the sense that they were using metal-to-metal and 
Haboush tried to use cement.44
41 See McKee (1958).
42 See Proceedings, BOA Spring Meeting, Manchester, 13–15 April 1961 [Journal of Bone and Joint Surgery 
(B) 43: 601; freely available online at www.jbjs.org.uk/archive/ (visited 8 November 2006)], where Charnley 
discussed his new form of low-friction hip arthroplasty and McKee reported that the failures of his similar 
operation involved loosening, but the use of cement was ‘a great advance’. A clinical meeting was also held 
at the Manchester Royal Inﬁrmary, with a clinical demonstration at Wrightington. 
43 Professor Mike Wroblewski wrote: ‘The last clinical meeting of the BOA, unless there were later ones, 
took place 15–17 September 1982, the Manchester meeting. One session was in Wrightington Hospital 
with a presentation of a group of patients with the longest follow-up. Charnley died in August 1982. 
I presented the patients in September while Tristram Charnley did the ﬁlming. The record is available 
[Waugh (1990): 229–30].’ Note on draft transcript, 20 June 2006. See also Proceedings and Reports, 
Journal of Bone and Joint Surgery (B) (1982) 65: 213 [freely available online at www.jbjs.org.uk/archive/], 
on the Autumn Meeting of the BOA at Manchester, with a memorial service for Sir John Charnley on 15 
September 1982.
44 Haboush (1953).
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Craven: It went in the acetabulum. John Charnley used the cement and there 
was a hue and cry about it, people didn’t want it. What is he using cement for? 
People didn’t want this, and as Kevin [Hardinge] said the ﬁrst time it was used 
at Wrightington, it was the [uncemented] Austin Moore prosthesis.45 This chap 
came in, an 18-stone man, who had been to several consultants, they didn’t 
know what was wrong with him, and I was in theatre with John Charnley when 
they did the operation. I don’t know whether John Read was there or not, but 
when they opened him up the prosthesis was wagging about in the medullary 
canal, and that was the ﬁrst time that John used the cement at Wrightington. 
And then when McKee started with his hip, where I say they were spiked, 
McKee got the cement through Charnley, and started cementing his sockets.
Lettin: I think we must move on, because we have touched on the materials and 
how the initial materials were not very good; we have talked about conﬁguration; 
and Michael Freeman has also mentioned the biological side of it. I think it’s 
time we brought in the engineers. Professor Alan Swanson, I would like you to 
talk about how the engineers became involved in this, and the importance of 
the materials, and the design and so on.
Professor Alan Swanson: I have been trying to think back 50 years, as no doubt 
other people have. Fifty years ago, I was employed, at a very junior level, in the 
making of aeroplanes in a laboratory in Bristol that dealt with materials, and one 
of the jobs I had was to write up the results of a long, continuing programme on 
the corrosion of so-called stainless steel. I can assure you that when you expose 
it to saltwater and air, it goes a lovely red colour. 
The fact is, of course, that what is colloquially known as stainless steel is always 
corrosion-resisting steel on the speciﬁcations, not quite the same thing. However, 
back 50 or more years ago, what I shall nevertheless call stainless steel – iron 
with carbon and lots of chromium and nickel – had been around since 1913, 
and was well known for its corrosion-resisting properties: good for chemical 
apparatus, food handling apparatus and all that, and of course, implants, if only 
for fracture ﬁxation. It was known to be very tricky stuff indeed if you tried to 
weld it, which was not normally a consideration. If, like Charnley, you had a 
solid head on the femoral prosthesis, you didn’t think about making a hollow 
45 The Austin Moore metal hip prosthesis was introduced in 1940 as the ﬁrst Vitallium prosthesis to replace 
the upper portion of the femur [Moore (1957)]. The most commonly used treatment of a displaced femoral 
neck fracture has been the uncemented hemi-arthroplasty and the cemented Thompson, although not 
entirely satisfactory. See Scales (1983); Weinrauch et al. (2006).
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head and welding two bits together. It was also a bit dodgy in contact with itself. 
In general engineering, there was a prohibition on the use of stainless steel nuts 
against stainless steel bolts, for example. And therefore stainless steel for both 
components of a hip prosthesis is not, I think, something that any engineer 
would have recommended. 
There were also cobalt–chromium-based alloys, which had been around in 
dentistry since the 1930s, and there had been some cross-fertilization or lateral 
thinking between orthopaedic surgeons and dentists, which had made people 
realize that they are on the whole at least as corrosion-resistant as the steel, 
perhaps more so, and somebody discovered, I know not who or where or when, 
that you could put cobalt–chromium alloys against themselves as a bearing pair 
without a disaster.46 Titanium was more or less exotic. Going back to my days 
of making aeroplanes, I remember we were doing tests on titanium alloys for 
high-speed aeroplanes and it was fabulously expensive, fabulously difﬁcult to do 
anything with, and therefore only of use in military applications, where in those 
days money was no object. That has changed, of course, and titanium alloys are 
now very respectable, although not good in general, as bearing materials. 
If we turn to plastics, back in the late 1940s and early 1950s, there was nothing 
like the range of plastics we have now, and nothing like the understanding. 
Hence, polyethylene was polyethylene, and only later did the high-density and 
the high-molecular weight characteristics begin to be distinguished, and only 
later did we move on to UHMWPE with its extra wear resistance. PTFE was 
known then as a slippery plastic and one can understand why Charnley, or 
anybody else, might have thought it attractive as a bearing material against steel, 
although as we all know there were difﬁculties, and polyethylene, if the right 
kind, turned out to be better. 
If we turn to ceramics, which I know were not in use then, but had been actually 
thought about and tried earlier, I think, for some interposition cups, way back, 
the point about ceramics is that you can make a much ﬁner surface ﬁnish than 
with metals, which ought to lead to lower wear. Another good thing in their 
favour, if you are thinking of a bearing, is that unlike corrosion-resistant steels, 
which depend for their corrosion resistance on an oxide ﬁlm that is likely to be 
rubbed off in a bearing and has to be continuously reformed (there are other 
troubles, as people here know, about the heads of screws in ﬁxation plates), 
ceramics are the same stuff throughout, and so you don’t have to worry about 
46 Conﬁrmation from clinical experience is provided by Howie et al. (2005); Fisher et al. (2004).
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the wear rate dramatically increasing because you rubbed off the protective 
surface ﬁlm. They are also more wettable in general, by aqueous solutions, than 
metals, and, therefore, that commends them also as bearing materials. But of 
course, they are brittle, less so now than they used to be, because, as with the 
alloys and the polymers, over 50 years people have learned a great deal about 
how to make and process them. But they are still rather more brittle than most 
metals that would be used, and I therefore do have doubts about ceramic heads 
being put on a conical stub on a metallic femoral stem. 
Lettin: We have another very eminent engineer here. Duncan Dowson, would 
you like to say something about the design? There are lots of variations of the 
shape of the stem and so on, and we perhaps should have mentioned, I suppose, 
Robin Ling’s contribution. Unfortunately, Robin is unwell and couldn’t be here, 
but we might mention it. It seems that there were lots of different designs of 
stem, but did it really matter?
Professor Duncan Dowson: It was interesting to hear Alan Swanson speak, 
because, like him, I was working in the aircraft industry before returning to 
the academic world. I had started some research on the wear characteristics of 
certain polymers, including polyethylene, for the defence industry, particularly 
for military aircraft. The industry required a bearing material that would operate 
in very strange environments, and particularly not be affected by the presence 
of water and high humidity.47 I was doing that work early in the 1960s when I 
ﬁrst met John Charnley. After his trauma with PTFE,48 Charnley was seeking 
an alternative polymer and we have heard the fascinating story about how the 
ultra-high molecular weight polyethylene came to his attention. He must have 
heard, and I know not how, of the research contract that we had at that time 
with the Ministry of Defence, as he came over to Leeds to see some of the 
experimental work that we were doing. This was after he had started to use 
polyethylene, and he became fascinated with our tribological studies. One of 
my lasting impressions of John Charnley is that he was a jolly good engineer.49 
He wanted to understand the engineering and the physical principles by which 
these different combinations of material and different bearing conﬁgurations 
would work. Since that ﬁrst contact, we had very frequent and stimulating 
exchange visits, myself to Wrightington and John to Leeds. 
47 Erli et al. (2003).
48 Charnley (1966a).
49 See, for example, Charnley (1965).
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It is interesting that the word serendipity has been used about him selecting 
the 7/8 inch (22.225mm) diameter femoral head. When in subsequent years, I 
invited a colleague of mine, Michael Longﬁeld, to do a mathematical analysis of 
this, he and John Charnley worked together and it was relatively easy to show 
that the optimum head diameter should be 50 per cent of that of the outside 
diameter of the cup, for maximum wear life, and that comes out, of course, at 
about 25–27mm.50 Charnley’s 22mm was ﬁne, so whether we deﬁne that as 
serendipity or not, I don’t know, but it was very close to the optimum diameter 
as far as wear life was concerned.
But wasn’t that a question of manufacturing? [From the ﬂoor: Yes.] I think the 
diameter was convenient for standard material, but Charnley clearly presented 
his selection in terms of two sound biomechanics principles. He was rightly 
obsessed at the time with reducing the frictional torque and this can be achieved 
by (a) selecting acceptable materials with the lowest coefﬁcient of friction and 
(b) by minimizing the torque arm or head diameter. McKee, I think, was a bit 
more interested at that time in the wear story, rather than the friction story, 
but John Charnley wanted to minimize friction, and minimize the frictional 
torque. 
There are two ways that you can do that. One is to minimize the coefﬁcient of 
friction between the sliding components, and PTFE was the polymer with the 
lowest known coefﬁcient of friction, so he naturally used PTFE initially. But, 
secondly, in order to minimize the frictional torque, you need to use the smallest 
acceptable diameter, and he adopted 7/8 inch or 22.225mm. His biomechanics 
was jolly good. That was how I ﬁrst came into contact with him, and since that 
time we have seen the story unfold and, as Alan Swanson mentioned, different 
and much improved materials, both for femoral heads and acetabular cups, 
have subsequently been introduced. 
The ceramic story has also been fascinating. It is interesting that at the present 
time, the current range of toughened ceramics is extremely good. They are good 
as bearing materials, but also exhibit very little fracture potential. The metals 
are greatly improved and the manufacturing procedures are also improved. In 
the past we have talked very much about the alternative material combinations, 
such as metal-on-polymer, or indeed of metal-on-metal. Now there is a whole 
galaxy of possibilities, metal-on-metal, ceramic-on-ceramic, metal-on-ceramic, 
50 Charnley et al. (1969). Later work on wear includes Geller et al. (2006).
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metal-on-polymers, ceramic-on-polymers and many of these are being very 
actively developed at the present time.51 It would be interesting to meet again in 
another 50 years to see which comes through as being the best combination. 
Lettin: We have talked a bit about wear and I think we rather neglected John 
Scales and the Stanmore THR. I think my recollections of the original Stanmore 
was that there was a cup that was ﬁxed to the acetabulum with nails – we had a 
gun which ﬁred these nails – and then another cup which actually slotted into 
that. I think from the wear point of view he [Scales] was very much involved. 
There was an engineer, Ian Duff-Barclay, who was seconded from British 
Petroleum and he designed, I think, the ﬁrst total hip simulator. Charnley sent 
his prosthesis down to Stanmore to be tested. There was a whole row of these 
things working day and night, all around the room, chugging away, lubricated 
with bovine serum, to determine the wear properties of the joint components. 
We ought to mention the custom-made prostheses and, I think, John Scales 
[Figure 19] was probably the ﬁrst to develop custom-made prostheses, 
particularly with regard to the treatment of tumours. Of course, Ginger Wilson 
was very much involved with the treatment of tumours, as I was with the knee 
rather than the hip, but I think that his contribution to custom-made prostheses 
should be recorded.52 Now it is very easy to do. I don’t think Ron Ansell is here, 
is he? [No.]53
Sweetnam: May I just say that you are absolutely right. I think that John Scales 
was the prime mover in this particular ﬁeld, but we shouldn’t forget that he did 
it in collaboration with Harold Jackson Burrows, the Bart’s Consultant. I think 
the major step between Wiles’ original concept of a total joint replacement 
and subsequent success was entirely due to two things: cement and new 
materials such as cobalt–chrome alloy and high-density polyethylene. It was the 
development of cement that later allowed the stem of the femoral component 
to be ﬁxed within the medullary cavity of the femur. Wiles used stainless steel, 
which we have heard from Professor Swanson was doomed to failure; Wiles 
used no cement, usually bolting his prosthesis on the femur, which was doomed 
to failure. So I think it is those two factors – the new materials and the ﬁxation 
51 Dowson (2001).
52 Wilson (1953, 1971); Burrows et al. (1975); Bradish et al. (1987); Roberts et al. (1991).
53 Mr Ron Ansell was unable to attend the meeting. He had been involved with the early development 
of the Stanmore artiﬁcial joint and was in charge of the design ofﬁce at the Department of Biomedical 
Engineering, RNOH, Stanmore.
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by cement – that changed the whole spectrum of total joint replacement after 
Wiles’ brilliant and original concept failed, because the suitable materials had 
not emerged in his day.54
Lettin: John Scales, of course, originally bolted in the prostheses and, I think, 
one of them replacing the distal femur and knee joint lasted for 18 years. 
Mr Ian Stephen: I will speak on behalf of Robin Ling, who sends his apologies 
because he is unwell. I speak as a disciple of the originator, because I arrived in 
Exeter in 1976, about six years after the ﬁrst Exeter prosthesis was implanted.55 
I think Robin’s great contributions were: ﬁrstly, the stem geometry with the 
development of the double-tapered straight stem, and, secondly, the improved 
cementing technique that resulted in greatly improved ﬁxation, as Rodney has 
been saying. 
54 Scales et al. (1965).
55 The original Exeter Hip (EN58J) was available for use in clinical practice from autumn 1970. See Figure 
20 and Appendix 3, page 105.
Figure 19: Professor John Scales, c. 1985. 
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It is my recollection that we, as registrars, were encouraged to be meticulous 
about our cementing technique during the operation. The development of 
the straight stem double taper combined with improved cementing technique 
turned out, by serendipity, to have many advantages that were not envisaged at 
the time the Exeter hip was designed.
Lettin: Are there any more comments anyone would like to make on this? 
Malcolm Swann, did children present particular problems which required 
attention? I expect you had most experience dealing with children with juvenile 
rheumatoid arthritis.56
Mr Malcolm Swann: We were certainly very much in touch with Stanmore 
about children with juvenile chronic arthritis. I was persuaded by the late 
Barbara Ansell, who many of you will remember was a rheumatologist at the 
56 Ansell and Swann (1983).
Figure 20: The Exeter stem, c. 1969.
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MRC Centre for Rheumatic Diseases, Taplow, Maidenhead, who thought we 
should be able to help these children with their hip problems.57 We are talking 
about children of 11 to 12 years of age and over, but they were all conﬁned to 
wheelchairs with destroyed hips, and they could no longer manage the pain. We 
felt something should be done. 
So we were faced with this problem of largely custom-made prostheses for them, 
because they had small skeletons. Children with juvenile arthritis are not just 
small, but they are smaller than small, they are minute. Graham Deane saw 
these as well. They have all sorts of problems, bone problems, hypervascularity, 
anatomical deviations, a lot of anteversion, so we did have to call on help from 
the custom-made prosthesis people. We did get a lot of help, particularly from 
Stanmore and John Scales. Of course, measuring at that time was very difﬁcult, 
there was none of the technology of today, you merely had to take an X-ray 
with the artiﬁcial hip prosthesis held alongside the patient, judge that the 
magniﬁcation was roughly the same, and then send off the X-ray to Stanmore. 
Often we were held on tenterhooks, because there were a lot of telephone calls 
as to when it was going to be ready, and I can recall it was pretty well when the 
patient was on the table, a motorcyclist would arrive from Stanmore with the 
prosthesis in his pocket and you hoped that it would ﬁt. Fortunately, mostly it 
did. I won’t go into details of the numbers and so on.
Lettin: You mentioned manufacturers. Of course, the manufacturers were very 
important, and Phyllis Hampson is here. Well, Phyllis, I am not quite sure 
what your role with the manufacturers exactly was, with Zimmer Orthopaedic 
and, of course, as an intermediary with Stanmore. But I think we should also 
mention that John Charnley, of course, had an arrangement with Thackray’s 
whereby they would not supply a Charnley replacement unless the surgeon had 
actually spent three days at Wrightington, in the tent, and learned how to do 
the operation. I in my time did exactly that, but I don’t know how long that 
lasted, how long Thackray’s kept that going.58 Michael Wroblewski, you have 
got a comment on that?
Professor Michael Wroblewski: It was the second half of 1970. Sir John Charnley 
informed past Residents of the Centre for Hip Surgery at Wrightington Hospital 
57 Arden et al. (1970).
58 Charles F Thackray Ltd of Leeds manufactured the Charnley prosthesis from 1963 until 1990 when 
Thackray’s was acquired by DePuy, now a Johnson & Johnson subsidiary. See Foreman-Peck (1995): 109–
10, 114. See also note 129 and Glossary, page 151–2.
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by letter, saying that hip components generally were being made available under 
pressure from the manufacturers.59 
Lettin: There you are, pressure from manufacturers. Phyllis, what about that? 
How much inﬂuence really did you have, or did the manufacturers have? You 
held the surgeons to ransom, I think?
Mrs Phyllis Hampson: No, I don’t think that’s true at all. I don’t think we held 
the surgeons to ransom. We [Zimmer Orthopaedic] weren’t really connected 
59 Professor Mike Wroblewski wrote: ‘It was 1970: the facts are that the Charnley prosthesis was not 
patented. Charnley took no royalties: £1 sterling from the sale of each hip prosthesis was put into research. 
Charnley insisted on keeping the cost low, because “The NHS has to pay for it”. The stem cost £18 and 
the cup £7. Other manufacturers were producing and copying the Charnley prosthesis. The manufacturer, 
Thackray, was constrained both by price and sales, hence the pressure from the manufacturer to make the 
Charnley prosthesis freely available.’ Note on draft transcript, 20 June 2006. A history of Smith & Nephew 
suggests that the socket was sold for £3 and the femoral prosthesis for £12 in 1968, with Thackray paying 
£1 to the Wrightington research fund for every prosthesis sold. Thackray had sole manufacturing rights, 
while Wrightington retained control over quality. Foreman-Peck (1995): 109.
Figure 21: Still’s disease – juvenile chronic arthritis – in plump male twins. The boy on  
the left has Still’s, which shows in his posture. 
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with any total joints until about 1970, when John Scales phoned us out of the 
blue one day, asking if we would be willing to make Stanmore total joints. My 
managing director at that time was Douglas Davidson, who would not, under 
any circumstances, make a total joint. But, luckily, just after that he went to 
Canada and the decision became mine. I decided that we were going into total 
joints with the Stanmore range. We started off having them made by Deloro 
Stellite, and then we set up our own company, Metallo Medical, in Swindon 
in 1970. 
I don’t think we held the surgeons to ransom, it was really John Scales who 
was holding us to ransom, because we had to promise not to make any other 
prostheses, apart from the Stanmore range, for at least two years, which we 
did and we kept to that. It went very well, and we started by manufacturing 
the metal-on-metal type [see Figure 17 on page 21]. I think we were the ﬁrst 
company to make vacuum-cast implants, which meant that they were cleaner, 
hopefully, than making them air cast and the ﬁrst one was inserted in 1963 by 
Ginger Wilson.60 I believe the majority of metal-to-metal are still going very 
strongly. Prior to our own manufacture, the joints were made by Deloro Stellite 
and, I believe, Jackson Burrows was the ﬁrst to insert one of these in 1956.61
Lettin: What about the British Standards for implants? Vic Wheble is here. Do 
you think that British Standards played an important part in this? How soon 
did they really come into having a standard?
Mr Victor Wheble: British Standards for clinical materials themselves started 
out as a technical committee in 1967 and this was chaired in the ﬁrst place by 
Geoffrey Blundell Jones.62 But by 1972 there was considerable interest from the 
Government, the Department of Health (DoH) and the corresponding Scottish 
organizations. So an international committee was set up and met in London 
at the British Standards Institution (BSI) headquarters. This was a special 
meeting called by Bernard Bloch of Australia, who suggested that perhaps this 
should be focused on international standards problems, and in fact there was no 
other committee existing at the time.63 Bernard Bloch persuaded people from 
60 See note 29.
61 Burrows (1966).
62 For a detailed timeline of the British Standards Institution, see www.bsi-global.com/News/History/index.
xalter (visited 12 July 2006). See also Appendix 2, pages 97–100, and Scales (1965).
63 Bloch (1958). 
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various countries to come, and the ﬁrst meeting took place in London, 27–28 
March 1972.64 This had representation from various other organizations such 
as the International Federation of Surgical Colleges and also from the various 
governments, of course, because they were interested in the fact that they were 
starting to supply prostheses for use in their hospitals. It went on from there. I 
only got into standards-making a little bit after that, because John Scales rang 
to ask me if I would join the committee, and I was on it from 1972 until 2004. 
I have actually had a lot of experience of all these committees.65 
Now as far as distribution is concerned, I am only going to talk about John Scales’ 
committee – he was chairman of the hip replacement committee – and he had 
many difﬁculties with the different people from all over the world, in arguing 
what could and couldn’t be done. At meeting after meeting, these arguments 
occurred and eventually it got to the point where he threatened to resign. At 
that point, they decided that they had better just keep him, because he knew 
more about the whole subject than they did. Unfortunately, he was not able to 
be present at the 25th anniversary meeting of the ISO Technical Committee in 
Singapore in 1997, when he would have been awarded the special gold award 
from this committee, because of his 25 years of service.66
Lettin: I think you deserve a medal for staying on it for so long. It was the worst 
committee that I have ever been on, and I’ve been on a good many. I think you 
were representing the BOA and I was representing the College of Surgeons. 
Phyllis, you may remember – this is very pertinent to the Charnley cup. We 
spent a whole afternoon arguing the difference between a bevel and a chamfer. 
And I don’t know what the answer was. John Paul – who was due to be here, but 
has had his knees replaced and couldn’t walk all the way from Glasgow – tried 
to explain. It was a terrible meeting. ‘Was the edge of the cup bevelled or was it 
chamfered’? This went on and on. Another question I can remember was: ‘How 
far should the eye be from the end of a Küntscher nail’? I admire you, Vic, for 
staying on it for so many years. 
64 Bloch and Hastings (1972).
65 See Appendix 2, pages 97–100. 
66 Mr Victor Wheble wrote: ‘John Scales was a founder member of the ISO/TC150. I understand from 
Phyllis Hampson that John did receive his 25th anniversary award privately, later in 1997.’ Note on draft 
transcript, 12 October 2006.
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Wheble: May I just comment on the nail? That was a small group of rather 
old professors from France, backed up by other members from Germany, who 
could not agree that the hole at the end of a Küntscher nail had to be a certain 
size, not a whole series of sizes. Each country wanted its own particular size of 
hole in the nail, so that its own hook would ﬁt. The argument continued until 
I managed to persuade them, after two hours sitting on a staircase in heated 
discussion with these eight people, that only one hole was needed, so if the 
largest hook would ﬁt, so would the smallest!
Lettin: This BSI committee doesn’t exist any more, does it?
Wheble: It does, it is still an active part of the BSI. 
Lettin: What about the Medical Devices Agency? Didn’t that take over from the 
BSI? [From the ﬂoor: No, it is not the same.] Oh, Keith, I didn’t see you arrive, 
I am sorry about that. Would you like to say something about the Medical 
Devices Agency?
Mr Keith Tucker: The Medical Devices Agency (MDA) does not exist any 
more as it has been amalgamated into the Medicines and Healthcare Products 
Regulatory Agency (MHRA). You asked me to talk a little about regulations. 
My introduction to orthopaedics was with Ken McKee and John Watson-Farrar 
in the late 1960s and so I learned about the things that you have been talking 
about today: ringing, polar bearing and so forth. I met Alan Chappell, a facio-
maxillary surgeon in Norwich, who recommended putting the studs on the 
back of a McKee–Farrar cup. I remember those times very well and they were 
very informative years for me, given what I have been doing since then. 
The prostheses in those days were matched, the socket and the stem came as a 
pair. This sometimes proved to be a problem during a revision. They [McKee 
and Watson-Farrar] were great people to work for and their prostheses did 
splendidly well. They were amazingly enthusiastic people, who commanded 
great admiration and sometimes bewilderment. Ken McKee’s prayer session, 
at the beginning of each ward round, often in the middle of a large ward, was 
sometimes a daunting prospect to me as a young Senior House Ofﬁcer. I took 
over McKee’s ﬁrm as a Consultant in 1978 and it was in the 1980s when you 
[Lettin] seconded me from the Council of the BOA to the MDA. The MDA 
(now the MHRA) has developed considerably and perhaps you saw me as 
something of a poacher turned gamekeeper. 
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It was just before that time that a European Directive had come along (1994), 
which directed that all hip replacements would have to have a CE mark. As 
you know, CE markings are graded and hip replacements were type 3B.67 
Susanne Ludgate headed the MDA, ably assisted by Andy Crosbie and John 
Hopper. By 1998, all knee and hip replacements had to have the CE mark to 
conform with the European Directives. One thing that we immediately realized 
was that manufacturers could get a CE mark a year after the introduction 
of a new joint. Thus, provided the joints survived a year, they got their CE 
mark, and that, ladies and gentlemen, was how it was in 1998. There was no 
post-market surveillance and we were told that if we wanted to get into post-
market surveillance we should have to turn over a European Directive from the 
European Commission, which sounded quite a formidable thing to do, even for 
orthopaedic surgeons. Realistically we got no further and, in fact, not as far as 
John Charnley. It is on record that John Charnley wanted to have some sort of 
joint registry right at the very beginning,68 and it was, of course, at Charnley’s 
instigation that surgeons could not acquire the tools to put in Charnley hip 
replacements without going to Wrightington to learn how.69 It is also interesting 
to me that Ken McKee and John Watson-Farrar, although they started doing 
‘large volume’ hip replacements in 1961, did not publish until they had ﬁve-
year’s data.70 In their words, ‘to see how they went’. Nowadays it is possible to 
put things in to the market more quickly.
67 The letters CE are the abbreviation of the French phrase Conformité Européene or European Conformity. 
For details, see note 142.
68 Sir John Charnley wrote in 1972: ‘Serious consideration should be given to establishing a central 
registry to keep a ﬁnger on the pulse of total implant surgery on a nation-wide basis. Surgeons should 
not be permitted to perform total hip implant work (especially those involving the use of cement) unless 
prepared to have weekly returns made of the operations as they are performed, and thereafter to have 
patients questioned annually by circular from the registry’. Wrightington Hospial, Internal Publication no. 
39, 1972 [see www.bitecic.com/events/Porter%20-%20What%20do%20Clinical%20Outcomes%20tell 
%20us.pdf (visited 9 November 2006)]. Jones (2000).The National Joint Registry for England and Wales 
was established in 2003 replacing the Trent and North West regional registers, and its ﬁrst annual report, 
dated September 2004, is freely available from www.njrcentre.org.uk/documents/reports/part1.pdf (visited 
17 July 2006).
69 Professor Mike Wroblewski wrote: ‘The Charnley hip replacement instruments were always freely available 
[to surgeons who had trained with Charnley]. To quote Sir John Charnley: “They could be used for other 
operations as well as hip replacement”. This hip prosthesis was not available until the second half of 1970.’ 
Note on draft transcript, 20 June 2006. See Figure 22.
70 McKee and Watson-Farrar (1966).
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Lettin: Was that about the time of that BOA meeting in Norwich? Mike Freeman 
was asking me what year that was.71
Tucker: The BOA meeting in Norwich was in 1981, but the meeting you are 
referring to was actually at the Royal Society of Medicine in the 1960s.72
Lettin: I think we have covered quite a lot of ground. You were talking about 
registers and regulations and I think, Rodney and Mike, you were both quite 
keen on that, way back. I seem to remember that was another committee that I 
was on, but it came to nothing.
Sweetnam: You are absolutely right, it came to nothing. On your seats is a copy 
of a paper, the only paper that I have ever written that I think was of any value, 
and it concerns a scheme which our committee proposed. [Lettin: Was that 
a BOA committee?] No, it was a DoH committee called the Advisory Group 
on Orthopaedic Implants, and the report of that group is on your chair, dated 
May 1981.73 I was chairman, Michael Freeman was a member, and after a lot of 
71 See note 43.
72 McKee (1958). See also note 42.
73 Sweetnam (1981). This report suggested a ‘recommended list’ of artiﬁcial joints considered by the 
Advisory Group to demonstrate adequate quality control during manufacture, the use of suitable materials, 
and of acceptable design. It was also mentioned in the recent review by Faulkner et al. (1998): 59–61, 
which noted the generally poor methodological quality of the 233 studies considered and that the results 
for different types of prostheses should be treated as estimates, although there were good results at ten years 
(given relatively poor evidence) for the Exeter, Lubinus IP, Charnley, Howse and Stanmore.
Figure 22: A Charnley acetabular reamer. 
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discussion, we came up with a scheme which would, I like to think, have spared 
us a lot of the disasters that have occurred in faulty joint replacements inserted 
thereafter. I repeat the date, 1981, a scheme put forward by our committee, 
accepted by the BOA, accepted by the DoH, indeed all the professional bodies 
accepted it. If it had gone into place, there would have been a surveillance 
scheme with a recommended list of prostheses, each prosthesis, each new design, 
would have been monitored. I repeat the date – 1981.74 Accepted by the DoH 
and the whole profession, it never got off the ground.75 My belief, and here I 
am going to come into conﬂict with another member in the audience, is that it 
never got off the ground because of the implant ‘industry’. Now, Phyllis will tell 
me whether that is right or not, but I am told that someone in a senior position 
in the industry at that time, managed to persuade the DoH not to progress 
this scheme. And I would commend this paper to you, which was quite largely 
dependent on the work of Michael Freeman, I have to say. 
Lettin: I thought he was the very important chap. Phyllis, are you going to 
respond to that barb?
Hampson: I really don’t think it has anything to do with the trade at all, Sir 
Rodney. I think we had many problems. Let’s be fair, Mr Ronald Furlong was 
never on any committee, not BSI, no BOA meetings, none of them.76 I really 
don’t think it was the trade who stopped the scheme.
74 Professor Mike Wroblewski wrote: ‘Charnley kept detailed records on punch cards. With the introduction 
of computers I had the information transferred to a very detailed database, which is updated after every visit 
and operation. This has formed the basis of the John Charnley Research Institute, a registered charity, with 
close to 30 000 records from November 1962 onwards.’ Note on draft transcript, 20 June 2006. 
75 Mr Mike Heywood-Waddington wrote: ‘I fully agree with Sir Rodney Sweetnam that it was a disaster, in 
terms of proper surveillance (see also page 39). The only local contribution I made was to ensure a regular 
follow-up of our own hip replacements (Charnley prosthesis through posterior approach), and ran a special 
hip clinic to achieve this, using the same methods of hip scoring and analysis as that used at Wrightington, 
for ﬁve years on an annual basis and then at ﬁve-year intervals. These results formed the basis of a successful 
thesis submitted for the MSc in Orthopaedics at the University of London by Mr S G Atrah FRCA in 1987, 
and were also the subject of a paper given by Mr John Dowell at the BOSG in 2003. A nation-wide register 
would, of course, have been far preferable.’ Note on draft transcript, 11 October 2006.
76 Sir Rodney Sweetnam wrote: ‘Ronald Furlong was head of a very successful hip implant manufacturing 
company.’ Note on draft transcript, 26 June 2006. Furlong’s Joint Replacement Instrumentation (later JRI 
Ltd) became the sole licencee importing Müller components from 1971, later casting the components in 
titanium alloy in the UK at their Shefﬁeld site. See details at www.jri-ltd.co.uk/ (visited 27 June 2006).
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Freeman: It was a good scheme, everybody apparently agreed, but it did not 
appear. Historically, I would be very interested to know why not.77
Lettin: But wasn’t it a question that it was limiting the implants that you and 
Rodney would have allowed? I seem to remember that the Stanmore knee would 
have been banned.78 I think there was a perception that it would have been very 
restrictive.
Sweetnam: I am sorry, but it had the overwhelming support of the whole 
profession, including the BOA and there was no justiﬁcation for not going ahead 
with it. The DoH agreed it, they asked me to write this paper, in a publication 
called Health Trends, which I did, quoting the DoH’s acceptance. It did not get 
off the ground, and my understanding was that it was due to powerful voices 
within – I don’t know whether they were members of the committee or not 
– the Surgical Trades Association. 
Freeman: I think Rodney and I are both speculating that this was a scheme to 
which you could hardly object in public, so all the bodies said, ‘Oh, well done’, 
and then went out to the loo and said, ‘Christ! As individuals we are not going 
to make any money if this comes off, so we must stop it.’ But that is my guess 
[From the ﬂoor: Yes, I was in the loo at the time.].
Wroblewski: Mr Peter Frank, Consultant Orthopaedic Surgeon from 
Manchester, and I were approached by the DoH and we had several meetings 
on the subject. The object of the exercise was to have a Register, now incorrectly 
called a Registry, to put on record, ﬁrst, all total hips, as well as hemi-arthroplasties. 
The project was obviously impossible for the two of us to do. I suggested that 
we could probably set up one locally, as a pilot scheme, to see whether this was 
going to be a working proposition. I suggested that to set it up from scratch 
would cost £250 000. That was the last time I heard from the DoH.79
77 Sweetnam (1981). Sir Rodney Sweetnam wrote: ‘The outcome was that there was no further action 
whatsoever, except that the DoH did introduce certain controls of materials and manufacture, which they 
called their Gold Standards, but never any clinical data or follow-up surveillance whatsoever. The DoH were 
simply too weak to grasp the nettle of “surveillance” and the only explanation I have for this is that they were 
not prepared to stand up to the “industry”. All the medical professional bodies supported the scheme, but 
only the DoH had the power to introduce it.’ Note on draft transcript, 7 October 2006.
78 Mrs Phyllis Hampson wrote: ‘I was never advised that the Stanmore knee should be banned. For what 
reason?’ Note on draft transcript, 9 October 2006.
79 Professor Mike Wroblewski wrote: ‘My handwritten notes of the meeting are dated 7 July 1987’. Note on 
draft transcript, 24 October 2006. 
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Lettin: I think it has proved a very interesting discussion, which perhaps came 
a bit after the historical part, but nevertheless I think it is important that it has 
been reported. Kevin, you want to say a bit more?
Hardinge: For the historical record, when Stanmore started making their hip 
replacement, they did approach John Charnley to see if they would be able to 
market the Stanmore–Charnley; John Charnley wasn’t too keen on this and he 
suggested that they should market the Stanley–Charnmore!
Wheble: There was an attempt at one time to do exactly that internationally, to 
get a standard where you could control some of these things, but it never came 
to anything at all. Of course, none of the companies was interested.
Lettin: It was difﬁcult enough getting the standards through for the metal, 
wasn’t it? Another thing that I can remember in that BSI committee was 
that the Swiss materials were very much worse than the British materials, the 
Americans somewhere in between, and we couldn’t agree a standard. I think the 
Swiss were still using old railway lines. They had bought up the Burma railway 
and were manufacturing the prostheses out of old railway lines. We couldn’t 
get an agreement: never mind an agreement on the design of prostheses, we 
couldn’t get one on the materials that they were made from. It was a very boring 
committee. I think we have talked about regulation and it doesn’t seem as 
though the manufacturers really hampered the orthopaedic surgeons, if Phyllis 
is to be believed. They didn’t say, ‘You can’t make it like this’; they ﬁtted in with 
whatever designs the surgeons produced. 
Hampson: Sometimes one had a note on the back of an envelope, or a cigarette 
box, saying: ‘Can you make this?’ You had to go along with the surgeon up 
to a point, but usually some modiﬁcation had to be made, with the surgeon’s 
approval.
Lettin: Are there any other points on the design or the materials? Michael 
[Freeman] mentioned the terrible fright that happened when he put all this 
wear material into rats and every lump that appeared in a patient that had had 
a hip replacement was thought to be a tumour [see page 22]. But, Michael, 
is there any more you would like to say on that? Or Alan [Swanson], for 
that matter.
Freeman: I am sure everybody knows. Alan [Swanson] knew, because he wrote 
it in a book that we edited, and I have just whispered to ask him if he would 
care to repeat what he said in the book, and he says he can’t remember writing 
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it.80 So I have to ask the audience. The point is if you gamma-irradiate in air, 
you cross-link the chains, which may be good mechanically, but in oxygen you 
also split the chains so that, strictly, the material is no longer UHMWPE. For 
a long period we gamma-irradiated in air, at a time when the atomic industry 
knew perfectly well what would happen, in principle, if you irradiated polymers 
in air. A lot of the wear problems that I think we hit in the middle period, after 
the period you are talking about, Chairman, were due to that. My question 
is: can the early Wrightington people tell us how the polyethylene cup was 
sterilized to begin with? Secondly, when gamma-irradiation was introduced, 
whether consideration was given to the downside mechanical consequences? I 
should say that I’ve whispered to John Read, and he says he can’t remember, but 
maybe Mike Wroblewski or somebody else can. Why did we gamma-irradiate 
in air without knowing what we were doing?81
Wroblewski: Until March 1967, the cups were machine-washed, soaked in 
formaldehyde, washed again, and then implanted. From March 1967 onwards, 
the manufacture was transferred to Thackray’s in Leeds, and it is at that stage 
that they were gamma-irradiated. 
Tucker: Very brieﬂy, following on from what Michael was saying, I think one 
of the important parts of the history, certainly as far as I am concerned, was in 
the mid-1970s, when Michael published his paper showing that allergy to metal 
ions,82 or what was thought to be allergic reaction, which he alluded to before, I 
think, probably ﬁnished off the metal-to-metal argument, certainly for quite a 
while. Perhaps it was the early 1970s, Michael, when you showed the acetabular 
components on metal-to-metal prostheses going in to the pelvis.83 If you can’t 
remember, I can.
Freeman: I don’t want to get into minutiae; I did publish on that subject, but I 
wasn’t the ﬁrst to publish on the issue of whether cobalt–chromium was in the 
hair, urine and so on.84 That wasn’t actually the point I was making, which was: 
80 Professor Alan Swanson wrote: ‘Professor Freeman credits me with too much. In the book referred 
to [Swanson and Freeman (1977): 164] I mention the degradation of mechanical properties caused by 
irradiation, but not the difference between irradiation in air and in vacuo.’ Note on draft transcript, 
26 June 2006.
81 Shen and Dumbleton (1974); Black (1978); Besong et al. (1998).
82 Evans et al. (1974); Benson et al. (1975); Elves et al. (1975); Lalor et al. (1991).
83 Heath et al. (1971). 
84 For example, Coleman et al. (1973).
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why did we sterilize by gamma-irradiation in air? Was it that nobody knew any 
better? Why was it? I mean, looking back, it was an incredible thing to do.85
Mr Krishna (Ravi) Kunzru: A bit of an anecdote on a totally different subject: 
I was Malcolm Swann’s and George Arden’s senior registrar, and I remember 
George Arden trying to put one of those custom-made prostheses into a child 
and it just wouldn’t ﬁt. The reason simply was that the stem was too long and 
we had to get a carborundum disc to cut the stem off in the theatre. We had 
to ﬁnd the engineer ﬁrst – I think he had gone home. We lived through rather 
interesting times.
Lettin: I think Ian Stephen touched on the pressurization of cement, because 
that was something that probably came about in this period that we are talking 
about. Certainly, John Scales was pressurizing the massive implants in humans, 
and he had a gun, which he got from De Havilland – it’s funny how the aircraft 
industry is mentioned again – which worked off an oxygen cylinder and it was 
really quite a fearsome thing and I had a certain amount of experience [with it] 
just after I got on the staff at Bart’s.86 It was a patient with a tumour of the upper 
end of the humerus and John might have been possibly one of the earliest, I 
don’t know, to ream [scrape with a reamer, see Figure 22] the medullary cavity. 
He brought his own reamers with him, which I think he probably got from the 
ironmongers, and when he got to reaming the humerus I had exposed, he said: 
‘You had better let me do this, it’s a bit tricky’, and so he reamed the shaft of the 
humerus. Then it came to putting in the cement, and he said: ‘You had better 
let me do this, this is a bit tricky’, and my house surgeon, who was holding the 
arm then, said: ‘Does it matter, sir, but the elbow’s swelling?’ John had obviously 
drilled through into the elbow joint and the cement was going into the joint. 
He said: ‘What are we going to do now?’ So I said: ‘We’ll put that prosthesis in 
as fast as we can’. We put the prosthesis in and then we took a plug of cement 
out from the elbow joint. John was in at the crack of dawn the next morning to 
see this patient, who had nothing worse than a transient ulnar nerve palsy [due 
to compression of the nerves].
85 See note 81.
86 Mr Michael Wilson wrote: ‘As I remember the hammer/drill was one of Scales’ inventions – a pneumatic, 
percussion hammer, which relied on ball bearings to provide the percussion element. I don’t think it lasted 
beyond the Heath Robinson stage, as the ball bearings would periodically fall out all over the theatre ﬂoor 
and have to be retrieved.’ E-mail to Mrs Lois Reynolds, 9 November 2006.
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Mr Tristram Charnley: On the question of sterilization, I certainly remember in 
the early 1980s, and Mike Wroblewski can probably conﬁrm this, but Thackray 
were vacuum-packing the cups before sterilization.
Freeman: I am very sorry, because Thackray’s were doing it in the 1970s, or not 
until the early 1980s, somewhere there. So, can I ask Phyllis: why did the rest of 
industry go on gamma-irradiating in air?
Hampson: I am terribly sorry, I have no idea.87
Freeman: But they were vacuum-packed and then sterilized. So, they were 
sterilized in a vacuum. [From the ﬂoor: Well]. What do you mean ‘well’? They 
were sterilized in a vacuum.
Ring: Mike Freeman has mentioned the possible toxicity of the metal-on-metal 
bearing and, I think, historically it’s important to record this. For that, and 
perhaps for other reasons, Ken McKee turned to metal-on-plastic in or around 
1980, and I did the same thing. Reports of toxicity, mostly if the implants were 
made out of cobalt, came from John Scales and from Mike Freeman, and the 
metal-on-plastic joints seemed to be giving rather better early results.88 In spite 
of the possibility that metal ions are hazardous, one way or another, there has 
been a resurgence of metal-on-metal joints. Perhaps progress is circular.
Lettin: I think Professor Swanson made this point earlier: that it was a question 
of the purity in the manufacture of the metals, which is so much better now. 
Perhaps that connects up with the Swiss railway lines.89 I think we should move 
on to the question of the operation. Each of the early pioneers seemed to adopt 
a different technique. Charnley, as we all know, took off the trochanter, which 
87 Mrs Phyllis Hampson wrote: ‘When I left school I went to work at the London Splint Company, 
which was owned by an American, Mr F I Saemann. In 1947 he sold the company and decided to start 
a manufacturing unit [Zimmer Orthopaedic Ltd]. The place he eventually chose was in Bridgend, South 
Wales. In 1968 or thereabouts the Managing Director of the company decided to live in Canada, hence 
my promotion to MD. When Mr Saemann died, his heirs decided to sell the company to Biomet [now 
Biomet Merck]. I stayed with them for a short while and then decided to retire in 1985. Unfortunately 
when Biomet bought the company, they closed and dismantled the London ofﬁce and the manufacturing 
unit in Swindon where the total joints were made. All of the history of the companies was destroyed.’ Letter 
to Mrs Lois Reynolds, 26 June 2006. Mr Ravi Kunzru wrote: ‘Zimmer bought the Swindon works from 
the ﬁrm Deloro Stellite, who had been making hip parts there for many years.’ Note on draft transcript, 
16 October 2006. See also pages 34–5.
88 Coleman et al. (1973); Heath et al. (1971).
89 See page 42.
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I think he tried to rationalize, but those of us in the south, perhaps, were more 
used to a posterior approach. Kevin [Hardinge], you developed an approach 
of your own.90 But perhaps we should start off with Mike Waddington and 
Ken McKee’s approach to the hip, which was an anterior approach [see the 
anterolateral incision in Figure 23], wasn’t it? We have got some ﬁlm later,91 
both of McKee and Charnley, but I think we will put those on during teatime 
so that people can have a look while they are drinking a cup of tea.
90 Hardinge (1982). For a more recent evaluation, see Barrack and Butler (2005).
91 The 1966 ﬁlm of Ken McKee operating, digitized on DVD, and a digital copy of the silent ﬁlm of John 
Charnley’s operation will be deposited, along with the tapes and other records of the meeting, in Archives 
and Manuscripts, Wellcome Library, London. 
Figure 23: Surgical approaches used in total hip replacement.  
L to R: (a) anterolateral incision; (b) direct lateral incision;  
(c) lateral or posterior incision; and (d) modern minimally invasive incision.  
Drawn by Mr Kevin Hardinge. 
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Mr Mike Heywood-Waddington: Reference has been made to serendipity, and 
I have to admit that my professional career was largely based on serendipity, 
rather than on any structural planning. One of the best examples of that is 
really how I got to meet Ken McKee. While working as senior registrar for the 
late Herbert Seddon at the RNOH, I was summoned to his ofﬁce, which, as 
you remember, Chairman, was slightly preferable to being invited to his rose 
garden.92 He said that he wished me to go to Norwich to act as the late Ian 
Taylor’s locum there, while he carried out a stint at Kano, Nigeria.93 As a result I 
spent four months at the Norfolk and Norwich Hospital from September 1965 
to January 1966. 
There was another item on the agenda, because, as I think you may testify, 
there was some scepticism amongst the staff at the Royal National Orthopaedic 
Hospital (RNOH) at Stanmore about the real merits of what was going on both 
in Wrightington and in Norwich, from Jackson Burrows in particular. So my 
instructions were to report back on the McKee hip: ‘Waddington, get this very 
clear, does the Norwich hip work, and will it last?’ 
Anyway, I went up there and everybody at Norwich was extremely kind to me, 
nobody more so than Ian Taylor, with whom I stayed before he departed for 
Nigeria. John Watson-Farrar and Ken McKee took me through the operation. I 
explained that I was being pressed to report back to the RNOH and asked if I 
could make the ﬁlm [shown during the meeting’s tea break],94 because I felt that 
if I couldn’t show McKee himself performing the operation, it might be thought 
that I was introducing my own modiﬁcations when I returned to Stanmore. 
92 Mr Michael Wilson wrote: ‘Concerning Sir Herbert Seddon’s rose garden, my father [‘Ginger’ Wilson] 
wrote the following for his speech to the Seddon Centenary, which would have been around July 2003: 
“The mere mention of a visit to the Rose Garden was sufﬁcient to put the fear of God into any registrar 
in training; for they knew it could be a prelude to being gently moved on. As a consultant I was never 
summoned there; for as I have already explained HJS [Sir Herbert Seddon] had other methods of dealing 
with recalcitrant junior colleagues. But JTS [John Scales] seems to have been a fairly regular attender. His 
experiences are worth recording, and I quote: “As we progessed through the garden engaged in erudite 
discussion, every now and then HJS would stop, bend forward, pick a weed from the lawn, and then 
continue his point. This method of progression could be somewhat disconcerting to a nervous visitor”.’ 
E-mail to Mrs Lois Reynolds, 17 October 2006.
93 Mr Alan Lettin wrote: ‘HJS asked me as his First Assistant to ﬁnd locums for consultants going to Kano.’ 
Note on draft transcript, 25 November 2006.
94 See note 91.
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But you are quite right, I should add that I was very privileged to know Ken 
McKee very well for a long time: he used to come down and stay with us when he 
operated from time to time at the Essex Nufﬁeld Hospital, Brentwood, after his 
retirement from the NHS. I also went on a regular basis to the well-known annual 
meetings of the British Orthopaedic Study Group (BOSG) at Zurs, Austria, 
attended by both McKee and Charnley.95 There was a lot of free and informal 
discussion through the 1970s from both of them, from which I learnt a lot. 
You are quite right that both Charnley and McKee had an almost doctrinal 
attitude to their surgical approach: McKee’s was the anterolateral approach 
(the Watson-Jones approach),96 and, of course, Charnley insisted on a lateral 
approach with trochanteric osteotomy. Charnley told me later that Kevin 
Hardinge would be allowed to do things his way, if he [Charnley] needed the 
operation himself.97 However, the ﬁlm shows the operation as performed by 
McKee, so I think it can speak for itself.
Lettin: The great problem with that approach was the chap under the sheets 
[the technician who manipulated the leg as required by the surgeon], wasn’t it?
Heywood-Waddington: Yes, and as you know we had our Terry [a technician] 
and, I think, they had their Keith [a technician] – I can’t remember his name – at 
Norwich. I have to say that that part of the technique was one thing that I gave 
up when I got my own consultant’s job, and adopted the posterior approach, for 
which I make no apologies.
Lettin: Mike [Wroblewski], did you continue to remove the greater trochanter 
throughout your working life?
95 Mr Mike Heywood-Waddington wrote: ‘Much of the conversation at the British Orthopaedic Study 
Group meetings was informal, but there exist minutes of the scientiﬁc papers given, which included regular 
contribution through the 1970s from both McKee and Charnley on their evolving views on the development 
of the artiﬁcial hip joint, and related matters. The proceedings are published annually, but have a private 
circulation to members, but can be made available to anyone properly interested who approaches the 
secretary, at present Mr Tim Morley. Their scientiﬁc validity is undoubted.’ Note on draft transcript, 11 
October 2006.
96 The anterior surgical approach to the total hip replacement is one of the oldest, developed in the 1930s by 
Boston surgeon Marius Smith-Petersen, later modiﬁed by British surgeon Sir Reginald Watson-Jones, both 
of whom used this approach to repair fractures of the femoral neck. See Smith-Petersen (1930); Watson-
Jones (1935); Charnley (1950b). See anterolateral incision illustrated in Figure 23.
97 Jolles and Bogoch (2004).
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Wroblewski: Mr Chairman, may I correct you. It is not merely a question of 
the trochanteric osteotomy, if we read Charnley’s description of the method of 
exposure, it was quite purposeful;98 all to do with the mechanics of the hip joint. 
To medialize the cup, reducing the medial lever while increasing the lateral 
lever by moving the trochanter laterally. We now have evidence to support that: 
medialized cups wear less, cups supported on the rim wear more.99 It is not 
merely the question of exposure. In fact, in later years, Sir John Charnley used 
to say that he did not charge his private patients to do a hip replacement, he 
charged them for reattaching the trochanter [Laughter], clearly emphasizing the 
beneﬁt of the reconﬁguring of the hip joint mechanics. 
The answer to your original question is yes – until 18 months ago when I retired 
from clinical practice.
Lettin: You have learned better since.
Wroblewski: That’s a matter of opinion.
Lettin: The perception in the south was that this was the way that the Manchester 
surgeons approached the hip: that Sir Harry Platt did it this way, and his pupil 
John Charnley did it this way. Of course, surgeons in the south didn’t approach 
the hip by taking off the trochanter, and that what you said was really an effort 
to rationalize the approach, which was the Manchester way. Now, we have some 
engineers here and I wonder whether they would go along with the thesis that 
Mike Wroblewski has put forward?
Mr Graham Deane: I am only half engineer [has an engineering qualiﬁcation], 
but what came to mind is a recollection of another great man, Edgar Somerville, 
whose registrar I was in 1969. I remember when we were doing Charnley hip 
replacements, Edgar Somerville was in conﬂict with many of his colleagues 
because he would not take off the trochanter. I remember we were having a 
problem with a hip replacement, and Edgar Somerville said, ‘I had better phone 
my friend John to see what’s wrong’. He phoned John Charnley and, of course, 
you only hear one side of the conversation. He would be holding the X-ray in 
98 Charnley and Ferreira (1964). Charnley’s technique for transplantation of the greater trochanter is 
represented there in Figures 3–8.
99 Wroblewski et al. [(2004): 499, Table 2] suggest that the medialized cup position contributed to both the 
low and high wear groups with a p value of 0.07. See also, for example, Perka et al. (2004).
Early Development of Total Hip Replacement
50
his hand and he would describe it all, then came the obvious pause, and quite 
clearly the question that came back from John Charnley was, ‘Did you take the 
trochanter off?’, and Edgar Somerville would reply, ‘Of course not, I never take 
the trochanter off ’. The end of the conversation was always, ‘You know why 
you are having a problem then’.100
Lettin: But that was a question of his approach, not the mechanical notion, 
which I was hoping the engineers might have.
Deane: The mechanical notion is certainly true, the practicalities of it were 
different. Another recollection of mine was from a visit to Wrightington. One 
thing that always puzzled me was that the laboratory, which had all the various 
test rigs, there were more test rigs on how to reattach the greater trochanter 
than for anything else. That always concerned me. Everything else was a single 
technique, but, from a practical point of view, the trochanter was obviously 
causing quite a bit of trouble.101
Lettin: That reminds me of a BOA meeting when John Charnley was reading a 
paper, I think, on his latest technique for ﬁxing the greater trochanter back,102 
which I am sure Mike Wroblewski must admit did sometimes prove to be 
difﬁcult, and a senior registrar by the name of Chris Colton got up and was 
100 See note 103. Professor Mike Wroblewski wrote: ‘The history of trochanteric osteotomy in THA is well 
documented [Wroblewski (1990): 19–28]’. Note on draft transcript, 20 June 2006.
101 Professor Mike Wroblewski wrote: ‘Visitors to Sir John Charnley: Michael Freeman 
(6 May 1965); Alan Swanson (6 May 1965); Ken McKee (26 August 1966); Alan Lettin (April 1967); John 
Scales (15 May 1969); “Ginger” Wilson (15 May 1969). Sir Robert Jones, Liverpool, visited Wrightington 
Hospital on 2 October 1932.’ Note on draft transcript, 20 June 2006. A copy of a page from 1932 of 
the Wrightington Hospital’s visitors’ register will be deposited along with other records of this meeting in 
Archives and Manuscripts, Wellcome Library, London. Mr Mike Wilson wrote: ‘I’ve checked my father’s 
diary for May 1969 when he went up to Wrightington. I enclose the following extracts: “14th May 1969: 
Went up to visit John Charnley today driven by John Scales [John was notorious for his driving technique]! 
Just after doing 92mph down a hill we had a ﬂat tyre!” “15th May 1969: Usual six arthroplasties in the day. 
A few more new gimmicks. He [John Charnley] has a good way of bringing the fat together with tension 
sutures and sponge protectors for the skin and a very neat way of using the stockinette as a dressing”.’ E-mail 
to Mrs Lois Reynolds, 17 October 2006.
102 See note 98. For details of the different approaches to the trochanter, see links from www.wheelessonline.
com/ortho/modiﬁed_hardinge_anterolateral_approach_to_the_hip (visited 27 July 2006).
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greeted in absolute silence when he said, ‘Why do you want to make an easy 
operation difﬁcult?’ There was absolute silence.103
Sweetnam: The last few contributions, I think, are pretty fundamental. What is 
this business of removing the greater trochanter? I went to see Sir John operate 
and I came back to London and I did his operation and I always took the greater 
trochanter off. I went to great pains to put the greater trochanter back exactly 
where it had come from, because that is what I thought I had been taught. 
Now I have seen specimens from, I think, his test rig, testing the methods of 
ﬁxation, and it looks to me as though it was done in the way I did it, that the 
greater trochanter was put on exactly from where it came. Now we hear that 
it’s fundamental that the greater trochanter is put somewhere else. I would like 
to have this sorted out. I believe there is a myth out there about any signiﬁcant 
shift in its position.104
Lettin: Alan Swanson is going to sort it out for you.
Swanson: I will say nothing about the problems of reattaching the greater 
trochanter, but I must say, as an engineer, I was most impressed when I read 
and re-read Charnley’s account of the operation, because it did seem to me 
that he was designing a process of which the prosthesis was part, and the idea 
of accepting that the centre of gravity of the body is where it is, moving the 
centre of the hip joint closer to that, to decrease that medial moment arm, and 
increasing the lateral moment arm of the abductor muscles, by moving the 
greater trochanter laterally, where you reattach it, thereby reducing the total 
level of force on the hip joint.105 It made excellent mechanical sense. Whether 
it makes better sense surgically or not I am not competent to say, but I was 
103 Professor Christopher Colton wrote: ‘I recall that at a BOA meeting at the Royal Festival Hall – can’t 
recall the year – there was a paper by Charnley on trochanteric osteotomy ﬁxation. I recall commenting 
that all these methods of ﬁxation were ﬁne and dandy, but that it was not necessary to take off the greater 
trochanter in the ﬁrst place. I think I complimented him on ﬁnding an elegant solution for a problem of 
his own creation. That went down like a pork chop at a bar-mitzvah – no wonder my career almost sank 
without trace. I do recall Michael Freeman agreeing with me publicly.’ E-mail to Mrs Lois Reynolds, 2 
October 2006. The BOA meeting at the Royal Festival Hall was held 13–18 September 1976. E-mail from 
David Adams, Chief Executive, BOA, 2 October 2006. See Proceedings and Reports [Journal of Bone and 
Joint Surgery (February 1977): 59] freely available at www.jbjs.org.uk/cgi/issue_pdf/frontmatter_pdf/59-
B/1.pdf (visited 9 November 2006).
104 Charnley and Ferreira (1964). See discussion on page 49.
105 Charnley (1961, 1979).
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impressed by what, I suppose, these days would be called holistic thinking, 
rather than, ‘Let’s just design a prosthesis’. 
Lettin: That’s very interesting. Duncan Dowson, you had been going to say 
much the same, I think. You were shaking your head in the afﬁrmative.
Dowson: Yes, I cannot make any comments on the surgical aspects of this, but 
I agree with Alan and I have enjoyed the last few minutes of the discussion.
Freeman: Can I slightly endorse Rodney’s point and read into the record the fact 
that I think that the ﬁrst person to do Charnley’s operation outside Wrightington, 
was John Read at the London [Hospital]. I am not sure if that’s true, I wonder 
if anyone can improve on that recollection of mine. And then to just make a 
brief contribution to the ‘where do you put things’ issue, I quite see Alan’s point 
that it’s a process, and it’s a rational process, but I must say as a surgeon, I fear 
I had the same problems as Rodney, that I couldn’t actually put the trochanter 
anywhere else, even if I had wanted to, and the idea of medializing it a lot has 
occasionally led to the odd problem that I seem to have seen, because you have 
only got a millimetre or two that you can reasonably go, haven’t you? 
Wroblewski: Sorry to take up so much time. I refer those unbelievers to the 
Swedish Hip Register to have a look for themselves at the results according to 
the exposure.106 But the thing that fascinates me is that discussions often end 
up on the opinions of trochanteric osteotomy. I have never, ever heard anybody 
who advocates trochanteric osteotomy arguing against another exposure. I get 
the feeling that those who didn’t have the proper exposure, somehow feel guilty 
that they are missing something. Am I correct?
Mr John Older: I just speak as one surgeon from the south of England who does 
the classical Charnley low-friction arthroplasty with a trochanteric osteotomy. 
And with my four and a half years working as an assistant and colleague with 
Sir John and following his very accurate and detailed explanation to me of 
his theory, I very much support what was said by our two engineers, Swanson 
106 Located at the Sahlgrenska University Hospital, Sahlgrenska, Göteborg, the Swedish nationwide study 
has been collecting and analysing data provided on a voluntary basis on all primary total hip replacements 
and revisions performed since 1979. Professor Peter Herberts and Associate Professor Henrik Malchau direct 
the study, supervised by a board elected by the Swedish Orthopaedic Association. See Malchau (1996). For 
further details, see www.jru.orthop.gu.se/ (visited 7 June 2006). The British debate favouring a national hip 
registry suggested that, over time, the Swedish registry reduced the range of different prostheses implanted, 
resulting in lower revision rates and improved surgical technique. Jones (2000).
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and Dowson, together with Wroblewski. I was very impressed with Charnley’s 
engineering arguments. The trochanteric osteotomy I have done throughout my 
career and never had any major problems – well, everybody has the occasional 
problem – but I found it successful and you do need it. Replying to Sir Rodney, 
it is correct that you don’t put the trochanter back exactly where you got it from, 
that’s part of Charnley’s concept. 
Lettin: I suppose at the end of the day there is little difference between the 
patients who have had their trochanters removed and stuck back lower down, 
and those who have not? I would be very surprised if there was any clinical 
evidence that the functional result was any better. Does anybody know?
Stephen: It is my recollection, and indeed in his history of the Exeter hip, Robin 
Ling has written that he considered the offset of the stem to be very important.107 
The original 44mm offset was to increase the abductor power by increasing the 
lever arm; this is another way of achieving the same effect. Another part of 
the rationale in the design of the Exeter hip was that it was speciﬁcally to be 
implanted through the posterior approach, which was commonly used in the 
south of England at the time [see Figure 23.].
Hardinge: I introduced the direct lateral approach, because I had seen a lot of 
problems with the Tobin trochanteric osteotomy, even if you have been trying 
to restore it in the proper position, it would fragment – the bone was diseased 
or whatever – or the wires would fracture. The thing I think people are missing 
is that you need to restore Shenton’s line.108 Movement of the trochanter distally, 
or moving it laterally, or getting supposed improved leverage by re-placement 
of the trochanter in some exotic position is a myth. The fundamental aim is to 
restore Shenton’s line, that’s what you do.
Lettin: Is Wroblewski going to speak to you after this?
Hardinge: I don’t know, you just have to have quite an open view. The anterior 
approach, the Watson-Jones approach, I look upon as the cat burglar’s approach 
to the hip. The posterior approach I look upon as the trademan’s entrance to 
the hip joint. You must have the patient lying in the supine position to be 
able to place the implants correctly. So you need trochanteric osteotomy, if 
107 Ling (1997): 9–11.
108 See Glossary, page 152.
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there’s an anatomical deformity around the hip.109 I will be the ﬁrst to say that 
you must use a trochanteric osteotomy if there’s some abnormality in this case, 
but if this was a perfectly straightforward anatomical case, then why take the 
trochanter off?
Lettin: I think that was the point that Chris Colton was making all those years 
ago.110 Keith, what approach do you use? I ought to know because you recently 
replaced my hip.
Tucker: Yes, you should! I continue using Ken McKee’s approach with some 
modiﬁcations. Ken always thought that the anterolateral approach would cause 
fewer dislocations.
Lettin: But it’s not Kevin Hardinge’s approach?
Tucker: Alan, when did the long posterior lip come in from Wrightington? 
Because I think that’s part of the history. 
Lettin: I can’t answer that. What about Mike Wroblewski?
Wroblewski: The long posterior wall Charnley cup was introduced in 1972. 
It was brought in to pacify some US orthopaedic surgeons who were worried 
about the dislocation of the hip. In fact, for the record, if I may, looking at 
22 066 primary LFAs over the past 32 years, there were only 55 revisions for 
dislocation (0.25 per cent).
Tucker: Alan, if I could just go back to the question about dislocation, which 
we haven’t discussed in a big way. Dislocation has been part of the history of hip 
replacement and formed a lot of the discussion in the last 25 years. It has been 
perceived that the posterior approach is the one with the greater dislocation 
rate, compared with the anterolateral approach.111
Lettin: We intend to have, as far as I can make it happen, a section after tea on 
complications and dislocation would be one of them, but there’s no reason why 
we can’t pursue that particular topic now. For the record, we have got the reason 
for people adopting different approaches. Kevin has explained quite clearly why 
he thinks his approach is satisfactory. Mike Wroblewski has focused on the 
well-known Charnley approach and it’s very interesting that the engineers have 
109 See Glossary, page 153. See also Figure 23, page 46.
110 See note 103.
111 Higuchi et al. (2003). 
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actually said, ‘This is sensible’, although I think the experience of some surgeons 
is that it makes an easy operation difﬁcult. But it’s interesting that we have got 
it for the records, because there was a considerable debate early on. I don’t know 
whether we have any current surgeons here, everybody is retired, except Keith 
[Tucker], who is the only one here still doing joint replacements. 
The more precise details of the approaches,112 perhaps it’s my fault that we put 
back the showing of the ﬁlm, because I thought that you would all have a lot 
more to say, but you have all been terribly good and nobody has spoken for more 
than four minutes, and not everybody has spoken. Before we go to tea are there 
any other people who want to come into the discussion, on any of the aspects?
Mr Geoff King: I was quite unsure why I was invited to this meeting, to be 
among the orthopaedic great and good of the country, and it now occurs to 
me that I am something of a living fossil. In 1963 I had a road trafﬁc accident 
and was admitted to the Norfolk and Norwich Hospital under Ken McKee 
and, at the time, John Watson-Farrar was his senior registrar. He put a 
Küntscher nail113 in my left femur, which I still have. Some ﬁve years later, I was 
working as a technician in the orthopaedic theatre with Ken McKee and John 
Watson-Farrar. 
There are two things that I can recall, one may be slightly apocryphal about 
the design of the McKee hip. He didn’t just turn to engineering, he also turned 
to tenth- and eleventh-century architecture. He copied the ﬂying buttresses of 
Norwich Cathedral for the shape of the stem of his prosthesis [see Figure 6, 
page 9].114 I was also a ‘Frank’ at one stage, in that I was under the covers 
manipulating the hip. During part of my career, I also remember that Watson-
Farrar had a unique operating facility, in that he had very strange little ﬁngers, 
with which he could poke the cement down the femoral stem. 
To continue my timeline as a bit of an antique, I actually had a hip replacement 
in May [2005], through the posterior approach, despite the fact it was done in 
Norwich. I think it was the Birmingham resurfacing, nothing too serious.115
112 A digital copy of the silent ﬁlm shown on 14 March 2006 will be deposited, along with the other records 
of the meeting, in Archives and Manuscripts, Wellcome Library, London.
113 A Küntscher nail, or intramedullary rod, was in frequent use until the 1970s and is a hollow rod of 
varying lengths and diameters secured to the medulla. See Glossary, pages 149–50.
114 Professor Mike Wroblewski wrote: ‘The ﬂying buttress was the basis of extra-articular (Norwich) hip 
arthrodesis [Brittain (1941, 1942, 1948); Langston (1947)].’ Note on draft transcript, 20 June 2006. 
115 See Appendix 3, page 106
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Lettin: I did ask Mike Freeman why his double cup wasn’t awfully well received, 
whereas McMinn’s seemed to be. I hear McMinn sold his ﬁrm for £60 million, 
I don’t know whether that’s true or not.116
Freeman: Yes, I am afraid I didn’t sell anything for £60 million, but there you 
are. The operation of resurfacing with polyethylene failed in everybody’s hands, 
I think, including dramatically in my own, and, I think, that was mainly because 
of the production of polyethylene debris, plus a level of surgical experience, 
which wasn’t what it is now.117 The polyethylene debris I think was partly 
due to the size of the head – a point that Charnley made to me, and he was 
absolutely right – but, I suspect, overwhelmingly, that the polyethylene was not 
UHMWPE, because it had been sterilized by gamma-irradiation in air, and that 
this was the signiﬁcant fact.
Derek McMinn’s operation is plainly a success, and it has the great attraction 
that a cobalt–chrome acetabulum is thinner, so you get more space for the 
two components.118 The engineering, as Alan has said, has improved, so the 
thing works from a mechanical point of view. I have to say that I don’t think 
we know what the long-term effects will be in younger people, of persistently 
elevated cobalt and chrome levels in the blood. It is now known that those 
ions, of all the transitional metals, are DNA splitters, which they share with 
X-rays, and if you talk to the fertility doctors, they are a little bit concerned 
about it, so we are going down into an age group where this is potentially a 
problem.119 Whether it will be, goodness only knows. But I think that answers 
your question, Chairman, doesn’t it?
Lettin: I think so. It reminds me of a question that I was going to put earlier, 
about patenting these devices. I think, Lady Charnley, that John never patented 
the original hip joint [No], but he did subsequently [Yes]. And what about Ken 
McKee? Does anybody know whether he did?
116 Midland Medical Technologies Ltd now trades as Smith & Nephew Bromsgrove Ltd. 
117 Freeman et al. (1975); Cameron and Freeman (1977); Freeman and Brown (1978); Freeman (1978a) 
[Issue 134 of Clinical Orthopaedics and Related Research contains articles by all the surgeons who had 
developed resurfacing arthroplasties.]; Freeman et al. (1978); Freeman and Bradley (1982); Levack et al. 
(1986); Hernandez-Vaquero (1987); Cotella et al. (1990).
118 McMinn et al. (1996). See also McMinn and Daniel (2006); Daniel et al. (2006); McMinn et al. (2005); 
McMinn (2003); Grigoris et al. (1993); Roberts et al. (1992).
119 Cobb and Schmalzreid (2006).
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Heywood-Waddington: Just a couple of points there. I don’t think he ever 
patented it, that I am aware of. But he did make several things clear to me during 
the 1970s at a meeting of the BOA, I think in Oxford.120 One point about metal 
sensitivity, he did not accept that that was a problem. I don’t mean in the longer 
term that Mike Freeman was referring to, I don’t think he directly commented 
on that, but as far as actual metal sensitivity, cobalt and chrome sensitivity, he 
dismissed this as a problem. The other thing that I think is important to say is 
that his paper in 1966, the deﬁnitive paper,121 paid tribute to John Charnley for 
the introduction of methylmethacrylate, and also to John Scales for advising 
McKee that chrome–cobalt was the ideal metal to be used.
Professor Sir Christopher Booth: I am a complete outsider, but listening to this 
discussion as a historian of the twentieth century, one has to wonder whether 
you are giving the impression that this was all happening in an international 
vacuum. What is extraordinary about medical equipment and prostheses and 
so on, is that the US manufacturers almost always moved in on anybody’s 
invention, took them over and then the US manufacturers become the people 
that did it. Is that what happened here? Or was it preserved in England?
Lettin: I think I might be able to throw some light on this because the cement – 
at least I think that Simplex C was the original bone cement – was manufactured 
in a back street in Stamford Hill in London and the owner of the ﬁrm was an 
American who happened to be a patient of mine, which is how I know the story, 
soon after I got on the staff at Bart’s.122 And there are people here who will know 
much more about the composition, but there were inhibitors in the compounds 
that had to be mixed together, and this company, North Hill Plastics it was 
called, had the patent on these inhibitors, and the US FDA (United States 
Food and Drug Administration) would not grant permission for the cement to 
be used.123 So, the Americans fell quite behind, and the patients were coming 
over to this country for hip replacements. (Jill Charnley is shaking her head.) 
120 Mr Mike Heywood-Waddington wrote: ‘It was a BOA meeting which I think was in Oxford at which the 
question of late (possibly neoplastic) effects of polyethylene debris was discussed.’ Note on draft transcript, 
22 June 2006.
121 McKee and Watson-Farrar (1966). 
122 Phillips et al. (1971).
123 In 1966 North Hill Plastics were located at 49 Grayling Road, London N16 [McKee and Watson-Farrar 
(1966)]. See Phillips et al. (1971), for discussion of its cardiovascular effects. For the properties of acrylic 
bone cement, see note 9.
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This irritated the Americans no end, and I think the ﬁrst person actually to do 
a total hip replacement in the US was Harlan Amstutz who had worked for a 
year at the RNOH [Stanmore] and went back to special surgery in New York 
with a McKee prosthesis in his pocket along with some cement and the FDA 
gave him permission to do a one-off operation in 1962/3. In the end, of course, 
the Americans bought out this company, but the owner knew that if he gave the 
formula to the US FDA it would be leaked and he could not afford to defend 
his patent against the big American companies. 
Hardinge: The surgeons who had been to Britain to train, like Harlan Amstutz 
and Joe Dupont, went back to the US and they had a licence to use the 
cement on a limited basis. Joe Dupont, who worked at Wrightington, went 
back to Phoenix, Arizona, and had 300 patients under treatment, pre-operative 
assessment, operated, and in rehabilitation. He was in the big time. He had an 
overdraft when he went back to Phoenix, and later he sent a Christmas card to 
a chap he knew, Walter George, also from Phoenix, which said, ‘Come quickly, 
Walter, the end is not in sight.’ So this was answering the American dream. 
Talking about patents, the other thing that happened in 1970 was that the 
ﬁrm Charles Bechtol discovered that the Charnley implant was not patented, 
so that’s when they brought out the Charnley type, so it was available to US 
orthopaedic surgeons in their technical stand.124 That’s when John Charnley 
realized he could no longer control it. He had been very proper and tried to 
control it. So after that, it was thrown open and you could get the instruments 
and start operating.
Lettin: Could you say anything about the manufacturers’ point of view, Phyllis, 
because I suppose they didn’t want to manufacture stuff that was going to be 
copied.
Hampson: That’s quite right, too. John Scales had all the Stanmore implants 
patented by the National Research Development Corporation (NRDC), and 
anybody who wanted to make Stanmore prostheses had to go to John Scales at 
RNOH, Stanmore, and nobody else made them until the licences lapsed. By 
this time our company had been sold to Biomet.125 Zimmer Orthopaedic used 
to pay royalties to the NRDC and part of the total amount went back to the 
RNOH. 
124 For details of Charnley’s development work, see Gomez and Morcuende (2005a and b). See also Foreman-
Peck (1995); Dorr et al. (2000); Bechtol (1973).
125 See note 87.
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Lettin: It didn’t go to the individual as it would now.
Dowson: Chairman, just one or two brief comments. You mentioned earlier, and 
reference has been made in the discussion, to a number of signiﬁcant meetings 
of the BOA and other organizations. I would like to remind people that in 
the engineering ﬁeld, a joint meeting between the Institution of Mechanical 
Engineers (IMechE) and the BOA was held in 1967. I think that this was a 
landmark in many ways, and John Charnley was on the planning committee 
of four people, as was John Scales; they were the two representatives from the 
BOA. When I look through the list of contributors, it reads like a Who’s Who of 
joint replacement history, on both the engineering and on the surgical side. 
Mike Freeman raised a point earlier as did, I think, Alan Swanson, which 
made me wonder about the way in which polyethylene replaced PTFE, since it 
appeared that there was some knowledge available at that time of the ill effects 
of radiation. It was a different era of information technology. Because in the 
same way as when John Charnley was introducing PTFE, engineers knew very 
well that it was a terrible material for wear. It had the lowest known coefﬁcient 
of friction for man-made materials, but manufacturers steered away from it as a 
bearing material in bulk form. I could never understand quite what persuaded 
John to go down that route. PTFE nearly always had to be strengthened as a 
bearing material for high loads. It had to be impregnated into metal, or involved 
in some other way, to be an effective bearing material. I think this point was 
important at that stage, alongside the irradiation issue.126 And ﬁnally, just to say 
something about the discussion of surface replacement joints which seem to 
be attracting so much attention at the present stage, in metal-on-metal form. 
From the engineering point of view, it is very interesting that they would all 
have difﬁculty with small diameters, because up to about 28mm or 30mm 
diameter, they are always rubbing one material on the other, all the time; they 
are rubbing bearings. When you go to a larger diameter, 36mm and certainly 
up to 50mm or so, then you start to get some very important contributions to 
load support from the lubrication, which you do not get at lower diameters. 
This is having a big effect on the resurgence of interest in (a) large diameter 
metal-on-metal, and (b) resurfacing approaches. Much of the current work is, 
as yet, theoretical and experimental, and has, of course, to be substantiated in 
practice. One of the difﬁculties is that we are going to have to wait so very long 
before we see the outcome of clinical performance of these very low-wear-rate 
joint replacements.
126 See note 7 and discussion on pages 37, 38, 50 and 57. 
Early Development of Total Hip Replacement
60
Sweetnam: I wanted to give Sir Christopher [Booth] an answer to his question. 
He asked whether all this work was being carried out in an international vacuum. 
Let us go forth from this meeting knowing that it was. This was a British 
innovative idea – British surgeons, materials, scientists, engineers – conceived 
the practical concept of total hip replacement. What you are talking about – 
why it [control of the industry] eventually moved to the US later – occurs after 
the events that we are considering today.127 This was a British initiative carried 
forward with great success. So that is the answer.
Booth: Thank you very much.
Freeman: I am very moved by Rodney’s view, but I do not think we should 
absolutely ignore the contribution of others. I’m not quite sure what this 
meeting today is about: UK joint replacement, or hip replacement? 
Lettin: Basically it is total hip replacement, UK. It is really Rodney’s view of life, 
I think. 
Freeman: It is perfectly all right that we mention Maurice Müller and some 
of these other people?128 [Yes.] The second question is that, although we are 
wonderful to have invented this [total hip replacement], we made a terrible 
industrial disaster. As an industry, it is entirely dominated by the US. I wonder 
whether anyone would like to comment on that part of the subject?
Lettin: I don’t know. It is certainly dominated by the US, there is only one 
British company now in the business and that is Smith and Nephew, isn’t it.129 
Minuscule.
Booth: But they are only jokingly English. It’s the business, really – the only 
ones in the business are Americans.
127 Dr Francis Neary wrote: ‘It was really manufacturing control that moved to the US when the small UK 
companies were mostly bought out by the US giants Zimmer, DePuy (later Johnson & Johnson), Biomet, 
Howmedica (later Stryker Howmedica) and Smith and Nephew (which retains a British connection)’. 
E-mail to Mrs Lois Reynolds, 15 October 2006.
128 Maurice Müller of Bern introduced a femoral prosthesis that had a high rate of stem breakages and was 
fabricated from cast cobalt–chrome alloy with a curved shape. Müller’s later stem had a 32mm head and was 
called the Charnley-Müller prosthesis. Klenerman (2002): 17. See also Schmalzried et al. (1996).
129 Foreman-Peck (1995).
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Lettin: But they can’t get the FDA to approve the McMinn.130 I don’t want to get 
into that, but Smith and Nephew’s head ofﬁce is in the UK, but the real action 
is in the US.
Kirkup: In 1915 the disposable surgical blade was introduced in the US. When 
the patent ran out in 1930 or thereabouts, Swann-Morton of Shefﬁeld took 
it over. And now, Swann-Morton is worldwide, the biggest manufacturer of 
blades, even supplying large areas of the US.131
Heywood-Waddington: In response to the comments on the British 
contribution, I have to say that with the recent progress since then in litigation 
and politics, I very much doubt whether Charnley and McKee would have 
succeeded in this day and age in their endeavours, it took so long. We owe a 
great deal, not only to their tenacity, but to the political and social side of the 
prevailing climate.
Kunzru: A question concerns the approach to children’s hips, because many of 
them were quite deformed. George Arden always took off the trochanter to do 
his hip replacements, his custom-built hips, but you [Swann] didn’t. Would you 
like to talk about your approach, please. 
Swann: The approach I used to these hips, which were all anatomically 
deformed, varied, but was basically the lateral approach. That was my favourite. 
Occasionally it was necessary to remove the trochanter, just from the technical 
approach point of view, not from any other reason, just to get at the joint.
Lettin: We’ll stop now for tea. I hope the ﬁlms and videos will be ready to view 
at your leisure. Thank you, you’ve all been very good. Francis Neary will start 
the post-tea session from a historical point of view.
Dr Francis Neary: I wanted to say a bit about the roots of the proposal of this 
seminar, and the research we have been doing in Manchester, because some of 
the people here might be interested in some of its products. This project was 
led by Professor John Pickstone and was called ‘Innovation, Assessment and 
Hip Prosthesis’. We looked at the work of Sir John Charnley, especially his 
relationship with Thackray, but also the development of the clean-air operating 
130 Mr Alan Lettin wrote: ‘I believe that the McMinn has since been approved by the FDA.’ Note on draft 
transcript, 25 November 2006. 
131 Swann-Morton, founded in Shefﬁeld in 1932, manufactures surgical blades, scalpels and handles. See 
www.swann-morton.com/ (visited 5 June 2006).
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system, and the relationship with Howorth Air Conditioning.132 We also 
considered two wider issues, and these were particularly relevant to this seminar 
today: the early local development of THR in the ﬁve centres that we have been 
discussing.133 One other issue, which we may move on to later on, perhaps, is 
the issue we have alluded to: why so many designs of hip replacements are now 
available, and why not one won out over the 50 years that total hip replacement 
has been available? Why are there so many different prostheses on the market? 
Very quickly, turning to the book on the history of hip replacement written 
with my colleagues Julie Anderson and John Pickstone, which will be available 
next year, I believe, and a series of journal articles.134 But more topically, there’s a 
new exhibition which I have done with Simon Chaplin at the Royal College of 
Surgeons, called ‘Hip Histories’, and what it does is it looks at the Charnley hip 
from the perspective of the nurse, the engineer, the surgeon, the patient and the 
manufacturer, and looks at its development. That’s on the second ﬂoor of the 
Royal College of Surgeons’ Hunterian Museum in the temporary gallery, called 
the Qvist Gallery.135 And the other thing that I just wanted brieﬂy to say is that 
we are also developing a patient information centre at Wrightington Hospital, 
which will open at the end of the month [March 2006] and has been generously 
supported by the John Charnley Trust. It will use history to explain the risks, 
beneﬁts and unknowns of joint replacement surgery and take the patient from 
initial referral to the hospital, right the way through to surgery and recovery. And 
the plan is to also open a new Charnley Museum at Wrightington, sometime 
later in the summer.
Lettin: Thank you very much, Francis. One of the themes of research that Sir 
Christopher [Booth] mentioned to me over tea was that these innovations in 
orthopaedics, and probably in other ﬁelds too, have come not from academic 
centres, but from part-time NHS consultants, working in District General 
Hospitals. I suppose this is not quite true of the Royal National Orthopaedic 
Hospital (RNOH) at Stanmore, although many people would regard it as a 
132 For the background of the Howorth ﬁrm, see note 24.
133 Development of the total hip replacment began in Norwich (between 1940–51); Stanmore (1956); 
Wrightington (1956); Redhill (1964) and Exeter (1969). See note 6.
134 See Anderson et al. (forthcoming, 2007); Anderson (2006); Pickstone (2006); Metcalfe and Pickstone 
(2006). For details of the Manchester hip project, see www.york.ac.uk/res/iht/projects/l218252045.htm 
(visited 23 May 2006).
135 For details of the exhibition, see www.hero.ac.uk/uk/culture___sport/archives/2006/radical_surgery.cfm 
(visited 3 January 2007).
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general hospital. I know it did have pretensions at one time of being an academic 
centre, but I think this is interesting, isn’t it? Sir Christopher felt that this was 
certainly something that should be part of the record. 
But having said that, I think the next topic that we put down on paper, was 
the question of complications, because of course no operation, in spite of what 
one might hope, is ever going to be free of complications, and I suppose we did 
mention earlier the question of dislocation. That in some ways, I think, goes 
with the operative technique, and we might go on to that in a bit. The ﬁrst 
thing that we should address is the question of mechanical failure, which was 
something that happened early on, but perhaps as a result of the BSI controls 
is not as common as it once was. What about the engineers, Alan, would you 
like to say anything about mechanical failure and the design? Was the design 
responsible, perhaps, or was it a question of manufacturing, or what?
Swanson: I could say a lot or little, I should prefer the latter, and no doubt 
you will too. I suspect that most of the mechanical failures, in the sense of 
the thing breaking, were due to the manufacture of the metal components. I 
think nowadays people just don’t make cobalt chromium alloys with the kind 
of segregation of alloy elements to grain boundaries, which did happen 50 years 
ago. The composition of the so-called stainless steel has been reﬁned enormously 
over the years, and again things are added or carbon contents get lower and so 
on and so forth. All sorts of things have been done to reduce the susceptibility 
to crevice corrosion for example, so I strongly suspect that we should now see 
far, far fewer breakages of the components, mainly because of attention to 
manufacture. It’s still possible for the surgeon to put the thing in less than the 
optimum alignment, for example, which might have an effect on cup migration 
and all sorts of things. But I strongly suspect that attention to the metal alloys 
and the manufacturing thereof is what really has made the difference. 
And while I am speaking, I would like to mention another point. The thing that 
would impress me most is long-term comparisons of different procedures. Of 
course, as soon as I start to say this, everybody else here knows at least as well 
as I do that one can’t compare one procedure against another because too many 
variables are involved. And so as an engineer, I am repeatedly frustrated if anybody 
asks me, as they sometimes do, ‘I am going to hospital to have my hip replaced, 
what do you recommend?’ I have to say, ‘I am sorry, the data, as far as I know, does 
not exist, where one could separate the effect of the prostheses’ designs, prostheses’ 
materials, the surgeon’s technique, the patient selection, and so on and so forth.’ 
And I fully realize that it would be an enormous task, but it seems to me that there 
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is an enormous gap in the knowledge we have available that would shed light on 
what to do. Any engineer can look at any prosthesis and think of a reason why it 
might fail, but what really matters is how often it does fail and when.
Lettin: I think we are coming to that, certainly when we talk about results and 
follow-up. That is something which one should be able to answer and I think 
there has been a move forward, and I know it does seem that three or four 
prostheses seem to have been going for a sufﬁciently long time, with sufﬁcient 
numbers to be able to make some assessment.136 
Wroblewski: May I make a comment for the record. Between 1962 and 1968 
– the beginning of the Charnley LFA – 2500 were carried out at Wrightington 
Hospital. There was not a single revision for a loose cup, a loose or fractured 
stem: six years, 2500 operations. The ﬁrst fractured stem appeared in 1968. 
The main problem was a loss, or lack of, proximal stem support, and bending 
torsion. A loose stem followed, and ﬁnally wear and loosening of the cup.137 
So, no problems in six years and 2500 operations. The information we have 
available has passed 30 years now and it makes fascinating reading. But to say 
that information is not available, is incorrect. Secondly, my dear sir, if you are 
worried, pick yourself a good surgeon.
Older: Just to pick up, you were asking about complications in the early days. 
I have been reviewing Charnley’s low-friction arthroplasties as performed by 
Charnley himself from 1970–74, that is nearly 300 LFAs, and some patients 
are still alive and I still see them. In that series, there has been 6 per cent with 
fractures of the stem of the femoral component. Michael Wroblewski has bigger 
ﬁgures and has looked at this in greater depth. Of the 6 per cent of fractures 
– some of them even fractured 20 years after Charnley put them in – but I am 
told that since 1982, when the manufacturers started using Ortron,138 there 
hasn’t been a single fracture of the femoral stem. That is an indication of a 
technical complication associated, not entirely as Michael perhaps suggests, on 
the loading, but I think it was also a reﬂection of the nature of the metal that 
was being used by Charnley.
136 See Table 1 on page 75.
137 Charnley (1975a and b); Decoulx (1975); Olsson et al. (1981); Wroblewski (1986, 1990); Pacheco 
et al. (1988).
138 Ortron 90 is the brand name used by DePuy International Ltd, Leeds, for ISO/5832-9 stainless steel. See 
Appendix 2 for early ISO standards. 
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Lettin: So the materials are obviously very important.
Stephen: As many of you will know, but for the record: in the early Exeter 
experience, there were a series of both stem and neck breakages due to 
manufacturing errors. Firstly, the material used in the stem, and later, 
overmachining of the neck, led to fatigue failure. I would support the contention 
of the engineers; this is a feature of the manufacturing process.
Lettin: Will the BSI overcome this, will standards cover so that this shouldn’t 
happen in the future? 
Wheble: There had been work done on this subject for the BSI committee. It 
was endurance testing to see what was happening to prostheses under load. The 
rigs used examined two problems: the effects of torsion applied to the prosthesis 
when under varying load and extended time; and the effects of various loads 
when applied directly to the ball of the prosthesis with the neck unsupported 
but the stem ﬁrmly ﬁxed. These tests were continued for long periods of time, 
but as far as I am aware, they never resulted in the writing of a standard for tests 
of this type.
Lettin: But the manufacturers test them all now. They are tested in batches 
presumably, Phyllis, not individually. 
Hampson: Our manufactured items were sent weekly to Stanmore for checking 
before we were allowed to have them back, repack, and sterilize and then sell 
them. 
Lettin: Does anybody know whether every individual implant is tested against 
these standards, or just batches?
Hampson: There’s no ‘you must check’ recurrence. That doesn’t come into it. 
We agreed because that’s what John Scales wanted and we thought it was a 
good thing, but I think now this doesn’t happen. I really don’t believe that every 
company tests batches of prostheses.
Swanson: On this question of testing, Chairman, one can measure each 
individual prosthetic component, for example one can do the surface ﬁnish, 
but when it comes to fatigue testing, or corrosion testing, it can only be done on 
a sample basis, and there are well known techniques in industries where these 
things matter, like aeroplanes, which I used to be in, where there are immense 
procedures, all laid down, about the frequency of sampling, and what you do 
if one isn’t quite right, and so on. I think we should understand that with joint 
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prostheses, as with cars and aeroplanes, and everything else, we are putting our 
faith in statisticians.
Hampson: That’s probably true to a great extent. But we also had an agreement 
with Stanmore that we would keep samples of all the materials used up to seven 
years, so that if Stanmore found a hip prosthesis on their test machine that 
wasn’t working properly, or it broke or whatever, we had to go through the 
whole of the numbering system and clear every prosthesis out of stock and 
check through the materials of the samples we kept.
Lettin: But I am right in concluding that although we have these standards, 
there is no obligation on the manufacturers to meet these standards? This is a 
very unsatisfactory state of affairs, isn’t it, Rodney?
Sweetnam: Yes, but it may have changed now.139
Lettin: At least I know that you agree with me anyway. Yes, so mechanical 
failure: is there anything that you would like to say, Duncan, about mechanical 
failure?
Dowson: The only additional thing I would say is that a lot of the implant 
performance characteristics which you may wish to know do not readily emerge 
from standard simulator tests. If you are going to evaluate whether or not a 
given total hip replacement is satisfactory from the point of view of wear, it may 
be necessary to spend six months on a simulator, for each implant design, and 
this is both restrictive and expensive. You have to rely on statistical methods for 
both laboratory and clinical evaluations, sooner or later. Few current simulators 
replicate the daily cycles of loads and motions to which implants are exposed 
in vivo.
Freeman: A point of order, Chairman, under mechanical failure, do you include 
wear? Or are you just talking about fracture? You are only talking about one of 
the two components.
Lettin: I was going to talk about wear next, if that’s all right. I was actually going 
to say that a deﬁnition of a statistician is a chap who when you ask him how his 
wife is, he says, ‘Compared with whom?’ [Laughter] Perhaps we should move 
on to wear. Would you start the ball rolling, Michael?
139 See note 65.
Early Development of Total Hip Replacement
67
Freeman: I would like to know from the regulators who we have here, what the 
requirements are for the polyethylene component: are they scrutinized in any 
way, on a batch basis, before they go out? Would it be possible, for example, to 
know how much oxygen they had in them, how cross-linked they were, etc.? 
And it has been said, I believe, that wear was the major problem. I wonder 
whether we agree, as historians looking back, that the major problem was due 
to the fact not that the high-density polyethylene polymer components were 
polyethylene, but because with some exceptions they were gamma-irradiated 
in air, they came to the market to a certain extent as, actually, a low-molecular 
weight polyethylene. Are we scrutinizing the polyethylene? Have we made a 
mistake in the past?
Lettin: I don’t know. Phyllis, were you scrutinizing the polyethylene?
Hampson: No, we weren’t. We used to visit the manufacturers in Germany 
every six months to ensure that we knew what they were doing, but of course 
they repeatedly changed the formula without telling anybody, so you couldn’t 
really check the polyethylene at all. 
From the ﬂoor: So you had no idea what this stuff was? 
Hampson: No.
Ms Clare Darrah: I am sorry there is nobody here from industry today, but I 
think in their defence they do comply with very stringent European standards 
and now, certainly, with the ISO/9000.140 Quite what they all mean is a bit of a 
mystery to me, but I think we should be a little careful to say that they are not 
complying.
Tucker: May I conﬁrm that. If you ask the so-called experts, they will say that 
there are European standards for pretty well everything, including surface ﬁnish, 
high-density polyethylene, etc. [see Appendix 2]. Companies will declare their 
standards, and if you challenge them they will say that they have quality control, 
and that they are manufacturing to the standard. From what I have gleaned, 
standards are quite lax. Take surface ﬁnish, for example, particularly on HDP 
acetabulae, the range offered by European Directives is quite wide.
140 ISO/9000 (2000) is a generic name given to a group of standards developed by the British Standards 
Institution that provide a quality management system framework to ensure consistency and improvement 
of working practices. It claims to be the most commonly used international standard for an effective quality 
management. See www.bsi-emea.com/Quality/Overview/WhatisISO9000.xalter (visited 14 November 2006).
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141 Weightman et al. (1991).
Lettin: There’s certainly no obligation for the standards to be met, but if it’s 
not met, and there was some problem, then of course litigation, compensation, 
would be multiplied considerably, I would imagine.
Tucker: They have to obey the European standard.
Lettin: But we don’t know how carefully they test their products. But that would 
be in their contract.
Swanson: A very brief point, I don’t think one should shelter too conﬁdently 
behind the ISO/9000 series. My friends, who are still active in engineering 
industry, tell me this is more about the ﬁrm’s general procedures and the integrity 
of its ﬁling system, than about actually looking at the product. I could tell you 
a horror story about a bus that was falling to pieces, run by a company that is 
accredited to ISO/9000, but I won’t.
Wroblewski: I think I would like to ask Professor Swanson a question. You have 
done some work with Barry Weightman on the quality of the high-molecular 
weight polyethylene, examining explanted Charnley cups with a follow-up of 17 
years.141 Perhaps you would be kind enough to remind us what the results were?
Swanson: I know I am getting old and my memory is failing. I have no memory 
whatever of myself or Barry Weightman handling an explanted Charnley cup. I 
think you may mean Professor Dowson.
Wroblewski: No, the two of you [Weightman and Swanson] looked at wear and 
degradation, examining the worn and the unworn parts of the cup, matching 
specimens, and testing them for wear characteristics. The conclusion was that 
there was no evidence of batch-to-batch variation or degradation of the material 
in the human body.
Swanson: I suppose I had better go home and look up my own publication list. 
I am sorry I have no memory at all of this.
Lettin: Anybody else? We are still on the subject of wear. 
Dr Alex Faulkner: Sorry, not quite on the subject of wear, but we shouldn’t 
leave the topic of standards without mentioning that hip implants have just 
(in 2005) been reclassiﬁed under European Directives as a grade 3 rather than 
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a grade 2B device, which means that clinical evidence will be required for new 
prostheses in all cases, which hasn’t been the case before.142 
Lettin: Yes, there are obviously very great difﬁculties from an orthopaedic point 
of view we only really know when they go wrong, and that is after a period of 
time often, and these directives they end after a year or something don’t they, 
Keith? You only have to provide one year of follow-up or something.
Tucker: That is the case with the CE mark, but fortunately in this country we 
have now managed to loop the political problems of ‘post-market surveillance’ 
and we have National Institute for Health and Clinical Excellence (NICE) 
guidelines. NICE commissioned the NHS Purchasing and Supply Agency to 
set up the Orthopaedic Data Evaluation Panel (ODEP), which is run by Andy 
Smallwood with myself as Chairman.143 This means for a product to be sold in 
the UK the implant has to have a rating. Thus, post-market surveillance is still 
not around, as such, but if a manufacturer wishes to sell an implant to a private 
hospital in the UK or into the NHS, the implant must have a benchmark. The 
ideal benchmark is 10A, which the Charnley, the Exeter and the Stanmore, 
together with quite a few overseas and newer prostheses,144 have acquired. If you 
develop a new product you go into pre-entry (which is not a benchmark) and 
then move through the three-, ﬁve- and seven-year benchmarks before acquiring 
a 10A. During the progression to 10A the company will have to collect data on 
its implant and satisfy the ODEP criteria. Thus we have looped the European 
nuisance of not allowing post-market surveillance by having this facility. The 
ODEP panel works closely with the National Joint Registry and the idea is to 
catch out prostheses which don’t work.145 Michael [Wroblewski], I know you are 
142 Dr Alex Faulkner wrote: ‘European Commission Directive 2005/50/EC of 11 August 2005 on the 
reclassiﬁcation of hip, knee and shoulder joint replacements in the framework of Council Directive 93/42/EEC 
concerning medical devices. Ofﬁcial Journal of the European Union, 12 August 2005, L210/41–3.’ 
E-mail to Mrs Lois Reynolds, 10 October 2006.
143 For further details, see www.pasa.nhs.uk/medical/orthopaedics/odepdatabase/ (visited 1 August 2006); 
see also NICE (2000).
144 See Appendix 3, pages 101–06.
145 The National Joint Registry was launched in April 2003. The contract to establish it was awarded to AEA 
Technology in September 2002, managed by a Steering Committee chaired by Bill Darling CBE and vice 
chaired by Professor Paul Gregg, then President of the BOA [DoH Press Release 2003/0146]. Northgate 
Information Solutions took over the management of the contract from April 2006. For further details, see 
the DoH website at www.dh.gov.uk/Home/fs/en (visited 14 November 2006).
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thinking that we have a long way to go, and I am sure you are quite right, but I 
think we are getting a bit further forward.146
Lettin: This is bringing us up to date, but historically we are going on in a 
minute to follow-up and I mean this is really all we have at the moment, is long-
term follow-up, isn’t it? We haven’t really got away from wear.
Dowson: Just a comment on that, Chairman. The typical wear rate in volumetric 
terms is, of course, generally related to the polyethylene, the UHMWPE, which 
is perhaps 30 to 50 cubic millimetres a year. If you now move to a well-designed 
metal-on-metal implant – and one reason for this being done is to minimize the 
wear volume, because of the osteolysis [bone loss] problem with polyethylene 
wear debris – then the wear in the ﬁrst year or two might be 1 or 2 cubic 
millimetres, and thereafter less than one tenth of a cubic millimetre per year. 
The question is related not to just the volume of wear, but the nature of the 
wear debris. And although the wear rate of the metal-on-metal is so much lower 
– impressively lower than that of the polyethylene from the metal-on-polymer 
conﬁguration – the size of the metallic particles of the metal-on-metal joint 
wear debris is so very small, that there are several times as many metallic wear 
particles as there are polyethylene particles generated each year. And the question 
is what do these particles do in terms of biological reaction and the jury seems 
to be out on this, as I think Mike Freeman was saying earlier.147 There may be 
cause for concern, superﬁcially, but we are awaiting the hard evidence. 
Lettin: This really does bring us on to the real problem of wear. From an ordinary 
layman’s point of view, the recipient of the hip replacement is concerned whether 
146 Mr Keith Tucker wrote: ‘My recollection is that in spite of provisional recommendations by Charnley, 
and later on by Mr Robin Ling in the mid-1980s, the DoH would not heed our suggestion of a hip registry. 
When I joined the MDA (MHRA) there seemed to be complete opposition to the idea of a registry. It was 
the National Audit Ofﬁce [(2000)] that recommended a hip registry in their report on the Capital hip 
replacement debacle. This was in the mid-1990s when NICE also supported the concept of a hip registry. 
To many of us it was sad that the DoH’s attitude towards a hip registry was so negative for so long. It stated 
in the Capital hip registry report that a hip registry had been in place at the time of the introduction of the 
Capital hip [see note 198] the problems may well not have occurred, or at least have been less widespread.’ 
Fax to Mrs Lois Reynolds, 28 November 2006. See National Audit Ofﬁce (2003), which notes that by this 
time 11 per cent of hip replacements used prostheses without adequate evidence of effectiveness, and 1 in 10 
orthopaedic consultants prioritized patients on the basis of the need to meet waiting list targets.
147 See the special issue on the development of monolithic and surface replacement metal-on-metal hip 
replacements in the Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in 
Medicine 220[H2]: 1–407. See also Willert et al. (1974); Willert and Semlitsch (1976).
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it will wear out. But that isn’t really the problem. The problem is, as you have 
highlighted, the effects of the products of wear and this is not really new, this 
is old, isn’t it? You were pointing out in that ﬁrst historical period, that we are 
supposed to be considering – I don’t know whether we have exceeded our brief 
in talking about current issues – Michael Freeman was talking about the effect 
on the DNA. Your original paper, Michael, as far as I remember, was on the 
carcinogenic effects of the wear products.148 It was his paper, not yours. [From 
the ﬂoor: You shared it? Freeman: Yes, F [Freeman] comes before S [Swanson] 
in those titles.] But this was known in the period that we are talking about, the 
1950s, 1960s, 1970s.
Freeman: May we read the name Hans Willert into the record. I know he 
is not English, he was German and worked in Switzerland, but he put the 
particle pathology business on the map in the early 1970s.149 So it’s not new, 
and we could have reduced the wear rate – I don’t want to harp on this – by 
understanding the effects of irradiation on the polyethylene. It is not only that 
the manufacturers kept making different stuff [polyethylene] and supplying it 
to the implant makers, but the implant makers then sterilized it, and sent it off 
in batches, to be gamma-irradiated in air.
Lettin: And then left it on the shelves for several months.
Freeman: And then left it on the shelf, but everybody was doing it. We were 
collectively ignorant of the physical consequences of doing that to polyethylene, 
and Mike Wroblewski and Duncan know much more about this than I do, 
but it was a major problem that has been hidden under the carpet, because the 
medico–legal consequences of taking it out from under the carpet don’t bear 
thinking about.
Wroblewski: Although what you say, Mike [Freeman], is partly correct, there 
is another issue. The main problem of cup-loosening is penetration, restricting 
angular movement by impingement. If you put off the moment of impingement 
by reducing the diameter of the neck, as it is possible to do with the Charnley 
stem in Ortron from 12.5mm to 10mm, you increase the range of movement 
by 18°. You do not generate any fewer wear particles. But over the 22 years 
that it has taken me to do this study, there is a reduction in the failure of cup 
148 Swanson et al. (1973).
149 See, for example, Willert (1977); Semlitsch et al. (1977); Semlitsch and Willert (1997).
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ﬁxation of 56 per cent. So, although the volume of plastic shed into the tissues 
has increased, the incidence of cup loosening, radiologically and on revision, 
has been reduced by 56 per cent. I have spent some time with Professor Hans 
Willert of Gottingen, looking through his histology slides. I have histology 
slides with PTFE showing calciﬁcation and new bone formation.150 Professor 
Willert accepts the evidence as a healing process. We do not know the full story. 
We cannot put it all down to just wear particles and tissue reaction to wear 
particles. That is not the full story.
Lettin: I think this really brings us on to the question of loosening, doesn’t it, 
and really this is what you are saying. There’s not just one cause of loosening, 
and perhaps we should explore that now. You are suggesting in fact that it’s 
operative fault that can lead to loosening?
Wroblewski: There are two problems: one is failure of geometry, and we call 
it arthritis and for that we do hip replacement, and the second problem we 
‘create’ is ﬁxation of components. I wonder how many common-or-garden 
orthopaedic surgeons actually know to what loads the hip joint is subjected.151 
The BSI would not accept ﬁve times body weight as a standard for testing 
femoral components.
Heywood-Waddington: Could I be enlightened on that?
Lettin: Who’s going to enlighten you?
Freeman: The answer is no, I don’t have any evidence and I don’t think there 
is any evidence, Mike. As far as I know there are a series of well-founded 
theoretical anxieties, but it’s a bit like smoking, it takes a lot of years, and I 
would be very surprised if the theoretical anxieties manifested themselves in a 
population of people over the age of 60. They might do, but I would be very 
surprised, and certainly the fertility anxieties on the whole, I shouldn’t think 
would, at that age, at least I hope to God they wouldn’t, but it’s when you get 
the younger people being hit by a lifetime of raised cobalt and chromium, then 
it might be different. Might, might not, I don’t know, but it’s an issue. While 
I am on this issue, I entirely agree with Mike Wroblewski, obviously, that the 
impingement issue of the lip of the acetabulum is a big thing, and you asked me 
why resurfacing arthroplasty failed and that is one reason – the head–neck ratio 
150 Wroblewski et al. (1995).
151 See note 170.
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is all wrong – and if you put in a 180° cup, you can hardly move it at all, before 
something bangs on something else. 
Lettin: Design fault. 
Wroblewski: Maybe we should ask a different question to answer the problem 
of tissue reaction to various metals. Maybe we should ask what are the 
recommended blood levels for these metals?
Lettin: I don’t know if anybody knows.
Sweetnam: The answer is, as Michael Freeman has said, that nobody knows and 
will not know for very many years, because this is a long-term potential worry. 
But I think the message that should go from this group, of people who have 
experience of the development of hip replacement over the last 30 years or so, is 
that we, in 2006, are still very concerned about the absence of clear surveillance 
of new prostheses and new techniques, particularly large head metal-on-metal, 
and the fears – the theoretical fears – that we all know may or may not, as 
Michael [Freeman] has said, lead to serious complications at the end of the 
road. I think that is the message that we should be giving. I like to think that 
somebody may be listening. We should say that we, as a group, are worried 
about the future, the lack of surveillance and the long-term effects of released 
metal ions, particularly in those having metal-on-metal implants at an early age. 
That’s my proposition, but maybe people don’t agree.
Lettin: It will be recorded, Rodney. What do we think the main reason is in 
everyday practice for loosening? Do we think it is malposition of the components, 
in other words bad operative techniques? Is it bad cementing techniques, or is 
it these terrible wear particles? What’s the feeling about this? What is the most 
signiﬁcant cause of loosening? Does anybody know?
Wroblewski: I am very fortunate because I have access to information going 
back to November 1962. If the failure occurs in the ﬁrst six years, i.e. loosening 
of the cup or loosening of the stem, in absence of infection, the problem is almost 
always technical. From then onwards, it is wear of the cup and loosening of the 
cup. After 12 to 14 years on the femoral side, it is proximal strain shielding.
Lettin: I think everybody knows that you have got very careful follow-up at 
Wrightington. Does anybody else have a comment? What about Ian Stephen for 
Robin Ling? He very carefully follows up all his patients, as I understand it.
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Stephen: Yes, indeed, the follow-up has been meticulous and he feels that he has 
overcome the problem of stem loosening by the combination of stem geometry 
and cementing technology due to the behaviour of the double taper straight 
polished stem, which is self-tightening, and self-adjusting under load.
Lettin: Have you any comment on that, Michael?
Wroblewski: I quite agree with Ian, I think we have got to look on the 
femoral side. The design and the surgical technique must employ the common 
engineering principles that of male and female tapers engaging under load. For 
that system to become load-bearing, there must be a slip. That slip must be 
of the stem within the cement mantle. The question now concerns the stem 
design, surface ﬁnish, and the surgical technique. The problem from then 
onwards is bending torsion. We project ourselves, while walking, upwards and 
forwards, not just forwards, so the rotation is downwards and backwards. It is 
the proximal stem support which is important, so I entirely agree with Ian.
Lettin: Any other comments on the question of loosening, of how we can 
minimize it? I suppose we will never prevent it.
Freeman: May I support Rodney Sweetnam on the issue of surveillance, because 
here we are, a bunch of old men looking back at the 1960s and 1970s; we 
have 30 or 40 years of experience of this, and actually, Chairman, we can’t 
answer your question, which is why do these damn things fail? The Swedes can. 
Apparently we are supposed to conﬁne ourselves to the UK, but the Swedes 
have got a reasonable data system in Sweden,152 which enables them to answer 
your question, but we don’t know the answer.
Lettin: What is their answer?
Freeman: There’s a thing called the Swedish hip survey which I suppose depends 
on the personality of Sweden and its size and the population and one thing and 
another.153 But unless we have such a thing here, and I actually can’t imagine 
how we would ever get it into operation. If we have this meeting in 20 years 
time, we still couldn’t answer your question.
152 Ahnfelt et al. (1990); Malchau (1996). All failures after total hip arthroplasty in Sweden have been 
recorded since 1979 using medical records from every implant and revision, which were documented and 
computer analyzed.
153 Malchau (1996).
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Implant:  
cup & stem
Period No. of implants 7-year survival
% 
10-year survivial
% 
Exeter mixed
 154 
1980–1995 3758 97.0 94.9
Charnley 1979–2000 38 769 94.7 92.0
Stanmore 1979–1998 1549 96.2 91.9
Exeter matt 1980–1986 2623 92.1 86.2
Table 1: Survival rates of Charnley, Stanmore and Exeter THR. 
Extracted from the Swedish Total Hip Replacement Register of 118 572 hips implanted between 
1979–2000, arranged by 10-year survival rate. 
Malchau et al. (2002): 9, Table 1
Figure 24: Howorth publicity literature on the inﬂuence of the clean-air enclosure (the inside of 
the enclosure is shown here) and the surgeons’ full-body exhaust suit, c. 1976.
154 The Exeter stems were polished from 1970–75; matt: 1975–86; polished monolithic: 1986–88 and 
modular polished (Exeter Universal) from 1988 on. The data shown here between 1980–95 has both matt 
and polished stems. 
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Older: This is a comment, because I don’t have an answer. But we are now 
looking at what I feel is the very guts of the longevity of a prosthesis, the interface 
between the prosthesis – whatever it is – and the patient’s tissue. The interface is a 
combination of a mechanical and a biological relationship: mechanical in terms of 
the prosthesis that has been put in, and the method of the entry of that prosthesis 
chosen by the surgeon. And then there is the biological relationship: how the 
body reacts at that interface, because of what has been put in mechanically. Isn’t 
it true that in those very few moments that the surgeon puts the prosthesis in, 
both he and the patient are going to govern the longevity of the prosthesis. So 
there is a very important mechanical aspect. One of John Charnley’s favourite 
sayings was: ‘Mechanical process is far more important than metallurgy’. Of 
course, the composition of the prosthesis is important, but it is this combination 
of mechanical and biological behaviour at the interface that is going to determine 
whether that prosthesis lasts one year or 20 or 30 years. The factors that affect 
that are very multi-factorial and, as Michael Freeman and Michael Wroblewski 
have said, we still haven’t got the answer.
Lettin: All these things were known in this period that we are supposed to be 
discussing: the second half of the twentieth century and even earlier. We still don’t 
know the answer. We are supposed to be discussing the early development, and 
I suppose we have drifted a bit from that, but these problems were known, and 
they haven’t been resolved. What about infection? That was certainly known, and 
who was it, somebody said John Charnley’s original infection rate was something 
like 6 per cent? [From the ﬂoor: Nearly 9 per cent.] [See Figure 24]
We have heard a bit about the greenhouse, and this was a very big thing at 
one stage, wasn’t it? The DoH was very much concerned whether the cost of 
introducing, building, or putting clean air theatres into hospitals, and all the 
rest of it, was cost-effective. This was a very big thing, and I think there was a 
study by the MRC,155 of where the infection came from, and to my recollection 
a chap came to the BOA and told us that it all emanated from the perineum 
of the surgeons and the nurses and the immediate consequences of that was 
that nurses no longer wore dresses in theatres, but wore trousers. It didn’t seem 
to me that that stopped the appropriately offending bacteria from descending 
the trouser leg. And I thought I would carry this to its conclusion and I went 
to the theatre one day and tied string around my trousers just below the knee, 
which looked rather like those pictures you see of labourers in the ﬁelds in 
155 DHSS and MRC, Joint Working Party (1972). 
Early Development of Total Hip Replacement
77
the nineteenth century and it caused considerable hilarity among the theatre 
staff, but the next day my anaesthetist went one better and came in wearing 
cycle clips on his trousers. I suppose the clean air theatre and the exhaust tubes 
were really eliminating expired air, which the MRC study, as I understand it, 
demonstrated was not a great source of bacteria.156
Wroblewski: Up-currents, skin scales, those are also important, not just 
exhaled air.
Lettin: No, but the MRC study, as I understand it, showed [that the source of 
the bacteria] was overwhelmingly from the perineum. Does nobody remember? 
[Much laughter.] Who was the chap at the BOA, who gave the talk, was it 
Lowrie or Lourie?157
Freeman: I have nothing to contribute except that skin scales, and the perineum 
are relevant, but not the end of the story.
Sweetnam: May I just raise one point. I keep on harking back to this business 
of somebody reading this discussion in 50 or 100 years’ time, and I think one of 
the things that we ought to discuss is the question of the relevance of clean air. 
Now we all accepted as gospel that clean air is responsible for the reduction of 
sepsis. Is that so? At the same time that clean air was introduced, prophylactic 
antibiotics were also introduced and became widespread, and that was the 
recognized fallacy of the study of that time into the efﬁcacy of clean air. So has 
the drop in infection in total hip replacements been due to clean air, which 
is widely used at vast expense, or prophylactic antibiotics?158 I don’t know the 
answer, maybe somebody else does.
Lettin: Didn’t the MRC do a multi-centre trial, which included Sweden, and 
they couldn’t get enough patients to make any signiﬁcant conclusions?
156 Lidwell et al. (1982). This is the ﬁrst report on the MRC study of ultraclean air in 19 hospitals in 
England, Scotland and Sweden, 1975–79. The 4-year follow-up study of 8052 operations on hips and knees 
appears in Lidwell et al. (1987).
157 Ted Lowbury. See Lidwell et al. (1982); Lowbury and Lidwell (1978); Lidwell et al. (1987).
158 See note 169. Discussion of clean air versus antibiotics continued throughout the period. For example, a 
letter to the BMJ by the authors of the MRC study [Lidwell et al. (1983)] pointed out possible misleading 
conclusions drawn by Dr P D Meers’ editorial, was printed along with Meers’ reply [Meers (1983a and b)]. 
Freely available at Pub Med, see gateway at www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed (visited 
22 November 2006).
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Sweetnam: That is my point, it was done, but not [directly] by the MRC.159 
Actually it was inconclusive by scientiﬁc standards, because of the introduction 
of antibiotics at the same time. Indeed the authors admitted in their abstract 
that ‘the design of the study did not include a strictly controlled test of the effect 
of prophylactic antibiotics’.160
Lettin: But they evaluated the antibiotics in that study, purely and simply. My 
recollection is that it was an improvement of ten times.161
Sweetnam: I am only talking about clean air, its value is likely but not entirely 
proven. There was criticism of the trial in the correspondence columns of the 
British Medical Journal (BMJ) later.162
159 Lowbury and Lidwell (1978); Lidwell et al. (1982). See note 156.
160 Lidwell et al. (1982): 10.
161 The number of patients being operated on in all conditions who did not receive antibiotics and whose 
implant had no sepsis was 2.3 per cent, compared to 0.6 per cent of those receiving antibiotics (ﬂucloxacillin). 
Lidwell et al. (1982): 13, Table IV. See also Hill et al. (1981); Taggart et al. (2002).
162 Meers (1983a). See note 158.
Figure 25: Casella slit sampler AIR14 used in the 1960 clean air enclosure, originally developed by 
the Medical Research Council. See Bourdillon et al. (1948): 15.
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Lady Charnley: If my memory serves me right, I remember very much that 
when that study came out John was absolutely delighted that it was agreeing 
with his ﬁgures, that clean air made a potential difference to infection. And I 
would also like to remind people that he developed the body exhaust system, 
which he found tremendously beneﬁcial. I am afraid, I think it has gone out 
of fashion,163 but it did have an enormous effect on the results of infection at 
Wrightington.
Lettin: It was very comfortable, in the sense that you had nice air.
Lady Charnley: He always said it was like operating on top of a mountain.
Mr Reg Elson: The MRC trial showed conclusively, as far as I am concerned, 
that there was a summation between the effects of systemic antibiotics and clean 
air.164 At Wrightington the infection rate fell steeply with the introduction of the 
clean air enclosure, and without systemic antibiotics. There is no doubt that if, 
for example, you stand over a Petri dish in a clean-air enclosure and you wave 
your arms about in a sterile down-draught, you will get [bacterial] cultures. 
Figure 26: Two Petri dishes from a slit sampler with a rotation time of 60 minutes,  
c. 1960. Bacteria grown from air sampled: L. inside enclosure; R. outside enclosure.
163 For a discussion of the recent decline of discipline in operating theatres, see S2C2 (2004a and b).
164 Bourdillon et al. (1941, 1948); Blowers and Crew (1960); Lidwell and Williams (1960); Hughes (1988). 
The incidence of infection in hip replacement surgery from the MRC trial was less than 1 per cent in 
Lidwell et al. (1982). See note 156. See also Lidwell (1990). 
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Lettin: But all orthopaedic theatres are now clean-air theatres.
Elson: In the majority of cases replacements are done in clean air. But you 
see, illogically, some surgeons operate without a hood, only a cap, and the 
down-draught is actually dangerous.
Craven: When we were doing this work at Wrightington, I made a slit sampler 
that would run for one hour and we used to take readings all the time John 
Charnley was operating. We took readings on a 6-inch culture plate, so these 
could be sent to the lab, and check what bacteria were on it [see Figure 26]. I 
remember Charnley put John Read in a bag and had him wave his arms about, 
as this gentleman in front of me was doing, and if you had recently had a 
shower, the bacteria that came out was worse than if you hadn’t, because all your 
pores were open.
Deane: The ﬁrst clean-air enclosure outside Wrightington was set up at the 
Nufﬁeld Orthopaedic Centre in Oxford, and I was responsible for commissioning 
this enclosure. It was all very splendid. There were quite a lot of running-in 
problems, getting it the way it was meant to be, because this was the ﬁrst one 
outside Wrightington. The week after it was commissioned I wrote to Howorth, 
because of interest from a foreign visitor, who had seen these enclosures in use 
in this ﬁrst week and liked the look of them. He expressed interest in possible 
supply to his country and I agreed to enquire for him. I had a letter back, the 
second sentence of which I will never forget. It said, approximately, ‘We no 
longer supply the Howorth-type enclosure as your speciﬁcation, as we consider 
it too costly for publicly-owned hospitals’. I still have that letter. Since that 
time, the excellent concept of clean-air theatres, including the body-exhaust 
system, has developed further. I am concerned that the development of clean-
air enclosures has produced some with horizontal laminar ﬂow, and some with 
vertical laminar ﬂow, but the body-exhaust system has disappeared. I think this 
is actually producing worse conditions with the unsterile surgeon and other 
people standing in a beautiful blast of clean air and interrupting its ﬂow over 
the patient, as Reg Elson has just said.165
Freeman: If you have vertical downﬂow and then you have to worry about the 
lighting of the operating table; unless they are very carefully cleaned, the lights 
165 While at the Nufﬁeld Orthopaedic Centre, Mr Graham Deane undertook research on horizontal laminar 
air ﬂow, photographing the air ﬂow over the operating  table and surgical team. The results were not 
published. For a discussion of the recent decline of discipline in operating theatres, see the Scottish Society 
for Contamination Control (S2C2) (2004).
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are a source of dirt that is blown straight down into the wound, so the air is 
sterile at the roof, but it isn’t on the level of the wound. Could you ask them, Mr 
Chairman, what is it that we are talking about? What is the infection rate now 
in the UK? As retired surgeons, we have no idea, I don’t think, have we?
Wroblewski: 1.2 per cent over 32 years.
Freeman: No, not yours.
Wroblewski: Oh, I see.
Darrah: The Health Protection Agency now run mandatory data collection on 
one of three indicators in any hospital at any time: in neck of femur fractures, 
total hips, or total knee replacements. Data is collected for three months – and 
this is mandatory government surveillance, unlike the National Joint Registry.166 
This is how infection rates are known. The rates are published, and every hospital 
in the country has to supply the data in one of those three indications. So, 
depending on what indications you collect the data for, you have the infection 
rate for that indicator for that hospital.
Lettin: What about Norwich?
Darrah: The infection rate for total hip replacement at the moment is under 1 
per cent.167 The Health Protection Agency has a mandatory data collection for 
a three-month period, in any 12 months, and they collect the data during the 
operative stay, and up to six weeks post-operatively.
Lettin: It did drop to 1 per cent at one time, didn’t it, in John Charnley’s unit?
Wroblewski: Three months is not long enough. If you are talking about patients 
with deep infection after total hip arthroplasty, you need about four years to 
cover about 43 per cent revisions for deep infection. Deep infection, given time, 
will present itself, but it takes longer than nine months.
Lettin: So we are talking about really acute infections, the incidence of acute 
infection within the three months of the operation is 2 per cent.
Freeman: If you are saying that the infection rate in a very good hospital is 
under 2 per cent, which means it’s above 1 per cent, nearly 2 per cent, within 
three months, and you multiply that by four or ﬁve to get the long-term ﬁgure, 
166 See note 145.
167 Ms Clare Darrah wrote: ‘For January–December 2005, 0.6 per cent’. Note on draft transcript, 
3 July 2006.
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we are looking at something like 8 per cent, 10 per cent infection rate, in the 
long term.
Elson: Also, there is another factor in this: the temporal sampling of three 
months, is totally inaccurate because these things go in bursts. What Mike was 
trying to say was that three months’ sampling is a worthless measure of deep 
infection. Ninety per cent of deep infections will occur during the ﬁrst year, but 
could come in any of the ﬁrst three months, and they tend to come in bursts. 
You get bursts of infection, localized to about a week.
Professor John Pickstone: I was struck by the account of Charnley of working 
in an old hospital, in a theatre that was used by lots of other people. Is it the case 
that the infection was more of a problem at Wrightington than it was at other 
early centres, before clean-air enclosures spread?
Lettin: It was certainly regarded at the time as being quite high, wasn’t it? And 
that was why John Charnley introduced the greenhouse.
Pickstone: Yes, I know that’s why he introduced the greenhouse, but were his 
problems particularly severe because of where he was working, or was he simply 
the ﬁrst person to get to grips with these problems?
Wroblewski: Because of different surgeons [using the same theatre].
Freeman: He was the ﬁrst to get to grips with them.
Pickstone: I mean the problems of bad theatres were by no means conﬁned to 
Wrightington. Were the infection rates at other early sites much the same as 
they were at Wrightington?
Freeman: They were much worse. There were birds ﬂying around.
Tucker: I would like to touch on the historical aspect. I think that the concepts 
of ‘deep infection’ and ‘superﬁcial infection’ (the words we use today) weren’t 
terribly well deﬁned in the late 1960s. Ken McKee would sometimes see a 
wound that was discharging, and he would say that it was a ‘rejection’. I don’t 
think we understood then what was going on. Swabs were taken and came 
back from the laboratory with reports of Staphylococcus epidermidis, coagulase 
negative Staphylococcus,168 or perhaps a bowel organism. The laboratories were 
saying that these were either normal skin ﬂora or contamination. 
168 Staphylococcus epidermidis, the most important of the coagulase negative staphylococci (CoNS), can cause 
infection in in-dwelling medical devices.
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Wahlig and Buchholz (1972); Wahlig et al. (1984); Taggart et al. (2002).
We now know that these organisms are an awful nuisance, and in hindsight 
they usually indicated the presence of a deep infection with a discharging sinus. 
At the time we were living with a view, emanating from many highly regarded 
bacteriology departments, that we shouldn’t treat infection until we had isolated 
the organism. Some bacteriologists said that prophylactic antibiotics were 
totally out of order. I think it should go on record that orthopaedics taught 
bacteriology departments quite a bit around the late 1960s and early 1970s. One 
thing we haven’t recorded in our discussion is the introduction of Gentamicin-
impregnated cement following the work of Buchholz.169 For many patients this 
made a lot of difference. 
Lettin: That is really going back to our original terms of reference, so to speak, 
and we have moved on quite a bit. I think probably this would be the appropriate 
time to move on to revision before we ﬁnally wind up with results and follow-
up. Reg [Elson], perhaps you would like to talk about revision, the most difﬁcult 
cause of which was infection, but no doubt you will embrace all the reasons for 
revising things and how difﬁcult it could be in mere mortals’ hands. 
Elson: I wondered what to say on the train coming down, and I am still 
wondering now. I have probably done as many revision hips and probably 
knees, as anybody else in the room. I have industrial deafness as a result of 
working with Charnley, that terrible noise of air rush against your eardrums: I 
am thinking of suing. 
Now it’s axiomatic that every hip will wear out, break, fall out, if the patient 
lives long enough. I am amazed that so many colleagues still will allow patients 
to do whatever they like in terms of physical activity; you see these glamorous 
photographs, in ﬁlms, of people playing tennis or skiing. Recently I have done 
a study on the actual loading of the hip in certain postures, and if – as the Swiss 
do, they allow their patients to go skiing – the load that you can calculate on 
the hip, is way above anything [John] Paul taught us: about 5.8 x bodyweight 
for normal brisk walking, ten times body weight, quite apart from any extra 
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170 Professor John Paul wrote: ‘The Biomechanics Group at the University of Strathclyde was asked by Mr 
James Tulloch Brown FRCS  to assist in the design of a device for ﬁxation of femoral neck fractures. A review 
of the literature provided the value of hip joint force of 2.4 times body weight when standing on one leg 
[Inman (1947); Pauwels (1935)] and the inter-segment forces and moments at the hip during level walking 
[Bresler and Frankel (1950)], but no values of joint force in walking had been established. We set up a gait 
laboratory, manufacturing a force platform for ground-to-foot force measurement and arranging two 16mm 
cine cameras viewing from the front and the side of the test subjects, which allowed determination of the 
three-dimensional coordinates deﬁning the position of the pelvis. This allowed us to calculate the inter-
segment force and moments acting between the thigh and the pelvis. Values of forces in the relevant muscles 
were calculated by selections from the two groups of extensor muscles, two groups of ﬂexors and one group for 
abductors and one for adductors. The joint force was then calculated from the ground force and the relevant 
muscle forces at time intervals of 0.02 seconds. The calculated joint force values were from 2 to 9 times body 
weight (a mean of 4.53). The 9 times value was developed by one subject walking at 2 m/s [metres/second] 
with a stride length of 2.2m. These studies suggest that the hip joint force in walking depends largely on 
the product of body weight and stride length. Joint forces of 6.6 and 5.8 times body weight respectively 
were found, and entry or leaving a car at 5.3 times. Mr Reg Elson [page 83] must be extrapolating from the 
foregoing data since we have not undertaken tests on runners. Tests undertaken on two of the patients who 
had received the telemetering hip joint replacement developed by Bergmann et al. [(1993)] gave curves of 
variation with time similar to those calculated from gait analysis although the maximum values differed by 
approximately 16 per cent on average. An important feature of hip joint loading is the direction of the joint 
force relative to the axis of the femur. In walking, this may be 35 degrees in the frontal plane and 15 degrees 
in the sagittal plane. The latter gives rise to a strong twisting moment between a femoral implant and the shaft 
of the femur and the effect will be greater in stair negotiation and sprinting.’ E-mail to Mrs Lois Reynolds, 
29 October 2006. See Paul (1966, 1999, 2005); Markolf et al. (1979); Berme and Paul (1979); Stansﬁeld 
et al. (2003). See also van den Bogert et al. (1999).
171 Stephenson et al. (1991).
dynamic component.170 It is extraordinary. But somebody standing with their 
hip at 90°, the inward force on that hip is beyond belief. I cannot believe that 
there will not be a need for revision in the future. 
I came on to the scene at a time of operating, relatively speaking. I had the 
beneﬁts of the English trio: Ring, Charnley and McKee. They had all the 
ingredients, albeit with different materials and the like, except for titanium and 
for HAC [hydroxyapatite coating].171 When the hip escaped from this country, it 
was largely the polyethylene against polished metal that was the popular image, 
and once it was released, especially in the US, because of the crude method 
of operating, without even the instruction that people [surgeons] would get 
from Wrightington, there was a vast failure rate. But it was also happening 
in this country, proportionally the same, I suspect. Alongside this, there was 
a lot of development activity on the Continent, although we live next door 
to them, remarkably we know nothing about [their work]. Now, if we forget 
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et al. (2000).
173 A radiolucent zone in an X-ray permits the passage of X-rays, unlike one that is radio-opaque.
174 See Table 1, page 75.
infection, which is one source of loosening (I will return to this later, if there’s 
time), the main serious problem is one of mechanical loosening – instability, 
dislocation and impingement – something that is obvious quickly. Mechanical 
loosening, so-called, is due to osteolysis, due to whatever cause – and that can 
be a bad surgeon, as has been shown in the Trent Regional Arthroplasty panel.172 
Otherwise it can simply be due to polyethylene debris. Now Michael Freeman 
was pivotal in my development in this train of thought, at an illustrious meeting 
in Paris that shall be nameless, I think, 20 years ago. Michael gave a lecture, 
which was unique in my experience, because he produced one slide which was 
a failed, cemented prosthesis, with all the characteristic ﬂufﬁness and in the 
radiolucent zones.173 He then challenged the audience to say what could be done 
to revise this. Dutifully, because I was a cementer, I put my hand up and said, 
‘I would cement it’. Subsequently, after that brilliant presentation, which you 
[Michael Freeman] don’t remember, but which changed my view, to the fact 
that revision surgery almost certainly should entail uncemented components, 
unless you are dealing with some impossible situation with very, very thin weak 
bone, or perhaps a stove-type femur, or perhaps an acetabulum that’s gone right 
through. Forgetting infection, I think that non-cemented revision is probably 
going to be the answer. I feel sad about it, because I have always been a cementer, 
but I must confess that if I were beginning again, I would be an un-cementer. I 
would still want to have cement available, and I would still want to know how 
to use it, because it is a very special tool, that has, I think, a special place. 
I want to pay tribute to Hans Buchholz, a name that has been mentioned. 
Buchholz produced a most remarkable series of joint replacements, the principles 
of which have survived, but he also introduced this naive concept of throwing 
some antibiotics into the cement and it would give you protection. There is no 
doubt that it does. Whether that’s a good thing, or whether we should be purists 
and rely on prophylactic antibiotics or clean air or both preferably, is not part of 
the argument. I think I will ﬁnish by just saying that failure is terribly important, 
it’s very important that we have revisions, because if you don’t have revisions, you 
wouldn’t really know which was the best prosthesis to use, would you?174
Lettin: Before you ﬁnish in terms of revision, may I ask when the concept of 
immediate replacement began in this period that we are considering? Initially 
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you did nothing, you basically left it [From the ﬂoor: Are you talking about 
infection?] [Yes], with an excision arthroplasty.
Elson: Until Buchholz introduced the one-stage – and sometimes two-stage 
– replacement with antibiotic-loaded cement, the majority of Charnley’s cases 
were always converted to a pseudoarthrosis, which was the only thing that could 
be done. I was privileged to treat some of John Charnley’s infections; there were 
very, very few, as you might imagine, and he didn’t believe in the Buchholz 
technique at ﬁrst.175
Lettin: It went against the accepted normal surgical principle didn’t it, to put 
foreign material into an infected area.
Elson: Absolutely, but there is no question that it works and it protects, for 
example, in morselized grafting, if you choose to go down that line.
Lettin: What was the date of that? When did we start?
Elson: As far as I am concerned, 1978.
Lettin: That was what I wanted to get down, because this was rather a big thing 
wasn’t it.
Elson: I thought it was, and I did some animal studies in this country and 
checked the various things that Buchholz recommended and it all seemed to ﬁt 
together.176 I remember Buchholz putting his hand on my shoulder and saying, 
‘Elson, you will come and work for me in Germany’, and I said, ‘Not on your 
nelly’. Anyway I went to Germany for a year – Buchholz had his faults – there’s 
no question – but he had charisma. 
I will tell you one little story. Buchholz came across just after the war, met 
Charnley, who wouldn’t talk to him because he had a sabre scar on his face. 
Charnley sent him away again, but Buchholz came back and by that time we 
were in the RCH 1000 high-density polyethylene era [1965]. Buchholz asked 
Charnley, ‘What is this stuff?’ He had already been to see Maurice Müller, and 
Maurice had got the magic formula from Charnley. Müller said, ‘Oh, it’s a trade 
secret’ and wouldn’t tell him. Charnley said to Buchholz: ‘The stuff was made 
in your country, you might as well use it, mightn’t you?’
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Lettin: I think you haven’t told us your contribution to this, but perhaps John 
Read, who was also a reviser, will tell us about these early revision techniques?
Read: The earliest revision technique was taking everything out and trying to 
cure the infection, and then often leaving them as a Girdlestone.177 Later we 
started revising them, and with antibiotic-loaded cement.
Lettin: Ian Stephen has gone, I think, because he would probably, well, Robin 
Ling would have a lot to say on the subject of putting bone grafts in and other 
things into infected surgical beds.178 
Elson: Alan, I think we should distinguish between revision for sterile loosening 
and for infection, they are two different things, except that in both the endosteal 
surface of the femur is damaged; very quickly it becomes smooth and glass-like 
and slimey, and is totally unsuited for cementing.179 I spent hours and hours and 
hours trying to cut grooves to give some key, but however carefully you do it, you 
cannot mimic the virgin rugose endosteal surface. Once the failure is recognized 
to be sufﬁciently progressive, revision should be done as soon as possible.
Lettin: I think we will have to press on. Has anybody anything else to say? 
Keith.
Tucker: We haven’t mentioned anaesthetists and anaesthetics. I wonder if we 
could, just for a moment, because they are quite important from the historical 
perspective. I remember how worried we were when cement was introduced to 
the femoral canal, when, with pressurization, occasionally patients could die.180 
The anaesthetists at that time tried to get the blood pressure up because they 
were worried about it falling, something of a reverse from today’s practice. Hip 
surgery has promoted specialist anaesthetists who now understand the use of 
spinal anaesthetics, epidurals, etc., and this has made hip replacement a lot safer. 
In the late 1960s and through the 1970s most patients had three units of blood 
as a minimum for a hip replacement, but with the advances of anaesthesia and 
the better understanding of haemodynamics, nowadays, many patients don’t 
have a transfusion.
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Lettin: Yes, most of you probably remember that Hugh Phillips and I and my 
anaesthetist published a paper in the British Medical Journal (BMJ) – only the 
second one I ever had in the BMJ – and that was on the cardiovascular effects 
of implanted acrylic cement.181 This ﬁts in with what I was saying earlier about 
this chap at North Hill Plastics,182 because he paid for a technician, but I am 
not going to go into that any further. It was something that concerned the 
DoH, which set up a working party on it, because people were getting alarmed 
about patients dying while having mainly cemented Thompson’s prostheses for 
fractures, rather than THR. We won’t pursue that, but you are quite right that 
the advances in anaesthetics are very important. 
We are getting close to time and we ought just to talk about the results of follow-
up, and we have heard how difﬁcult it is and how we haven’t done our job 
properly, but Michael Wroblewski certainly has. I beg your pardon, Graham.
Deane: Sorry, I didn’t manage to catch your eye, Chairman, on a point on 
anaesthetics. When I was in Oxford, this business of drop in blood pressure 
associated with cement was being looked into. They came to the conclusion – I 
am a little bit hazy on this, not knowing the anaesthetic side – that the use of a 
neuroleptic-analgesic type of general anaesthetic seemed to avoid this particular 
problem. 
Another aside as well, there was another particular anaesthetic problem with 
the airway in juvenile rheumatoids. Malcolm Swann knows better than I do, 
and along with my predecessor George Arden, that operating on juvenile 
rheumatoids’ hips in the days before the laryngeal mask was hazardous, due to the 
dreadful airway they so often had that prevented intubation. The anaesthetists 
used a clever drug called ketamine. Now, the side effect of ketamine, from the 
surgeon’s point of view, is that everything can bleed profusely, making control 
of the bleeding difﬁcult. I am sure Malcolm Swann will probably add to this, 
that ketamine added to the difﬁculties of surgery already complicated by the 
distorted anatomy of these children. However, ketamine made it possible to 
perform surgery safely. It has now gone out of use with the development of 
newer techniques such as the laryngeal mask that can deal with the difﬁcult 
airway and has made a lot of difference to this aspect.183 
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Lettin: Am I right in thinking that at Norwich you have a pretty comprehensive 
follow-up of McKee’s replacements? Who’s going to answer that, Keith or your 
follow-up lady Clare Darrah?
Tucker: In 2005 the British Hip Society invited practitioners who work with 
hip surgeons to come to our annual scientiﬁc meeting. It was recognized that 
there were many people up and down the country helping with the evaluation 
of hip replacements and the management of patients post-operatively. After the 
meeting, the Arthroplasty Care Practitioners Association was born, through the 
efforts of Clare Darrah here and her colleagues.184 Thus, through hip replacement 
another step forward has been made in the care and long-term follow-up of hip 
replacements.
Darrah: For those of you who don’t know, I have been employed at Norwich 
for the last ten years and been involved in what we call our joint replacement 
follow-up programme, so we are keeping an eye on all of our implants in 
Norwich, some of them very historical, and some are more recent. We have 
just founded the Arthroplasty Care Practitioners Association, who are mainly 
physiotherapists and nurses working with orthopaedic surgeons around the 
country, collecting data, so I hope that the tide has turned and that with the 
National Joint Register doing its bit as well, that we are actually going to have 
better outcome data in the next ten or 15 years.
Lettin: What about McKee’s early results? Michael Wroblewski can go back 
to Charnley’s results, with almost continuous records from the beginning, as 
I understand it. Can you do that with McKee or not? [Tucker: No.] We can’t 
really have a comparison of the long-term results from metal-on-metal, and the 
metal-on-plastic.185 
Heywood-Waddington: Chairman, as part of my preparation for this meeting, 
I reviewed my own ‘audit’, as I like to call it, of the early McKee replacements 
to compare them with each other and with my own, while I still did these 
operations. I also tried to take account of any modiﬁcations introduced. I 
Early Development of Total Hip Replacement
90
186 See note 95.
187 McKee (1974, 1982); McKee and Chen (1973).
188 Dandy and Theodorou (1975). A retrospective review of 1042 McKee–Farrar prostheses inserted in 
Norwich from January 1965 to December 1972.
189 For Charnley survivorship analysis, see Wroblewski et al. (2002); for the Stanmore, see Dobbs (1980). 
Survivorship was determined from modiﬁed life tables according to Armitage (1971): 408–14. 
obtained information formally, and was privy to those minuted at the meeting 
in Austria every year, until about 1979, 1980.186 Among these were papers by 
McKee himself, giving his 10-year and 12-year follow-ups of his own hips,187 
and by Christopher Partridge from Worthing. There was also a paper by 
Dandy and Theodorou, comprising a restrospective review of 1042 McKee hip 
replacements, performed in Norwich between 1965–72. One in 12 of these 
required revision at some stage.188 I also entered into informal correspondence 
with colleagues I knew to be performing this operation. 
From all this evidence I came to the conclusion that the overall results were 
remarkably similar, irrespective of whether the surgeons concerned had 
received formal training in Norwich, or not, and independently of any minor 
modiﬁcation to the technique that they may have introduced, and irrespective 
of the ‘learning curve’. There was about 85 per cent to 90 per cent patient 
satisfaction rate up to ﬁve years and an ultimate 10 per cent to 15 per cent 
revision rate overall. As one would expect, most of the early revisions were due 
to surgical error rather than inherent defect. 
Wroblewski: When we talk about long-term results, and long not being deﬁned, 
there is one thing that I don’t think that anybody – I don’t only mean here, but 
anywhere – has actually realized that long-term results can only be achieved in 
young patients. So, when we talk about long-term results, they are results in 
young patients. Let me give you a bit of information, if I may. If we assume that 
all the patients are operated on day one as we do for survivorship analysis,189 for 
every year of follow-up, the mean age of patients at primary surgery, those that 
are still attending, declines by eight months. So to get a 25-year follow-up, that 
patient at the time of surgery must have been about 50. So it is not just long-
term results, but long-term results in young patients. So when we hear that a 
new design or material, especially metal-on-metal, is suitable for young patients, 
the question is: ‘Have you got long-term follow-up?’ Long-term follow-ups are 
results in young patients.
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Lettin: What about your follow-ups of the early Charnley replacements? 
Wroblewski: Those that are alive? You see, originally the patients’ mean age 
was 65, and that has basically remained unchanged. We have early results. The 
longest follow-up we at Wrightington have is 42 years and going strong.190
Lettin: But in terms of the proportions of those early ones?
Wroblewski: It is age, how old those patients were at the time of surgery.
Lettin: But in terms of the survival analysis which takes that into consideration, 
as you have already said, how does that compare with McKee?
Wroblewski: I don’t know what the McKee results are, but if we look at patients 
with rheumatoid arthritis, a mean age of 36 years at the time of surgery, and all 
under the age of 51 by the 32-year follow-up, the patient dies before revision 
becomes indicated, the arthroplasty outlasts the patient.191 
Tucker: I want to point out, for the historical record, that today’s meeting has 
reinforced and added to what has been happening over the past 30 years. Hip 
surgeons have been dedicated to keeping records and everything we have been 
talking about today bears witness to this. Out of hip replacement has come 
the Journal of Arthroplasty, which Mike Freeman has run so well [as European 
Editor, 1996 to 2001],192 and endless articles in the JBJS (Journal of Bone and 
Joint Surgery).193 This is part of our history, but it has stimulated orthopaedic 
surgeons to look even more critically at what they do and continue to do. 
Lettin: I am going to ask Peter Ring if he would like the last word. He almost had 
the ﬁrst one, and hasn’t really said a great deal, although he has lived through all 
of this. What about your own results, Peter?
Ring: The results which I have had fall into two groups. If you use uncemented 
metal-on-metal implants, you can get a 20-year survivorship of 95 per cent. If 
you use uncemented metal-on-plastic, it’s much less good. I don’t know what 
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194 Godsiff et al. (1992). See also Fitzpatrick et al. (1998). This review found the most favourable prostheses 
in terms of revision rates, at that time, were the Exeter, the Lubinus IP, a German prosthesis, and the 
Charnley.
195 Salvati et al. (1982). 
196 Ring (1974).
197 Ring (1978, 1981, 1983); Bertin et al. (1985).
20 years is, but even at 10 to 12 years, you are looking at 10 to 12 per cent of 
failures, and the difference between the two is clearly the effect of polyethylene 
debris upon the interface both on the outside of the cup and on the femoral 
side. Of the metal-on-metal debris, which we have seen, there have been three 
or four examples of aggregates of metal forming cysts near the joint, but that 
is no more than three or four in some 1200 patients.194 We have looked at the 
interface between the implant and bone in loosening implants, and certainly 
you get metal debris down there, but you do not seem to get a reaction at that 
point. So there may be some problems with the long-term effects of metal, but 
the survivorship does look quite good. 
The other thing that strikes me, having listened to this, is that I operated for 
most of my time within a theatre that was also used by a gynaecological team 
and occasionally for a general surgical emergency. We used a horizontal laminar 
air ﬂow system,195 no exhausts or anything like that, and the advantage of your 
horizontal system is that you can sterilize all your implements and apart from 
the implants, you have got everything ready there, everything for the actual 
replacement, everything for breaking the femur when you put the implant in 
too tightly, and that has a great advantage, and it seemed to us to be better 
than the vertical system. And as far as infection was concerned, we were able 
to do 1000 metal-on-metal implants without anything other than superﬁcial 
infection.196 So I think when people talk about the infection rate in total hip 
replacement, it’s got to be associated with the statement that these are implants 
that are cemented into position, and I do think there is a difference. Most people 
with uncemented implants don’t look upon infection as a major problem.197 
Sweetnam: May I just brieﬂy ask one question. All of us here have the 
accumulated experience of witnessing the development of hip surgery. We have 
lived through a most exciting time in surgery, and, in fact, I think we have been 
discussing one of the greatest advances in surgery ever. We have made some 
mistakes along the way, I am sure, and I just wonder whether there is any view 
that we ought to give to those people who may be reading this in many years’ 
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198 For example, in 1998 the DoH issued a Hazard Warning Notice [HN9801] due to ‘poor short-
term performance of the femoral component’ to hospitals to recall and review all patients who received 
a 3-M™ Capital™ Hip implant between 1991–97, when the device was discontinued, less than 2 per 
cent of UK hip replacement operations over that period. A fund established by 3M Healthcare paid for 
clinical review and revision if needed, for these patients, which closed in 2003, leaving further care to the 
NHS. See www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ 
ID=4024446&chk=AMG%2BAI; and www.dh.gov.uk/assetRoot/04/01/49/75/04014975.pdf (visited 14 
November 2006). National Audit Ofﬁce (2000).
time, as to how those mistakes might be avoided in the future and particularly 
what the mistakes were. I think it’s quite important, looking back over 30 years 
of a new surgical procedure, to note that it was a triumph in the end for the vast 
majority of patients, but a failure for some less fortunate, who were in receipt of 
less than perfect prostheses.198 
Lettin: I have tried to get people to say what they think were the causes of hip 
failure, and I didn’t really have a great deal of success in pinning down people 
as to whether it was technical. I think John Older probably summed it all up by 
saying that it was a mixture of all these things. I don’t know whether you feel 
that you can do any better.
Sweetnam: I only asked the question because I knew the answer. The answer is 
that we have failed miserably in surveillance. I mean we have been watching a 
new procedure develop over 35, maybe 40 years, and we are still asking questions 
that we can’t answer because we do not have the correct surveillance procedures 
in place and I think personally that’s the message for the future.
Freeman: May I add something to that? I totally agree, and although there is no 
convincing evidence, I don’t think that new implants are any better. So it may 
be true that we are moving forwards, but I am not sure that we have evidence 
that we are moving forwards, since the opening period that you described, 
Chairman.
Mr Michael Wilson: Could I just say I am extremely happy to be here today in 
this august company and one of the things that my father [‘Ginger’ Wilson] was 
very keen on, was to take notes, meticulous notes, and we have a cellar full of 
patients’ records, which he referred to occasionally if anyone rang up. He could 
ﬁnd them within about a matter of minutes, through an extraordinary cross-
ﬁling index that I never really understood myself. But that was one of his great 
things, that things should be written down and noted particularly. The other 
thing was that, I think, part of the reason that John Scales dealt exclusively with 
Early Development of Total Hip Replacement
94
Phyllis’ company, was that they wanted to cut down on any variables so that the 
quality of the materials they received wasn’t in question and obviously that helps 
with the analysis of data later on. 
Lettin: I think we have to bring things to a conclusion. 
Dowson: The discussion brings to mind one of Winston Churchill’s 
observations:199 ‘Success is never ﬁnal’.
Lettin: Thank you very much, everyone, for keeping very much to time and I 
hope that the Wellcome Trust’s History of Twentieth Century Medicine Group 
have what they wanted. We have drifted away from history, I am afraid, and 
come up to the present time, but there we are, that’s the way it went. You 
wanted a free and easy discussion.
Christie: Absolutely. I want to thank you all for participating in this afternoon’s 
seminar and also to thank Alan Lettin for his excellent chairing of this 
occasion.
199 Enright (ed.) (2001): 92.
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Appendix 1 
Notes on Materials by Professor Alan Swanson200
Metallic Alloys
Corrosion-resisting steel 
(stainless steel)
Iron (Fe) plus a small percentage of carbon (C) and about 20 per 
cent chromium (Cr) and 10 per cent nickel (Ni). Driven largely 
by the needs of joint replacement, both the composition and the 
manufacture of the surgical grades have been reﬁned until they 
are now very different from the general-purpose alloys from 
which they are derived, with many other constituents to improve 
resistance to fatigue and corrosion. Its strength varies according to 
whether it is annealed or coldworked. 
Cobalt–chromium alloys Cobalt (Co) with a substantial percentage of chromium (Cr) 
and smaller quantities of other elements. Highly resistant to wear 
and corrosion (for example, as hard facings in earth-moving 
machinery) and used by dentists because of their suitability for 
precision-investment casting and their corrosion resistance. Fifty 
years ago, and probably is still, the only alloy type that can be 
seriously considered for both surfaces of one bearing. Nobody has 
yet produced or discovered another material, or if they have, it is 
impossibly expensive.
Titanium alloys Titanium (Ti) is lighter than steel or cobalt and has good corrosion 
resistance, but it and its alloys were very expensive 50 years 
ago and very difﬁcult to manufacture. Titanium alloys retain their 
strength and stiffness to higher temperatures than do aluminium 
alloys, so they are used for aircraft that ﬂy fast enough (signiﬁcantly 
supersonic) to undergo signiﬁcant kinetic heating. The needs of 
the aerospace industry had led to development which made it 
practical, and an alloy with some aluminium and vanadium in it 
was being used for femoral prostheses by 1978. The Standard was 
revised and republished in 1996. 
200 Additional information provided by Mr Ravi Kunzru and Mr Victor Wheble. 
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Polymers
Polymethylmethacrylate 
(PMMA)  
(Perspex®, Plexiglass®)
Used as a solid material by the Judet brothers for femoral heads 
[Judet and Judet (1950), see also Appendix 3], but has been a 
major factor in hip replacement since c. 1960.  
Used as the monomer, with an accelerator, and inserted between 
prosthesis and bone and allowed to polymerize in situ, it takes 
about 10 minutes to form bone cement.
Two proprietary brands of PMMA were used in the UK: CMW 
and Simplex [North Hill Plastics], essentially the same chemically, 
but different in detail. Charnley used CMW. See note 9.
Polytetraﬂuorethylene (PTFE)  
(Fluon®, Teﬂon®)
Low friction, but not particularly wear-resistant. See Figure 4.
Polyethylene 
(UHMWPE, HDP)
Took over from PTFE in 1961 as the material of choice for the 
plastic element of a metal-on-plastic bearing in hip replacement. 
Friction is higher than with PTFE, but still much lower than metal-
on-metal, and the mechanical properties are better, leading to 
better wear resistance. Widely used outside orthopaedics, but the 
needs of joint replacement have driven developments to obtain 
better wear performance, particularly by increasing the length 
of the molecular chains to give ultra-high molecular weight and 
high-density versions. As with all polymers, the additives that are 
usual for non-surgical purposes (ﬁllers, colours, lubricants) must be 
strictly controlled or eliminated.
Ceramics
Alumina  
(aluminium oxide)
Like most metallic oxides, this ceramic is hard and capable of being 
ﬁnished to a very high polish with suitable machinery. It is found 
in less-reﬁned forms in general engineering where its brittleness 
is acceptable, but the orthopaedic form is less brittle and more 
homogeneous, permitting better surface ﬁnish and lower wear 
rates.
Zirconia 
(zirconium oxide)
One of many other ceramics that are potentially useful to 
orthopaedics and has been used as an alloying constituent with 
alumina.
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Appendix 2
Surgical implant material standards, 1960–70s  
by Mr Victor Wheble (28 June 2006)
There were a few British standards available for materials used in making 
prostheses in 1960–70 and standardization work was just beginning in this 
ﬁeld, possibly also in other countries.201 There were no generally accepted 
International Standards at that time. The British Standard for wrought stainless 
steel (BS3531) was only made redundant when suitable International Standards 
were ﬁnally developed. The ﬁrst group of these were published in 1970 and 
included stainless steels and chrome–cobalt alloys, followed by titanium and 
titanium alloys in 1979, though work at the international level on many of the 
other metallic materials had commenced in 1972. At the beginning it was a 
bit of a ‘free for all’, though the British were working towards standardization 
of other materials, and there was standardization activity in France, Germany, 
Switzerland and the USA. New materials were being suggested from time to 
time, but they were not always accepted for Standardization.
The inaugural meeting of the ISO Technical Committee [ISO/TC150] took 
place in London in 1972, and a start was made at a meeting in Pforzheim, 
Germany, in the following year. At the second meeting in Copenhagen, 
Sweden, in 1975, discussion took place on the standardization of such matters 
as materials for implants. A task group at that conference was set up to look at 
quality control as this was the beginning of the system of making international 
standards for bone and joint replacements. The large number of relevant ISO 
standards that subsequently appeared has been increased further as a result of the 
European Union (EU) setting up their CEN standards organization. Most of 
the CEN standards are the same, in essence, as those produced by ISO, because 
they are generally written by the same delegates. The only serious difference 
between ISO and CEN standards is the legal requirement for compliance with 
CEN standards throughout the EU. ISO standards are not legally binding in all 
the world, but they are accepted in most of the countries involved in implant 
manufacture, and companies who make implants do have to be careful how 
they produce their products. Such standards are not as rigid as they would be 
201 Scales (1965) describes the early work of the British Standards Committee, SGC/18, under the 
chairmanship of Mr Norman Capener, and the creation of BS3531:1962, the basic requirements for metal 
surgical implants, twist drills and screwdrivers. See also Capener (1965); British Standards Institution 
(1962, 1964). BS3531-1 covered stainless steel; and BS3531-2 cobalt-chromium alloys.
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if they were legally binding, but perhaps they do constitute the best available 
method of quality control that is acceptable by manufacturers on a worldwide 
basis. I must emphasize, however, that the CEN standards do have legal status 
in the EU.
I have no record of other relevant British Standard numbers before 1978, but 
there were many heated discussions in the BSI and ISO meetings on the subject 
of materials between 1967 and 1978. Materials supplied to manufacturers in 
England during the 1970s would have been made to such British Standards as 
existed. I doubt whether there were British Standards on other materials than 
stainless steel. It is more likely that various formulae for chrome–cobalt alloys 
were being used by different manufacturers and probably the same situation 
applied with other materials, like titanium and the titanium alloys. (The ‘DIS’ 
in the standards numbering system means a Draft International Standard that 
is not yet fully approved.) 
All International Standards are brought to attention every ﬁve years and if 
necessary they are then revised, but more often are accepted for a further ﬁve-
year period. ASTM Standards are American in origin and are also revised in the 
same way. Some of these eventually become ISO Standards after revision.
The International Organization for Standardization (ISO) produces Standards 
for metallic materials that are generally acceptable worldwide.202 If there is a 
need to quote the compositions of these materials, the details can be obtained 
from the ISO Central Secretariat at 1 Rue de Varembe, Case postale 56, 
CH-1211 Genève 20, Switzerland (Tel +41 22 749 01 11, or the Sales Department 
+41 22 734 10 79); catalogue available at www.iso.org/iso/en/CatalogueListPage.
CatalogueList (visited 11 July 2006). 
202 See, for example, BS EN 12010:1998. Non-active surgical implants, joint replacement implants, 
particular requirements. The international equivalent is EN 12010:1998, which covers implants (surgical), 
joints (anatomy), orthopaedic equipment, prosthetic devices, performance, life (durability), surface texture, 
marking, inspection, sterilization (hygiene), instructions for use, compatibility, metals, alloys, non-metals, 
and medical equipment. Standards that apply are: ISO/5832-1:1997; ISO/5832-2:1993; ISO/5832-
3:1996; ISO/5832-4:1996; ISO/5832-5:1993; ISO/5832-6:1997; ISO/5832-7:1994; ISO/5832-8:1997; 
ISO/5832-9:1995; ISO/5832-10:1996; ISO/5832-11:1994; ISO/5832-12:1996; ISO/5833:1992; 
ISO/5834-1:1997; ISO/5834-2:1997; ISO/6474:1994; ISO/13356; ISO/5839:1985; ISO/6018:1987; 
ISO/7206-1:1995; ISO/7206-4:1989; ISO/7206-5:1992; ISO/7206-6:1992; ISO/7206-8:1995; 
ISO/7206-9:1994; ISO/7207-1:1994; ISO/DIS 7207-2:1996; ISO/8828:1988; ISO/TR 9325:1989; 
ISO/TR 9326:1989; ISO/9583:1993; ISO/9584:1993; BS6324-1; BS6324-2; BS6324-3; BS6324-4; 
BS6324-5; ASTM F 746; ASTM F 897; ASTM F 1147; ASTM F 1223; ASTM F 370; ASTM F 604; 
ASTM F 997; ASTM F 1185; ASTM F 1351; ASTM F 1378; NF S 94-065; 93/42/EEC; 
EN ISO/14630:1997; ISO/7206-2:1996; ISO/14630:1997.
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Relevant standards for surgical implants during the period 1970–96
(a) Metallic materials
Part 1: Wrought stainless steel 
British Standard, BS 3531:1968.
ISO/DIS 5832–1. (1970)
Part 2: Unalloyed titanium 
Revised 1993.
ISO/5832–2. (1978)
Part 3: Wrought titanium-6-aluminium 4-vanadium alloy 
Revised, 1980, 1996. 
ISO/5832–3. (1978)
Part 4: Cobalt–chromium–molybdenum casting alloy 
Revised, 1996.
ISO/5832–4. (1978)
Part 5: Wrought cobalt–chromium–tungsten–nickel alloy 
Revised, 1993, 1997.
ISO/5832–5. (1980)
Part 6: Wrought cobalt–nickel–chromium–molybdenum alloy  
Revised, 1997.
ISO/5832–6. (1980)
Part 7: Forgeable and cold-formed cobalt–chromium–nickel 
molybdenum–iron alloy
ISO/5832–7. (1994)
Part 8: Wrought cobalt–nickel–chromium–molybdenum– 
tungsten–iron alloy. Revised, 1997.
ISO/5832–8. (1987)
Part 9: Wrought high nitrogen stainless steel  
Revised, 1995.
ISO/5832–9. (1992)
Part 10: Wrought titanium 5-aluminium 2.5–iron alloy 
Revised, 1996.
ISO/5832–10. (1993)
Part 11: Wrought titanium 6-aluminium 7-niobium alloy ISO/5832–11: (1994)
Part 12: Wrought cobalt–chromium–molybdenum alloy ISO/5832–12: (1997)
(b) Other materials
Implants for surgery – acrylic resin cements ISO/5833: (1992)
Ultra-high Molecular Weight Polyethylene (UHMWPE):  
Part 1: Powder form
ISO/5834–1: (1985)
Ultra-high Molecular Weight Polyethylene (UHMWPE):  
Part 2: Moulded form
ISO/5834–2: (1995)
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For example, composition of selected standards:
Standards
Element
ISO/5832-5 (1993)
Co-Cr-Ni-W  
(%)
ISO/5832-6 (1997)
Co-Cr-Mo  
(%)
ISO/5832-7 (1994)
Co-Cr-Ni-Mo-Fe
(%)
carbon (C) 0.05 0.25 0.15
chromium (Cr) 20.0 27.0 2.0
cobalt (Co) 50.25 61.5 40.85
iron (Fe) 2.5 0.75 15.0
manganese (Mn) 1.0 1.0 2.0
molybdenum (Mo) 0.0 6.0 7.0
nickel (Ni) 10.0 2.5 15.0
silicon (Si) 1.0 1.0 0.0
tungsten (W) 15.2 0.0 0.0
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Appendix 3
Selected prosthetic hips203
Wiles’ acetabular cup and resurface of 
head of the femur, 1938
Mr Philip Wiles 
The London Hospital, UK 
Single bolt-on femoral component, 
stainless steel, 1938.
See: Wiles (1958).
See also Figure 3. 
Smith-Petersen mould, 1938
Dr Marius Smith-Petersen 
US
Vitallium® mould (cobalt–chromium–
molybdenum alloy) arthroplasty 
interposed between refashioned surfaces 
of acetabulum and head of the femur.
See: Smith-Petersen (1939).  
Also appears as Figure 11. 
Judet brothers’ acrylic femur head-
replacement, late 1940s
Drs Jean and Robert Judet 
France
Acrylic, short-stem, mushroom shape 
‘resection-reconstruction’ of the femur 
head, with stem designed to pass through 
to the neck of the femur.
See: Judet and Judet (1950);  
An advertisement from 1950 is 
reproduced in Tennent and Eastwood 
(1998): 386.
203 For advertisements of various prostheses available, for example in 1973, see www.jbjs.org.uk/cgi/issue_
pdf/backmatter_pdf/55-B/3.pdf (visited 12 December 2006).
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 Moore intramedullary endoprosthesis, 
1950s –
Dr Austin Moore 
US
Later model of Moore Vitallium® 
prosthesis, tapered stem and collar, 
uncemented.
See: Moore and Bohlman (1943).
Thompson intramedullary prosthesis, 
1953 –
Dr Frederick Thompson 
US
Curved solid Vitallium® stem, large head, 
cemented. Introduced in the US in 1953.
See: Thompson (1952).
McKee total hip replacement, 1956 –
Mr Kenneth McKee 
Norfolk and Norwich Hospital, UK
Vitallium® prosthesis with various cup 
models from 1963. 
Manufactured by: Down Brothers Ltd, 
London; later Hunton Engineering, 
Norwich. 
See: McKee (1951); 
McKee and Watson-Farrar (1966).
See also Figures 6 and 7. 
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Charnley low-friction arthroplasty,  
1958 – 
Sir John Charnley 
Wrightington Hospital, nr Wigan, UK
(a) L to R: Thompson prosthesis with a 
PTFE cup; Low-frictional torque, 28mm 
diameter femoral head and PTFE cup 
with maximum external diameter ; 25mm 
diameter femoral head with PTFE cup. 
 
(b) L to R: 4 models, 1962–86: original 
1962 ﬂat-back 316J stainless steel stem 
with a polished ﬁnish; 1974, round-back 
Charnley stem with a vaquasheen ﬁnish; 
1975, round-back Charnley stem with a 
ﬂange; 1986, Charnley stem (Ortron 90) 
and Alumina Ceramic head.
 
 
 
 
 
 
(c) L to R: 1962, original Charnley cup; 
1977, pressure injection ﬂange added to 
the cup to improve acetabular ﬁxation; 
1982, Ogee ﬂange added to the cup to 
stabilize acetabular ﬁxation by enhancing 
cement pressurization.
 
  
(d) The Ortron 90, 1980.
Manufactured by: Thackray, 1962–90;  
DuPuy, from 1990.
See: Charnley (1960, 1961).
See also Figures 4 and 15.
a
b
c
d
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Stanmore total hip replacement,1963 –
Mr John Scales 
Institute of Orthopaedics, RNOH, 
Stanmore, UK
(a) L to R: 1963–72: Mark 1–5, cobalt–
chrome-on-cobalt–chrome stem and cup; 
1970s cobalt–chrome-on-plastic stem  
and cup. 
(b) Stanmore range with various diameter 
heads and femoral components of various 
lengths, c. 1970s.
 
 
 
 
 
 
 
 
(c) Stanmore ceramic head, Alivium  
(a vacuum cast cobalt base alloy) stem and 
polyethylene cups, c. 1970s.
 
 
 
 
 
 
 
(d) Stanmore: 3 matt stems: bottom to 
top: Mk10 32mm head, Alivium, standard 
stem, c. mid-1960s; Biomet 29mm head, 
straight stem, c. mid-1970s; Alivium stem, 
29mm head, c. mid-1970s.
Manufactured by: Zimmer Orthopaedic 
Ltd to 1984; Biomet from 1984 
See: Duff-Barclay et al. (1966); Scales and  
Wilson (1969); Wilson and Scales (1973).  
See also Figure 17.
a
b
c
d
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Ring total hip replacement, 1968 –
Mr Peter Ring,  
Redhill Group of Hospitals, UK
Uncemented, metal-on-metal implant 
in cobalt–chrome with single pelvic 
component and three sizes of femoral 
stem.  
Manufactured by: Downs Surgical Ltd, 
Mitcham, Surrey. 
See: Ring (1968, 1970).  
See also Figure 5. 
Exeter total hip replacement, 1970 –
Professor Robin Ling 
Princess Elizabeth Orthopaedic Hospital,  
Exeter, UK
Dr Clive Lee 
University of Exeter, UK
(a) In clinical practice from autumn 1970 
in polished stainless steel (EN58J) with 
a head size of 29.75mm, cemented with 
acrylic bone cement and in two sizes 
(standard and lightweight). The cup was 
made from high-density polyethylene in 
three sizes (not illustrated).
(b) Universal Exeter stem, modular  
polished, 1988–  
Manufactured by: London Splint Company  
(now Stryker Howmedica Osteonics). 
See: Lee and Ling (1974); Ling (1997).  
See also Figure 20. 
a b
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ICLH double cup or resurfacing 
arthroplasty prosthesis, 1972 –
Professor Michael Freeman 
Imperial College and The London Hospital, 
UK
Professor Alan Swanson 
Imperial College, UK
A thinly cemented HDP prosthesis with 
a stainless steel acetabular cup, ﬁrst 
implanted in 1972. A specially designed 
reamer shaped the femoral head until it 
ﬁtted into the prosthesis. From 1974 the 
prosthesis was of cobalt–chrome with an 
HDP acetabular component. 
Left is an X-ray of a bilateral implantation,  
c. 1980, which is taken from Figure 18.
Manufactured by: Protek AG, Münsingen/
Berne, Switzerland
See: Freeman et al. (1975). 
See also Figure 18. 
McMinn Birmingham resurfacing, 1991 –
Mr Derek McMinn 
Birmingham Nufﬁeld Hospital, Edgbaston, 
UK
Metal-on-metal prosthesis developed at 
the Birmingham Nufﬁeld Hospital, and 
introduced in 1997.
Manufactured by: Midland Medical 
Technologies Ltd; later Smith & Nephew 
Bromsgrove Ltd.
See: McMinn et al. (1996).
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Sir Christopher Booth
Kt FRCP (b. 1924) trained as 
a gastroenterologist and was 
Professor of Medicine at the 
Royal Postgraduate Medical 
School, Hammersmith Hospital, 
London, from 1966 to 1977 and 
Director of the Medical Research 
Council’s Clinical Research Centre, 
Northwick Park Hospital, Harrow, 
from 1978 to 1988. He was the 
ﬁrst Convenor of the Wellcome 
Trust’s History of Twentieth 
Century Medicine Group, from 
1990 to 1996, and Harveian 
Librarian at the Royal College of 
Physicians from 1989 to 1997.
Mr Harold Jackson Burrows
CBE FRCS LRCP (1902–81), son 
of Harold Burrows FRCS, trained 
at St Bartholomew’s Hospital, 
London, where he had house 
duties, returning to Cambridge on 
a Beaverbrook Research Scholarship 
from the Royal College of Surgeons 
to study tissue culture and later 
at the Rockefeller Institute, New 
York, NY. He was appointed 
surgical registrar at the RNOH 
in 1931, and chief assistant in 
the orthopaedic department 
at Bart’s from 1931–36, and 
assistant orthopaedic surgeon from 
1937 to 1948. He was Surgeon-
Commander in the Royal Navy 
Volunteer Reserve during the 
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editor of the Journal of Bone and 
Joint Surgery until 1973. See 
Anonymous (1988).
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Lady (Jill) Charnley
Wife of Sir John Charnley.
Professor Sir John Charnley
Kt CBE DSc FRCS FRS 
(1911–82), orthopaedic surgeon, 
invented the low-friction hip 
replacement in the early 1960s. 
He served in the Royal Army 
Medical Corps at Dunkirk and 
in Cairo and was appointed 
assistant orthopaedic surgeon, 
Manchester Royal Inﬁrmary, later 
Consultant Orthopaedic Surgeon 
at Wrightington Hospital, near 
Wigan, Lancashire, from 1947 to 
1980. He established and became 
the ﬁrst director of the Centre 
for Hip Surgery, Wrightington 
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Professor of Orthopaedic Surgery at 
the University of Manchester from 
1972 to 1976, later Emeritus. His 
many honours and awards include 
the honorary fellowship of BOA, 
1981, and the Lister Medal of the 
Royal College of Surgeons, 1975. 
Following his death in 1982, Lady 
Charnley established the John 
Charnley Trust, which supports the 
John Charnley Research Institute. 
See Charnley (1950, 1960, 1983). 
See also Wroblewski (2002) and 
Figure 9.
Mr Tristram Charnley
Son of Sir John Charnley.
Professor Christopher Colton
MB FRCS FRCSEd (b. 1937) 
trained at St Thomas’ Hospital, 
University of London. He was 
Consultant in Orthopaedic and 
Accident Surgery, Nottingham 
University Hospital from  
1973–97, and Special Professor in 
Orthopaedic and Accident Surgery, 
Faculty of Medicine, University 
of Nottingham, from 1993 until 
his retirement from the NHS in 
1997, later Emeritus. He has been a 
member of the BOA since 1970, its 
President in 1995/6; and a member 
of the Editorial Board of the 
Journal of Bone and Joint Surgery in 
1989–91 and 1994/5. He is now 
an independent specialist in clinical 
and medico–legal practice.
Mr Harry Craven
(1928–2007) started his 
apprenticeship in engineering at 
Walker Brothers (Wigan) Ltd, 
engineers and mining machinery 
manufacturers, in 1942, where 
he worked until 1954. He joined 
the Metal Box Company Ltd as a 
management trainee until 1958, 
when he became Chief Research 
Technician for Mr John Charnley at 
Wrightington Hospital, near Wigan. 
There he designed and built many 
components used by orthopaedic 
surgeons. He moved to Liverpool 
University in 1966 to set up the Bio-
Engineering Department testing the 
loading of bone fractures, checked 
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by X-rays. In 1976 he went to the 
Groote Schuur Hospital, Cape 
Town, South Africa, returning to the 
UK to become works manager at 
Surgical Implant Engineering (SIE) 
in 1982, until it closed the following 
year. He started his own business 
making joints for 14 hospitals until 
he retired in 1995 due to ill health. 
See Figure 10.
Ms Clare Darrah
RGN DipSci (b. 1958) trained as a 
nurse at St Bartholomew’s Hospital, 
London, from 1977–80, and has 
been Clinical Research Manager 
at the Institute of Orthopaedics, 
Norfolk and Norwich University 
Hospital, Norwich, since 1996. 
She conducts the joint review 
programme to provide long-
term surveillance of hip and knee 
replacements. She is a founder 
member of the Arthroplasty Care 
Practitioners Association.
Mr Graham Deane
MB MSc FRCS (b. 1939) 
orthopaedic surgeon, graduated 
in biomechanics in 1970, was 
appointed Lecturer in Orthopaedics 
to the University of Oxford in 
1971 and Consultant to the 
Oxford Orthopaedic Engineering 
Centre in 1973 at the Nufﬁeld 
Orthopaedic Centre. He moved to 
Heatherwood and Wexham Park 
Hospitals [formerly the Windsor 
Group of Hospitals], in 1978 until 
his retirement in 2002. His major 
interests and publications have been 
in biomechanics, orthotics and total 
joint replacements, particularly 
the knee. He has designed surgical 
devices, including two knee joint 
prostheses. He was Vice-Chairman 
of the Court of Examiners and 
Senior Examiner at the Royal 
College of Surgeons of England  
in 2000.
Professor Duncan Dowson
CBE PhD DSc FEng FRS  
(b. 1928) was Research Engineer 
at Sir W G Armstrong Whitworth 
Aircraft Co., from 1953 to 1954, 
then Lecturer in Mechanical 
Engineering in 1954, later Senior 
Lecturer, Reader and Professor 
of Engineering Fluid Mechanics 
and Tribology at the University 
of Leeds from 1966 until his 
retirement in 1993. He served as 
Head of Department of Mechanical 
Engineering (1987–92), Dean for 
International Relations (1987–
93) and Pro-Vice Chancellor 
(1983–85). He was President of 
the Institution of Mechanical 
Engineers (1992–93), a Foreign 
Member Royal Swedish Academy 
and co-founder with Professor 
Verna Wright of the Leeds Bio-
Engineering Group for the Study 
of Human Joints in 1966 and 
the Centre for Studies in Medical 
Engineering in 1971. See Dowson 
and Wright (1978, 1981).
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Mrs Sheila Edwards
(b. 1947, née Wilson), ‘Ginger’ 
Wilson’s daughter.
Mr Reg Elson
FRCS (b. 1930) qualiﬁed at 
Cambridge in 1954, having done 
clinical work at the London 
Hospital. Subsequently he trained 
as an orthopaedic trauma surgeon 
and was appointed to the Northern 
General Hospital in Shefﬁeld in 
1967 in charge of the trauma 
service there. As a result of a 
delay in rebuilding in Shefﬁeld, 
he reverted to joint replacement 
surgery and in 1977 worked at 
the EndoKlinik in Hamburg, 
almost staying there permanently. 
He returned to Shefﬁeld where a 
unit was established dealing with 
revision surgery, especially infected 
cases. He has been President of 
the European Hip Society and of 
the British Hip Society, and was 
a founder of the Cavendish Hip 
Fellowship Trust.
Dr Alex Faulkner
MA PhD (b. 1952), medical and 
healthcare sociologist, researches 
and writes about new medical 
technologies in the context of 
healthcare systems and health 
policy. He was appointed to the 
Department of Social Medicine 
at the University of Bristol from 
1990 to 1999 and has been 
at Cardiff University’s School 
of Social Sciences since 1999. 
He led a ‘systematic review’ of 
the performance of total hip 
replacements in 1998 See Faulkner 
et al. (1998); Faulkner (2002); Kent 
and Faulkner (2002).
Professor Michael Freeman
FRCS (b. 1931) trained at the 
London Hospital. Along with Alan 
Swanson, he was co-founder of 
the Biomechanics Unit, Imperial 
College, London, in 1964, 
appointed Consultant Orthopaedic 
Surgeon at the London Hospital 
from 1968 until his retirement 
in 1996 and Research Fellow at 
Imperial College, London from 
1968 until 1979. He has been 
Honorary Consultant, Royal 
Hospitals NHS Trust, since 
1996. He originated new surgical 
procedures for reconstruction and 
replacement arthritic hip, knee, 
ankle and foot joints. He was 
President of the International Hip 
Society from 1982 to 1985; the 
British Hip Society from 1989 to 
1991; and the BOA from 1992 to 
1993. See Freeman (ed.) (1973); 
Swanson and Freeman (eds) 
(1977).
Mrs Phyllis Hampson
(b. 1927) started work at the 
London Splint Company in 1944, 
moving in 1947 to work for 
Zimmer Orthopaedic Ltd (ZOL), 
Bridgend, South Wales, as non-
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executive director. She returned 
to London in 1949 to start ZOL’s 
sales ofﬁce, was promoted to Sales 
Manager in 1958, Director of Sales 
in 1966 and Managing Director in 
1968. ZOL was sold to Biomet in 
1984 on the death of the owner, 
and Mrs Hampson retired in 1985.
Mr Kevin Hardinge
FRCS (b. 1939) qualiﬁed at 
Liverpool and held house and 
registrar posts at the Liverpool 
Royal Inﬁrmary. He was appointed 
Consultant Orthopedic Surgeon at 
the Manchester Royal Inﬁrmary, 
1973–76; and has been Consultant 
Orthopedic Surgeon at the 
Wrightington Hospital, Wigan, 
since 1976; Honorary Lecturer 
in Orthopedics at the University 
of Manchester, since 1979; and 
Hunterian Professor at the Royal 
Society of Surgeons of England, 
since 1972. 
Mr Mike Heywood-Waddington
MA FRCS (b. 1929) qualiﬁed 
at Cambridge; trained at Exeter, 
Stanmore and Great Ormond 
Street Hospital, London; and 
served with the Royal Air Force. He 
was Consultant in Orthopaedic and 
Traumatic Surgery to Mid-Essex 
and North Essex Health Authorities 
from 1967 to 1992 and Honorary 
Orthopaedic Consultant since 
1992. He is a Founder Member 
of the British Hip Society and the 
British Orthopaedic Sports Trauma 
Association; a past President of 
the Orthopaedic Section of the 
Royal Society of Medicine; a 
Senior Fellow of the BOA and 
is Orthopaedic Surgeon to Essex 
County Cricket Club. 
Mr Geoff King
(b. 1947) had multiple fractures 
following an accident involving 
a lorry in 1963, the treatment of 
which resulted in his interest in 
the health service. He worked in 
the NHS for 36 years, initially as 
a technician in the orthopaedic 
theatres in the Norfolk and 
Norwich Hospitals where the 
McKee and the McKee–Farrar hip 
joint replacements were developed. 
Latterly he was a general manager 
in the NHS before retiring in 2004 
and had a hip replacement (the 
Birmingham re-surfacing double 
cup type, suitable for use in the 
‘younger’ patient) in 2005.
Mr John Kirkup
FRCS DHMSA (b. 1928), 
orthopaedic surgeon and surgical 
historian, qualiﬁed at St Mary’s 
Hospital, London, in 1952 and, 
after service in the Royal Navy, 
worked with Kenneth McKee 
at the Norfolk and Norwich 
Hospital from 1956 to 1958; John 
Charnley in 1959 and at the Bath 
and Wessex Orthopaedic Hospital 
from 1961 to 1964, becoming 
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Consultant Orthopaedic Surgeon 
to the Bath Clinical Area from 
1964 until 1988. He introduced an 
ankle joint replacement in 1976. 
He was a UK Travelling Scholar 
(1964) and Honorary Archivist to 
the BOA (1980–2005); President 
of the British Orthopaedic Foot 
Surgical Society (1984); Brattstrom 
Lecturer to the Swedish Society for 
Rheumatoid Surgery (1985); and 
Vicary Lecturer (1976), Sir Arthur 
Keith Medallist (1998) at the Royal 
College of Surgeons of England and 
Honorary Curator of the Historical 
Instrument Collection there since 
1980. 
Mr K M N (Ravi) Kunzru 
MS FRCS DHMSA (b. 1937) was 
Consultant Orthopaedic Surgeon at 
Whipps Cross University Hospital, 
London, from 1973 until his 
retirement in 1998, later Emeritus 
Consultant and Medical Historian. 
The ﬁnal part of his training as 
Senior Registrar included working 
with Arden, Ansell, Maudsley 
and Swann on joint replacement, 
including children’s joints, at the 
Windsor Group of Hospitals. He 
is current President of the History 
of Medicine Section of the Royal 
Society of Medicine (2005/06) 
and Vice President of the Medical 
Society of London (2005–7), 
Past President of the Hunterian 
Society (currently co-Curator of its 
collection); and Past President of 
the British Orthopaedic Foot and 
Ankle Surgery Society.
Mr W Alexander (Scottie) Law
OBE MD LRCP FRCS  
(1910–89) qualiﬁed at the London 
Hospital in 1935 with junior 
appointments in orthopaedic 
surgery there followed by war 
service in the RAMC, receiving the 
OBE for his military service. He 
returned to the London Hospital 
as consultant orthopaedic surgeon 
in 1947, later consultant to the 
Royal Masonic Hospital and the 
Italian Hospital, London, and 
associate surgeon to the Robert 
Jones and Agnes Hunt Hospital, 
Oswestry. He spent the year of 
1948 with Smith-Petersen at the 
Massachusetts General Hospital, 
Boston, learning about cup 
arthroplasty, which he introduced 
on his return to London in 
1949. He was President of the 
Orthopaedic Section of the Royal 
Society of Medicine.
Miss Betty Lee
RGN (b. 1925), trained in nursing 
at Mile End Hospital, London, in 
1943, became a staff nurse in the 
male orthopaedic ward, Norfolk 
and Norwich Hospital, Norwich, 
from 1950 to 1953, a ward sister 
from 1953 to 1967, and was 
appointed to the teaching staff of 
the Broadland School of Nursing, 
Norwich, from 1967 until her 
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retirement in 1985, including work 
on the RCN teaching course. She 
was Mr McKee’s staff nurse and 
ward sister from 1950 until 1966.
Mr Alan Lettin
MS FRCS (b. 1931) qualiﬁed 
at University College Hospital, 
London, received his orthopaedic 
training at the RNOH and became 
lecturer and ﬁrst assistant to Sir 
Hubert Seddon at the Institute of 
Orthopaedics. He was Consultant 
Orthopaedic Surgeon at St 
Bartholomew’s Hospital, London, 
from 1967 to 1996 and the Royal 
National Orthopaedic Hospital, 
Stanmore, from 1968 to 1995. 
He collaborated with John Scales 
at the Institute of Orthopaedics, 
University of London, in the 
development and introduction of 
the Stanmore range of artiﬁcial 
joints and was responsible for the 
ﬁrst total shoulder replacement 
in the world in 1970. He was 
President of the BOA (1994–95) 
and Vice-President of the Royal 
College of Surgeons (1995–97).
Professor Robin Ling
OBE HonFRCSEd FRCS 
(b. 1927), co-originator of 
the Exeter Hip, was educated 
in British Columbia, Oxford 
University and St Mary’s Hospital, 
London. He was appointed 
Consultant Honorary Lecturer in 
the Department of Orthopaedic 
Surgery of the University of 
Edinburgh, 1960 to 1963; 
Consultant Orthopaedic Surgeon at 
the Royal Inﬁrmary of Edinburgh 
and the Princess Margaret 
Rose Orthopaedic Hospital, 
Edinburgh, 1961 to 1963, and 
moved to the Princess Elizabeth 
Orthopaedic Centre, Exeter, 
Devon as Consultant Orthopaedic 
Surgeon in 1963 until 1991, which 
culminated in the implantation of 
the ﬁrst Exeter Hip in the autumn 
of 1970. He set up a system to 
allow the prospective gathering of 
all data on hip arthroplasties from 
that time. He has been President of 
the British Orthopaedic Research 
Society, the BOA, the British Hip 
Society and the International Hip 
Society.
Mr Ken McKee
CBE FRCS (1905–1991), the 
ﬁrst to replace a hip joint in 1951 
by a reproducible method that 
others could use, qualiﬁed at St 
Bartholomew’s Hospital, London, 
and trained in orthopaedic surgery 
at Chailey Heritage Hospital, 
Lewes, East Sussex, under Reginald 
Cheyne Elmslie (1878–1940), 
Sydney Limbrey Higgs (1892–
1977) and Sam Brockman 
(1894–1977). He was Orthopaedic 
Registrar at Norfolk and Norwich 
Hospital from 1935 to 1939 and 
Consultant Orthopaedic Surgeon 
there from 1939 to 1971. 
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Dr Austin T Moore
MD (1899–1963), US orthopaedic 
surgeon, performed and reported 
the ﬁrst metallic hip hemi-
arthroplasty surgery in 1942. His 
original head and stem was made 
of the metal vitallium, about 12 
inches long and was bolted to the 
cut end of the femoral shaft; a 
later version, the Austin Moore, 
is still used today for fractures of 
the femoral neck. See Moore and 
Bohlman (1943). 
Dr Francis Neary
PhD (b. 1971) is a research 
associate in the Centre for the 
History of Science, Technology 
and Medicine at the University of 
Manchester. His recent research has 
been concerned with the history 
of twentieth-century medical 
technologies and he has curated 
exhibitions on joint replacement 
at the Royal College of Surgeons 
of England and at Wrightington 
Hospital, near Wigan in 2006.
Mr John Older
FRCSEd FRCS (b. 1935) qualiﬁed 
at Guy’s Hospital, London and did 
his orthopaedic training in Bristol. 
He was a Senior Clinical Research 
Fellow, Toronto, Canada, before  
being appointed Consultant 
Orthopaedic Surgeon at the 
Royal Surrey County Hospital, 
Guildford, Surrey, from 1975 to 
2001. He was a pupil, assistant 
and colleague of Sir John Charnley 
from 1978 to 1982 at the King 
Edward VII Hospital, Midhurst, 
West Sussex, where he remained 
until 2006, following the closure 
of the hospital. He has been 
Clinical Anatomist at King’s 
College London Medical School, 
Guy’s Campus, London, since 
2001. He continues a special 
interest in primary and revision hip 
replacement surgery and continues 
to review the long-term results of 
the LFA. See Older (2002).
Professor John Paul
(b. 1927) was appointed in 1949 
to the Department of Mechanical 
Engineering of the institution that 
was to become the University of 
Strathclyde, Glasgow. He became 
Senior Lecturer in Bioengineering 
in 1969, received a personal chair 
in 1972, and became Professor and 
Head of the Bioengineering Unit in 
1978; Emeritus on his retirement 
in 1992, a position which he still 
holds. He has been Chairman 
of the International Standards 
Organization Sub-committee on 
Bone and Joint Replacements since 
1992. 
Professor John Pickstone
PhD (b. 1944) trained in 
biomedical sciences and in history 
and philosophy of science. Since 
1974 he has worked in Manchester 
where he founded the Wellcome 
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Unit and the Centre for the 
History of Science, Technology 
and Medicine at the University 
of Manchester. Since 2002 he 
has been the Wellcome Research 
Professor at the Centre. His present 
projects include recent histories of 
cancer, the artiﬁcial hip and the 
NHS in Manchester. He also writes 
on the historical sociology of the 
history of science, technology and 
medicine. See Pickstone (2000); 
Cooter and Pickstone (eds) (2002).
Mr John Read
FRCSEd qualiﬁed at University 
College Hospital, London, and 
spent three years in the Royal 
Army Medical Corps as a Clinical 
Ofﬁcer in surgery at the British 
Military Hospital and 33 General 
Hospitals in Hong Kong. He 
was appointed Registrar at the 
Sunderland Orthopaedic and 
Accident Hospital, later registrar to 
John Charnley at his new Centre 
for Hip Surgery at Wrightington 
Hospital; and senior registrar at 
the London Hospital. He was 
Consultant Orthopaedic Surgeon 
to the Harlow, Hertford and 
Harlow Hospitals, later Welwyn 
Garden City Hospital, continuing 
his special interest in primary and 
revision hip joint replacement 
surgery.
Mr Peter Ring
MS FRCS (b. 1922) was 
Consulting Orthopaedic Surgeon 
to the Redhill (Surrey) group of 
hospitals and Surgeon-in-Charge 
of the Joint Replacement Unit, 
Dorking Hospital, from 1959 to 
1988.
Professor John Tracey Scales
OBE (1920–2004), designer of 
the Stanmore hip, was lecturer 
then reader at the Institute of 
Orthopaedics, Royal National 
Orthopaedic Hospital (RNOH), 
London and Stanmore, from 
1952 to 1974. During this time 
he developed airstrip dressings. 
He was appointed Professor of 
Biomechanical Engineering in the 
University of London, in 1974, 
until his retirement in 1987, 
later Emeritus. He started the 
biomedical engineering department 
at the RNOH, the Institute 
of Orthopaedics, part of the 
University of London. He designed 
the Stanmore range of total joints 
for hips (with the assistance of 
Alan Lettin), knees, shoulders 
and elbows. He was honorary 
director of research at the RAFT 
(Restoration of Appearance and 
Function Trust) Institute for Plastic 
Surgery at Mount Vernon Hospital, 
Northwood, London, where he 
produced a low air-loss mattress to 
prevent pressure sores, based on the 
reverse principle of the hovercraft. 
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See Hampson (2004); www.raft.
ac.uk/common/jts.html (visited  
1 August 2006). See also Kenedi  
et al. (eds) (1976) and Figure 20.
Sir Herbert Seddon
Kt CMG DM FRCS (1903–77) 
was Resident Surgeon at the 
country branch [Stanmore, 
Middlesex] of the RNOH from 
1931 to 1939 and Nufﬁeld 
Professor of Orthopaedic Surgery, 
University of Oxford, from 1940 
to 1948. He was appointed 
Director of Studies at the Institute 
of Orthopaedics, University of 
London, a joint appointment 
between the RNOH and the 
Institute, from 1948 to 1965 and 
was Professor of Orthopaedics there 
from 1965 until his retirement 
in 1967. He was a member of 
the Medical Research Council, 
from 1956–59 and was interested 
in African and tropical medical 
problems. See Seddon and Scales 
(1949); Seddon (1950); Nicholson 
and Seddon (1957); Parsons and 
Seddon (1968).
Mr Edgar William Somerville 
MB FRCSEd (1913–96) qualiﬁed 
in 1938, and served in the Royal 
Air Force until he was demobilized 
in 1946. He was Consultant 
Surgeon at the Wingﬁeld Morris 
Hospital, Oxford (renamed the 
Nufﬁeld Orthopaedic Centre in 
1956), Oxford, until his retirement 
in 1977, specializing in the 
treatment of children’s deformities 
and the pathology and treatment 
of congenital dislocation of the 
hip. He was Editorial Secretary 
and then Vice-President of the 
BOA; President of the Orthopaedic 
Section of the Royal Society of 
Medicine, the British Orthopaedic 
Research Society and the ABC 
Orthopaedic Club. See Girdlestone 
and Somerville (1952) and 
Somerville (1982).
Mr Ian B M Stephen
MB FRCS (b. 1944) trained at 
Cambridge, Bristol, Exeter and 
Montreal, Canada, was Consultant 
in Orthopaedic and Trauma 
Surgery, East Kent Hospitals, 
from 1983 to 2002 and Clinical 
Director, Trauma and Orthopaedic 
Surgery, 2000 to 2002, and has 
been an independent consultant 
orthopaedic foot and ankle 
surgeon, Margate, Kent, since 
2002. He is Past President of the 
Orthopaedic Section, Royal Society 
of Medicine, Archivist of the BOA, 
and member of the Expert Witness 
Institute. 
Mr Malcolm Swann
FRCS (b. 1931) was Consultant 
Orthopaedic Surgeon to the 
Windsor Group of Hospitals from 
1967 until his retirement in 2001. 
His special interest is in paediatric 
orthopaedics and he worked closely 
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with Professor Barbara Ansell, the 
Paediatric Rheumatologist, and 
later established a surgical service 
for patients with juvenile chronic 
arthritis at the Canadian Red Cross 
Hospital at Taplow. See Ansell et al. 
(1997).
Professor Alan Swanson
PhD DSc FREng FIMechE 
(b. 1931) graduated in mechanical 
engineering from Imperial 
College, London, in 1952. He 
worked in engineering laboratories 
at Bristol Aircraft (1955–58), 
was appointed Lecturer in 
Mechanical Engineering, Imperial 
College, in 1958, Reader in 
Biomechanics, 1969 and Professor 
of Biomechanics from 1974 until 
his retirement in 1997. With 
Michael Freeman he founded the 
Biomechanics Unit at Imperial 
College in 1964, where work was 
done on the mechanical properties 
of bone and articular cartilage, 
internal ﬁxation devices and joint 
replacements.
Sir Rodney Sweetnam
KCVO CBE FRCS FRCSEd 
(b. 1927) was Consultant 
Orthopaedic Surgeon to the 
Middlesex Hospital and University 
College Hospital, London, from 
1974 to 1992, later Emeritus. 
He served as Consultant Adviser 
in Orthopaedic Surgery to the 
Department of Health (1981–90); 
Orthopaedic Surgeon to the Queen 
(1983–92); President of the BOA 
(1985); President of the Royal 
College of Surgeons of England 
(1995–98) and a Fellow of UCL. 
See Wiles and Sweetnam (1965); 
and Hughes and Sweetnam (eds) 
(1980). 
Mr Keith Tucker
MB FRCS (b. 1945) was Senior 
House Ofﬁcer to Ken McKee 
in 1970; Senior Registrar at St 
Bartholomew’s Hospital, London, 
Surgical Training Programme in 
Orthopaedics, including Senior 
Registrarships to Messrs Lettin, 
Read, Phillips, Watson-Farrar, 
Taylor, Wilson and Kemp, from 
1973 to 1977. He has been 
Consultant Orthopaedic Surgeon, 
Norfolk and Norwich University 
Hospital, Norwich, since 1978. 
He is a founder member of the 
British Hip Society and has been 
Honorary Secretary (1998–2005) 
and Vice President (2005–07) and 
will serve as President in 2007/08; 
elected a member of the Steering 
Committee of the National Joint 
Registry in 2006; Chairman of the 
Orthopaedic Data Evaluation Panel 
(ODEP) since 2002; and BOA 
representative to the MDA/MHRA 
since 1994.
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Sir Reginald Watson-Jones
Kt FRCS HonFRCSEd 
(1902–72) qualiﬁed and trained 
at Liverpool University, and 
later held lectureships and 
demonstratorships in anatomy, 
physiology and physiotherapy 
there. He was resident house 
surgeon at the RNOH and clinical 
assistant at Great Ormond Street 
Hospital for Children, returning to 
Liverpool in 1926 as senior surgical 
tutor and registrar at the Royal 
Inﬁrmary, where he was later an 
orthopaedic surgeon. He organized 
the Royal Air Force’s orthopaedic 
services during the war; was Hon. 
Consultant, later Director, of 
the Orthopaedic and Accident 
Department, London Hospital, 
from 1943; orthopaedic surgeon to 
King George VI, 1946 to 1952 and 
to the Queen from 1952. He was 
the ﬁrst British Editor, Journal of 
Bone and Joint Surgery, from 1947; 
President, BOA, 1952–53; Senior 
Vice-President, Royal College of 
Surgeons of England, 1953–54; 
Member of the Court of Examiners 
of the RCS, and Hunterian 
Orator, 1959; and President of the 
Orthopaedic Section of the Royal 
Society of Medicine, 1956.
Mr Victor H Wheble
FRCSEd (b. 1919) qualiﬁed at 
Oxford and trained at King’s 
College Hospital Medical School, 
London, and served as a member 
of the Baptist Missionary Society 
in the Belgian Congo. Following 
a serious illness in Africa, he was 
Registrar and Senior Registrar at 
Manﬁeld Orthopaedic Hospital, 
Northampton. He was appointed 
Consultant Orthopaedic Surgeon 
at Ashton-under-Lyne General 
Hospital, near Manchester, from 
1960 to 1984. He was a Visiting 
Fellow and Lecturer at the 
University of Salford, undertook 
research at UMIST with Dr Jan 
Skorecki, and had close ties with 
Professor Garth Hastings at the 
Biomedical Engineering Unit, 
Staffordshire Polytechnic, Stoke-
on-Trent [now Staffordshire 
University]. He has been a member, 
and frequently Chairman, of 
many national and international 
committees concerned with the 
standardization of surgical implants 
from 1972 to 2001, representing 
the BOA and subsequently the 
Royal College of Surgeons of 
England. See Wheble (1994). 
Mr Philip Wiles
FRCS (1899–1967) served in the 
Army and the Royal Flying Corps, 
joined his father in the City of 
London, and came to medicine late, 
a mature student at the Middlesex 
Hospital, London. He became a 
Consultant there at age 36. He 
served in the Middle East and 
India in the Second World War, 
becoming a brigadier. Retiring early, 
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he moved to Jamaica, becoming 
Chairman of the Scientiﬁc Research 
Council and encouraged the growth 
of the medical school. His textbook 
on orthopaedics ran to four editions 
and several reprintings. He was the 
treasurer to the British edition of 
the Journal of Bone and Joint Surgery, 
became President of the BOA. See 
Seddon (1967).
Mr James Noel (Ginger) Wilson
OBE ChM FRCS (1919–2006) 
co-designer with John Scales of the 
Stanmore Hip System, qualiﬁed 
at Birmingham, joining the Royal 
Army Medical Corps in 1943, 
with the 1st Airborne Division 
in Europe and Norway. He was 
Orthopaedic Registrar at Robert 
Jones and Agnes Hunt Orthopaedic 
Hospital, Oswestry, 1949–52, 
then Consultant at Cardiff Royal 
Inﬁrmary, and BOA Travelling 
Fellow to the USA in 1954. He was 
Consultant Orthopaedic Surgeon 
and a Director of the Accident 
Service at the RNOH, London, 
and Stanmore, from 1955–84, and 
Assistant Director of Postgraduate 
Training at RNOH from 1968–72, 
Clinical Teacher at the Institute of 
Orthopaedics, University of London 
and Consultant Orthopaedic 
Surgeon to the National Hospital 
for Nervous Diseases, Queen 
Square, London, from 1962–84. 
He worked extensively in the Third 
World developing orthopaedic 
training programmes, even after 
retirement, and served as Professor 
of Orthopaedics at Addis Ababa 
University, Ethiopia in 1989. He 
was a founding member of World 
Orthopaedic Concern (WOC) 
and edited the WOC Newsletter 
for over a decade in his retirement; 
President of the Orthopaedic 
Section of the Royal Society of 
Medicine, later Honorary member; 
Editorial Secretary of the BOA 
(1974–78), and Vice-Chairman of 
the IMPACT Foundation (1985–
2001). See Watson-Jones (1976, 
1982); Owen (2006).
Mr Michael Wilson
MA (Glasgow) (b. 1956), ‘Ginger’ 
Wilson’s son.
Professor B Michael Wroblewski
FRCSEd (b. 1934) trained at Leeds 
Medical School and after posts 
at Leeds, Manchester, Oswestry, 
Wrightington and Birmingham, 
he was appointed Consultant 
Orthopaedic Surgeon at the Centre 
for Hip Surgery, Wrightington 
Hospital, Lancashire, from 1973 to 
2004. He was also External Professor 
of Orthopaedic Biomechanics at 
the University of Leeds in 1992. 
He helped to establish the John 
Charnley Research Institute 
and Charitable Trust in 1992, 
which has funded 25 Clinical 
Research Fellows, 1987–2001. See 
Wroblewski (1990, 2002).
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arthrodesis of the hip 
The surgical fusion of the femur 
(thigh bone) to the pelvis, in which 
the hip joint surfaces are surgically 
removed and the denuded joint 
surfaces pressed together and ﬁxed 
with special plates and screws. Also 
known as fusion.
arthroplasty 
Surgical replacement of all or part 
of the hip joint with an artiﬁcial 
device to decrease the friction and 
wear between the femoral head 
prosthesis and the cartilage of the 
acetabulum or its prosthetic lining. 
Metal, polyethylene and ceramic  
or combinations have been used.
bone cement, self-hardening 
A cement which hardens when its 
components are mixed together.  
No external physical agency,  
such as heat or UV light, is  
needed to initiate the hardening 
process. In implant surgery, the 
hardening process is usually one  
of polymerization.
Birmingham resurfacing 
arthroplasty (BSA) 
A metal-on-metal prosthesis, 
introduced in 1991 by Derek 
McMinn, Birmingham Nufﬁeld 
Hospital, and manufactured by 
Midland Medical Technologies 
Ltd, which covers the hip joint 
surfaces with accurately machined, 
large-headed metal prostheses, 
instead of replacing them. The 
acetabular component is ﬁxed with 
a hydroxyapatite coating, while 
the femoral component is cemented 
in place. See McMinn et al. (1996); 
Appendix 3, page 106.
British Hip Society 
Michael Freeman, Robin Ling and 
Hugh Phillips founded the Hip 
Society in 1989, an afﬁliate of the 
BOA. Phillips was involved in the 
inception of the National Joint 
Register, the Capital hip enquiry, 
and wrote the ﬁrst edition of The 
Guide to Best Practice in Hip Surgery, 
published by the BHS in 1999.
CE marking or EC mark 
The letters CE are the abbreviation 
of French phrase Conformité 
Européene or European 
Conformity. Initially the term 
was ‘EC Mark’, replaced by 
‘CE Marking’ in 1993 by 
European Directive 93/68/EEC. 
A product with this mark has a 
manufacturer’s declaration that 
the product complies with the 
Glossary*
* Terms in bold appear in the Glossary as separate entries
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essential requirements of the 
relevant European health, safety 
and environmental protection 
legislation, and conforms to 
European product directives. 
For further details see www.dti.
gov.uk/innovation/strd/cemark/
page11646.html (visited  
11 September 2006). 
cobalt–chromium (Co–Cr) alloys 
A family of alloys with cobalt as the 
main constituent, used in general 
engineering for resistance to wear 
and corrosion, and in dentistry and 
orthopaedics.
corrosion 
A reaction between the surface of a 
metal or alloy and the surrounding 
medium (air, liquid or both). The 
resulting metallic oxides, chlorides 
etc., may remain ﬁrmly attached or 
may readily detach, which makes 
the alloy unsuitable for implants, 
whereas the former characteristic 
makes certain alloys ideal for use as 
implants.
endosteal surface of the femur 
The inner surface of the bone 
around the marrow cavity. 
Exeter hip 
The original, made in EN58J steel 
[BS 970 Grade 316S16, austenitic, 
non-magnetic, offers high resistance 
to corrosion] was available for use 
in clinical practice from autumn 
1970, manufactured by the London 
Splint Company (now Howmedica 
UK Ltd) in polished stainless steel 
with a head size of 29.75mm, 
cemented with acrylic bone cement 
and in two sizes (standard and 
lightweight). The cup was made 
from high-density polyethylene 
in three sizes. See Ling (1997): 7, 
10–11. See also www.exeterhip.
co.uk/ex_pag_redirect-about-
us.htm (visited 29 June 2006)  
and Figure 21.
Fluorosint® 
A proprietary plastic mixture 
where synthetically-manufactured 
mica is chemically linked to 
polytetraﬂuoroethylene (PTFE), 
resulting in properties not normally 
attainable in reinforced PTFE.
Girdlestone 
A resection arthroplasty of the 
hip, where the resected part of 
the ball or head of the thigh 
bone (femur) and the rest of the 
femur is left loose, allowing some 
movement between the femur and 
hip (acetabulum). The muscle and 
soft tissues, including the scar of 
the previous operations, infection 
or inﬂammation prevent the femur 
riding up a great deal past the hip 
bone socket. The leg shortening can 
be several inches. The movement 
of the pseudoarthrosis allows the 
patient to sit more easily in a chair 
than with a fused hip. See the 
classic article by Professor Gathorne 
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Robert Girdlestone (1881–1950), 
the ﬁrst Nufﬁeld Professor of 
Orthopaedic surgery at the 
University of Oxford, who devised 
this treatment for tuberculosis of 
the hip and later has been used 
in severe osteoarthritis and more 
recently as a last resort for failed 
total hip replacements that could 
not be revised. Girdlestone (1943).
hemi-arthroplasty 
Surgical replacement of only the 
head of the femur. It is often called 
an Austin-Moore or Thompson. 
A bipolar hemi-arthroplasty uses 
a femoral prosthesis with an 
articulating acetabular part, but not 
ﬁxed to the acetabulum.
high-density polyethylene (HDP) 
See ultra-high molecular weight 
polyethylene (UHMWPE)
hydroxyapatite coating (HAC) 
A bioactive material applied 
to uncemented prosthesis to 
encourage the bonding of the bone 
to secure the implant. 
International Organization for 
Standardization (ISO) 
An international non-governmental 
organization that began as the 
International Electrotechnical 
Commission (IEC) in 1906 (later 
the International Federation 
of the National Standardizing 
Associations (ISA), 1926–42). A 
new postwar organization, the ISO, 
started in 1947 to coordinate and 
unify industrial standards. The 
abbreviation ISO is based on the 
Greek isos, meaning ‘equal’.
Journal of Bone and  
Joint Surgery (JBJS) 
Originated as the Transactions 
of the American Orthopedic 
Association and vol. 1 contained 
the proceedings of the meetings 
of 1887 and 1888. Volume 16 
(1903) of the Transactions is also 
vol. 1 of the American Journal of 
Orthopedic Surgery. It became the 
ofﬁcial publication of the British 
Orthopaedic Association in 1919 
and the name changed to the 
Journal of Orthopaedic Surgery, vol. 
1 (new series), with the present 
title the Journal of Bone and Joint 
Surgery adopted in 1922. In 1948, 
the A (American) and B (British) 
volumes were established, while the 
American Orthopedic Association 
remained the owner until an 
independent non-proﬁt corporation 
was created.
Küntscher nail,  
or intramedullary rod 
A hollow rod of varying lengths and 
diameters secured to the medulla, 
the hollow cavity inside the femur, 
which was in frequent use until 
the 1970s. Named after Gerhard 
Küntscher, a German surgeon who 
used it. Some attribute its use to 
explain why German soldiers in the 
150
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Second World War were back in 
action a few months after fractured 
femurs, whereas the Allied soldiers 
were back, in traction.
laminar ultraclean  
air ﬂow systems 
Unidirectional clean-air systems 
for surgical theatres that became 
widely used in the 1960s, designed 
for 300+ air changes per hour, re-
circulating the air through ﬁlters 
and ﬂowing horizontally through 
a wall module or downwards from 
an air inlet overhead. These systems 
led to very low numbers of airborne 
bacteria. See Lowbury and Lidwell 
(1978); see also note 158.
low-frictional arthroplasty 
Sir John Charnley’s operation for 
total hip replacement, available 
from 1962, cemented using ﬁnger 
packing. See Charnley (1979).
medialized cups 
Acetabular prosthesis inserted 
deeply.
morselized graft 
A cancellaus bone graft impacted 
into the proximal femur. The bone 
is usually taken from the femoral 
head in a primary replacement, 
and the proximal femur, if it is a 
revision. The bone is chopped into 
chips using a bone mill and used as 
a graft. A cadaver graft is used if an 
allograft is not available.
Ortron 
A cobalt–chromium alloy 
originally developed by Krupp in 
Germany for dental implants and 
has excellent corrosion resistance. 
Adopted by DePuy for use in the 
Charnley prosthesis after 1990.
osteolysis 
The dissolution of bone through 
disease, commonly due to infection 
or by loss of blood supply to the 
bone, and a common cause of 
loosening; a major failure in total 
hip replacement.
polyethylene 
A polymer of ethylene (C
2
H
4
) 
widely used for buckets. Higher 
levels of polymerization allow closer 
packing of the molecules with 
fewer voids, and the resulting high- 
or ultra-high molecular weight 
polyethylene has improved wear 
resistance.
polymethylmethacrylate cement
Made by mixing a powder 
polymethylmethacrylate 
plus an activator with a ﬂuid 
methylmethacrylate plus an 
inhibitor in a bowl with a spoon 
and spatula. The mixture becomes 
creamy and then doughy. After 
three to four minutes it begins to 
set and as it does so, it becomes 
hot, producing a characteristic 
smell. The material, having become 
viscous, is plastic, then elastic, 
before becoming solid.
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polytetraﬂuoroethylene (PTFE) 
A thermoplastic discovered 
unexpectedly in 1938 when a 
cylinder stored under pressure 
was cut open. It became available 
commercially in the US and the 
UK in 1948. It is resistant to high 
and low temperatures, has low 
loss dielectric properties over a 
wide frequency range, a chemical 
inertness and anti-stick properties, 
which led to its early use in the 
aerospace industry and as non-
stick cookware (Teﬂon® pans were 
ﬁrst sold at Christmas 1961) and 
plumber’s thread tape. See www.
plastiquarian.com/ptfe.htm (visited 
20 June 2006).
proximal stress shielding 
This occurs when the stiff proximal 
end of a femoral prosthesis 
transmits most of the load between 
the hip joint and the femoral 
shaft, and the surrounding bone, 
being subjected to abnormally low 
stresses, is resorbed over time by the 
normal remodelling process, which 
responds to stress levels, among 
other things.
RNOH 
see Royal National Orthopaedic 
Hospital
radiolucent/radio-opaque 
A radiolucent zone in an X-ray 
permits the passage of X-rays, 
unlike one that is radio-opaque.
rasp or broach 
An instrument used for clearing the 
femoral canal.
reamer 
A burr-like instrument used during 
the hip replacement operation to 
remove arthritic bone from the 
acetabulum, by rasping; or to shape 
the medullary canal. An acetabular 
reamer is hemispherical; the 
femoral is straight, tapered or pin-
shaped. See Figure 22.
Royal National Orthopaedic 
Hospital (RNOH), Stanmore 
RNOH was recognized by the 
University of London in 1946 as a 
postgraduate teaching hospital and 
the Institute of Orthopaedics and 
Musculoskeletal Science (IOMS) 
was founded there, initially located 
in Great Portland Street, London. 
By 1948 most of the facilities had 
moved to Stanmore, Middlesex, 
called the country branch of the 
hospital. A unit looking into 
research on plastics began in 
1948, renamed Biomechanics and 
Surgical Materials in 1954, later 
Biomedical Engineering, and led 
by Professor John Scales bringing 
together the various applications 
of engineering to orthopaedic 
problems. Stanmore Implants 
Worldwide (SIW) was formed for 
the manufacture of specialized 
prosthetic implants, which became 
a limited company in 1996. A 
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collection of radiographs has been 
held in the Wellcome Museum of 
Orthopaedics and the Radiological 
Department for the Museum of 
Orthopaedic Radiology, supported 
by £5300 of grants from the 
Wellcome Trust to adapt and equip 
rooms at Great Portland Street, and 
opened by Sir Henry Dale in 1956. 
See Cholmeley (1982).
self-curing acrylic bone cement 
see polymethylmethacrylate 
cement
Shenton’s line 
A radiographic, curved line formed 
by the top of the obturator foramen 
and the inner side of the neck of 
the femur, used to determine the 
relationship of the head of the 
femur to the acetabulum. Also 
known as the Ménard-Shenton-
Makkas line, after Edward Warren 
Hine Shenton. See Renner (1925).
slit sampler 
An instrument which sucks air 
through a narrow slit onto the 
surface of a culture medium, 
rotated slowly, just below the slit. 
See Bourdillon et al. (1941) and 
Figure 25.
Staphylococcus epidermidis 
A gram-positive pathogenic 
bacterium common in medical 
device-associated infections.  
S. epidermidis normally lives on the 
skin and only causes infection if 
introduced around a foreign body, 
such as an implant. See www.ebi.
ac.uk/2can/genomes/genomes.
html?http://www.ebi.ac.uk/2can/
genomes/bacteria/Staphylococcus_
epidermidis.html (visited  
1 August 2006).
Stanmore 
see Royal National Orthopaedic 
Hospital
Stanmore hip 
The original Stanmore prosthesis 
was available from spring 1963. See 
Figure 17 and Appendix 3, page 
104. 
survivorship analysis 
A statistical method that looks 
at the frequency of revision of a 
prosthesis by the number of years 
of clinical implantation, taking into 
consideration the loss of patients at 
follow-up due to death and other 
factors.
Teﬂon® 
The trade name for a family of 
PTFE resins produced by DuPont, 
Wilmington, Delaware, USA.
Thackray’s 
Charles F Thackray Ltd of Leeds 
started as retail pharmacists in 
1862, diversifying into surgical 
equipment and orthopaedics in 
1947. They manufactured the 
Charnley prosthesis from 1963 until 
1990 when Thackray’s was acquired 
by DePuy, the US subsidiary of a 
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private German ﬁrm, Boehringer 
Mannheim, in 1990, taken over by 
Johnson & Johnson. The Charnley 
total hip replacement is currently 
manufactured under the name of 
DePuy International. See www.
jnjgateway.com/home.jhtml?loc=G
BENG&page=viewContent&cont
entId=09008b9880bba4bc (visited 
19 October 2006). The Thackray 
Museum, Leeds, was established in 
a former workhouse building of the 
St James’s Hospital, Leeds, by Paul 
Thackray, a former director and 
major shareholder in Thackray’s in 
1997, initially as an archive of the 
company. 
titanium (Ti) 
A light metal with high resistance 
to corrosion. Since the Kroll 
process was developed in 1937, 
it can be made in considerable 
quantities, mostly used by the 
aircraft industry, the chemical 
industry and for medical 
applications. 
total hip replacement 
The surgical replacement of 
the head of the femur and the 
acetabulum with manufactured 
components.
tribology 
The study of mechanisms of 
friction, lubrication and  
wear of interacting surfaces that  
are in relative motion. See  
Dowson (ed.) (1998). 
trochanteric osteotomy 
An operation to cut the greater 
trochanter, with all its muscles 
attached, from the femur to 
expose the hip joint, or to alter its 
mechanics. See Wroblewski (1990): 
19–28.
ultra-high molecular weight 
polyethylene (UHMWPE) 
A polymer used in orthopaedics 
that is classiﬁed as a linear 
homopolymer formed from 
ethylene (C
2
H
4
). The densely 
packed and curled molecular chains 
give it good wear characteristics. 
Irradiation for sterilization should 
be in a vacuum, otherwise the 
chains of the molecules unravel. It 
has been used in hip replacement 
since 1961 when Charnley used it 
for its low-friction and high-wear 
resistance properties for his metal-
on-plastic hip joint. Since then 
it has been used in a large range 
of joint replacements for the hip, 
knee, ankle, elbow and shoulder. 
Vitallium® 
A trademarked alloy of 60 per cent 
cobalt, 20 per cent chromium, 
and 5 per cent molybdenum 
used for prostheses, implants 
and instruments since 1936. See 
Venable and Stuck (1943).
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acetabular cups
ﬁxation, 8–9, 13, 24, 30
loosening, 64, 71–2, 73
materials, 12, 14, 27
medialization, 49, 150
standards, 67
wear, 19, 68, 71–2
see also Charnley cups
acetabular reamer, 39
acrylic see methylmethacrylate; 
polymethylmethacrylate
advertisements, 75, 101
Advisory Group on Orthopaedic 
Implants see Department of  
 Health
air see clean air; Casella slit sampler; 
aircraft industry, xxvii, 26, 27, 28, 44, 
65; see also de Havilland Aircraft  
 Co. Ltd; Bristol Aeroplane  
 Company Ltd 
allergy, metal, 43, 57
Alumina ceramic (aluminium oxide), 
96
anaesthesia, 87–8
anaesthetists, 13, 87
animal experiments, 6, 22, 42, 86
ankylosing spondylitis, 24
anterolateral (anterior; Watson-Jones) 
approach, 46, 48, 53–4
antibiotic-impregnated cement, 83, 85, 
86, 87; see also gentamicin- 
 impregnated cement
antibiotics, prophylactic, 77–9, 83
approaches to total hip replacement, 
surgical see anterolateral; lateral;  
 posterior
arthritis, 10, 24
juvenile chronic, 32–3, 34, 88
rheumatoid, 91
arthrodesis, hip, 6, 8–9, 24, 25, 147
arthroplasty, 147
Arthroplasty Care Practitioners 
Association, 89
Austin Moore prosthesis see Moore 
intramedullary endoprosthesis
bacterial cultures, 79, 80
ball bearings, 19, 44
Bart’s (St Bartholomew’s Hospital), 
London, 30, 44, 57
benchmarks see Orthopaedic Data 
Evaluation Panel (ODEP) 
BHS see British Hip Society
biological effects of implants, xxviii, 
22, 43, 70–3, 76
biomechanics, 29, 84
Biomet Ltd (now Biomet Merck Ltd), 
Swindon, 45, 58, 60, 104
Birmingham resurfacing arthroplasty 
see McMinn Birmingham  
 resurfacing arthroplasty
blood pressure, 87, 88
blood transfusion, 87
BMJ see British Medical Journal
BOA see British Orthopaedic 
Association
body-exhaust system, 75, 79, 80; see 
also clean air enclosure
bone cement, xxviii, 30, 147; see also 
CMW; Simplex
antibiotic-impregnated, 83, 85,  
86, 87
application technique, 31–2
cardiovascular effects, 87–8
Index: Subject 
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dental (pink), xxvii, 13, 22
introduction, 11, 13–14, 22–3, 
25–6, 57–8
patents, 57–8
pressurization, 44, 87
properties, 8
revision surgery, 85, 86
self-curing acrylic (PMMA), 8, 21, 
22, 152
standards, 99
use by McKee, 24, 25, 26
bone grafts, 87
morselized, 86, 150
BOSG see British Orthopaedic Study 
Group 
bovine serum, 30
Bristol Aeroplane Company Ltd (later 
Bristol Aircraft Ltd; and part of  
 British Aircraft Corporation  
 from 1960), Bristol, 26
British Hip Society (BHS), 89, 147
British Journal of Surgery, 5
British Medical Journal (BMJ), 77, 78, 
88
British Orthopaedic Association (BOA)
archives, 6
implant surveillance scheme, 40, 41
meetings, 25, 39, 50–1, 57, 59, 76, 
77
representation, 36, 37
British Orthopaedic Ski Group, xxviii 
British Orthopaedic Study Group 
(BOSG), xxviii, 48
British Standards Institution (BSI), 40, 
63, 72, 98
British Standards, 35–6, 97–98
broach, 151; see also rasp
BSI see British Standards Institution
Capital hip implant, 70, 93
carcinogenic effects of wear debris, 71
see also DNA damage
Casella slit sampler, 78
CE mark (EC kite mark), 38, 69–70, 
147–8
cement see bone cement
CEN standards see Comité Européen 
de Normalisation
Centre for Hip Surgery, Wrightington 
see Wrightington Hospital
ceramics, 27–8, 29–30, 96
Charles F Thackray Ltd see Thackray’s
Charnley acetabular reamer, 39
Charnley low-friction arthroplasty 
(LFA), 150
complications, 54
cups, 103
 Fluorosint®, 14
 loosening, 71–2
 Press-Fit, 14
 PTFE, 12, 14, 19, 23–4, 103
 RCH 1000 grade UHMWPE,  
 14, 86
 UHMWPE, 14, 16–19
  chamfer/bevel, 36
  illustrations, 18, 103
  long posterior wall, 54
  sterilization, 43
 wear, 68, 71–2
exhibition, 62
ﬁlm, silent, 46
instruments, 38
prosthesis (Charnley hip), xxviii, 7,  
 103
 benchmark, 69
 controls on supply, 33–4, 38, 58
 costs, 34
 design, 23, 28–9, 71–2
 illustrations, 18, 103
 manufacture, xxvii, 34
 patents, 34, 56–7, 58
 wear test, 16
results and follow-up, 64, 75, 91
surgical technique, 45–6, 48, 49–55
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Charnley Museum, Wrightington, 62
Charnley PTFE double-cup implant, 
7, 12, 22–3
Charnley–Müller prosthesis, 60
children, hip replacement in, 32–3, 44, 
61, 88
chrome–cobalt alloys see cobalt–
chromium alloys
clean air, 76–81
air (slit) samplers, 78, 79, 80
Charnley’s greenhouse, xxvii, 13, 
15–16, 18, 61–2, 76
efﬁcacy, 77–80
ﬁlters, 15, 17
infection rates before, 12, 76
laminar, 80–1, 92, 150
publicity material, 75
cobalt–chromium (Co–Cr) alloys, 27, 
95, 148
biological effects, 22, 43, 56, 57, 
72, 73
durability, 63
ICLH implants, 21–2
McKee prosthesis, 10
standards, 97, 98, 99, 100
see also Vitallium®
Comité Européen de Normalisation 
(CEN), the European Committee  
 for Standardization, Brussels,  
 Belgium, CEN standards,  
 97–8
 legally binding in EC, 97
complications, 63–83
Conformité Européene or European 
Conformity (CE) mark (EC kite  
 mark), 38, 69–70, 147–8
corrosion, 26, 27, 63, 148
costs, Charnley prosthesis, 34
CMW bone cement, 8, 96  
cups, acetabular see acetabular cups
custom-made prostheses, 30, 33, 44
de Havilland Aircraft Co. Ltd, Hatﬁeld 
(a division of Hawker Siddeley  
 Aviation from 1959), 44
defence industry, 27, 28
see also aircraft industry
Deloro Stellite, Swindon, 35, 45
dental cement, xxvii, 13, 22
dentistry, xxvii, 27
Department of Health (DoH), 35, 41, 
70, 88, 93 
Advisory Group on Orthopaedic 
Implants, Department of Health,  
 39–40
DePuy International Ltd (later 
Johnson & Johnson), 33, 60, 64,  
 103, 152–3
see also Thackray’s
design, prosthesis, xxvii–xxviii, 28–30, 
31–2
impact on longevity, 74, 76
impact on wear, 71–3
variations, 62
diameter, femoral head prosthesis, 29, 
59
DIS standards see Draft International 
Standards
dislocation, prosthetic hips, 54, 63
district general hospitals, xxvi, 62–3
DNA damage, 22, 56, 71
double cup arthroplasty, ICLH see  
Imperial College London  
 Hospital (ICLH) double  
 cup or resurfacing  
 arthroplasty prosthesis
Down Brothers Ltd (later Downs 
Surgical Ltd) 24, 102
Downs Surgical Ltd, Mitcham, Surrey, 
9, 105
Draft International Standards (DIS), 
98
DuPont Company, Wilmington, DE, 
7
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EC kite mark see Conformité 
Européene or European  
 Conformity (CE) mark
EC see European Council
endosteal surface, femur, 87, 148
engineering principles, 23, 49–50, 
51–3, 59, 74
engineers, liaison with, xxvii, 15–16, 
24, 26–30, 59
Essex Nufﬁeld Hospital, Brentwood, 
48
European Council (formerly European 
Union)
Directives, 38, 67–9
European Committee for 
Standardization, Brussels,  
 Belgium, CEN standards,  
 97–8
excision arthroplasty, 86, 87
Exeter, xxvi
Exeter hip prosthesis, 31–2, 53, 105, 
148
benchmark, 69
mechanical failures, 65
results and follow-up, 75
FDA see Food and Drug 
Administration
femoral components, prosthetic
cemented, 22, 25, 26, 30
design, 23, 29, 31–2
loading, 72
loosening, 64, 73, 74
materials, 12, 26–7, 28, 64–5
mechanical failure, 64–5
uncemented, 26, 30–1
femur
endosteal surface, 87, 148
fractures, 25, 26
fertility, 22, 56, 72
ﬁlms, THR operation, 46, 47, 55, 61 
see also Charnley; McKee
ﬁlters see clean air
ﬁxation methods (prosthesis to bone), 
xxviii, 8–9, 24, 30–1
Fluon®, 7; see also ICI
Fluorosint®, 14, 148; see also Charnley 
LFA
follow-up, 64, 69–70, 73–4, 89–93
see also post-marketing surveillance; 
results
Food and Drug Administration (FDA), 
USA, 57–8, 61
forces, hip joint, 72, 83–4
formaldehyde sterilization of implants, 
xxvii, 43
fractures
femoral prostheses, 64–5
hip/femur, 8, 25, 26, 88
friction, minimizing, 11, 29, 59
frictional torque, 23, 29
Furlong’s Joint Replacement 
Instrumentation  
 (later JRI Ltd), 40
gait laboratory, University of 
Strathclyde, 84
gamma-irradiation
in air, 21, 43–4, 45, 56, 67, 71
in a vacuum, 45
gentamicin-impregnated cement, 83
Germany, 14, 16, 37, 67, 86
Girdlestone arthroplasty, 6, 24, 87, 
148–9
greenhouse, Charnley’s, xxvii, 13, 
15–16, 18, 61–2, 76, 82
see also clean air ﬂow systems
HAC see hydroxyapatite coating
Hawley orthopaedic table, 11
HDP see ultra-high molecular weight 
polyethylene (UHMWPE)
Health Protection Agency, 81
Health Trends, 41
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hemi-arthroplasty, xxv–xxvi, 41, 149
high-density polyethylene (HDP) see 
ultra-high molecular weight  
 polyethylene (UHMWPE)
hip fractures, 8, 26, 88
‘Hip Histories’ exhibition, Royal 
College of Surgeons of England,  
 London, 62
hip joint
anatomy, 4
forces (loads), 72, 83–4
surgical incisions, 46
Hoechst, Oberhausen, Germany, 14
Howmedica (later Stryker Howmedica 
Osteonics), London, 60, 105
Howorth Air Conditioning (originally 
Howorth Surgicair and later  
 Howorth Airtech Ltd),  
 Bolton, xxvii, 15–16, 62,  
 75, 80
Hunterian Museum, Royal College of 
Surgeons, London, 6, 62
hydroxyapatite coating (HAC), xxviii, 
20, 84, 149
ICI see Imperial Chemical Industries 
Ltd
ICLH see Imperial College London 
Hospital
IMechE see Institution of Mechanical 
Engineers
Imperial Chemical Industries (ICI), 
London, 7
Imperial College London Hospital 
(ICLH) double cup or resurfacing 
 arthroplasty prosthesis, 3,  
 20–2, 23, 56, 106
infections, 76–83
Charnley’s early operations, 12, 15, 
76
deep, 81, 82
prevention, 13, 15–16, 17–18, 
76–81, 92
rates, 79, 81–2, 92
revision surgery, 85, 86, 87
sources, 76–7, 79, 80
superﬁcial (acute), 81, 82
‘Innovation, Assessment and Hip 
Prosthesis’ project, University of  
 Manchester, 61–2
Institution of Mechanical Engineers 
(IMechE), 59
International Federation of Surgical 
Colleges, 36
International Organization for 
Standardization (ISO), 98,  
 149; see also British Standards  
 Institution
chamfer/bevel, 36
standards, 97–8, 99–100
Technical Committee (ISO/
TC150), 35–7, 42, 65, 97
ISO/9000, 67
interpositional arthroplasty, xxv–xxvi
intramedullary rod, 149–50
see also Küntscher nail
irradiation see gamma-irradiation
ISO see International Organization for 
Standardization
ISO/9000, 67, 68
ivory prostheses, xxvi
John Charnley Research Institute, 
Wrightington Hospital, nr Wigan, 
 40
John Charnley Trust (1984), 62
Journal of Arthroplasty, 91
Journal of Bone and Joint Surgery 
(JBJS), 22, 91, 149
JRI Ltd (formerly Furlong’s Joint 
Replacement Instrumentation),  
 40
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Judet brothers femoral head prosthesis, 
xxvi, 7, 101
juvenile chronic (rheumatoid) arthritis 
(Still’s disease), 32–3, 34, 88
Kano, Nigeria, 47
ketamine, 88
Küntscher nail, 36–7, 55, 149–50
laminar clean air ﬂow systems, 80–1, 
92, 150
laryngeal mask airway, 88
lateral surgical approach, 46, 48, 53
Leeds, xxvii, 28, 33, 43, 64
LFA see Charnley low-friction 
arthroplasty
local development, hip prostheses, 
xxvii, 62–3
London Hospital (now Royal London 
Hospital), London, 52
London Splint Company, 45, 105
loosening, 64, 71–2, 73, 74, 85–6, 87, 
92
low-frictional arthroplasty see Charnley 
low-friction arthroplasty
low-frictional torque, 23, 29
MCA see Medicines Control Agency 
McKee (McKee–Farrar) prosthesis, 
10–11
design, 37, 55
ﬁlm of McKee operating (1966), 46
ﬁrst use, 7, 10
illustration, 9, 102
materials, 10, 57
results and follow-up, 89–90, 91
surgical technique, 24, 47, 54
use in US, 58
McMinn Birmingham resurfacing 
arthroplasty, 20, 55–6, 61, 106,  
 147
Manchester, 22, 25, 41, 49, 61–2
Manchester University see University of 
Manchester
manufacturers, xxvi–xxvii, xxix, 33–5, 
58–9
US domination, 57, 58, 60–1
attitude to surveillance scheme, 40, 
41
compliance with standards, 67–8
implant testing, 65–6; see also 
Charnley; RNOH; Stanmore
manufacturing
early Charnley prostheses, xxvii
problems, 63, 65
masks, surgical, 17
materials, implant, xxvii, 26–8, 29–31, 
95–100 
durability, 63, 64–5
early experiments, xxvi, 7, 12
minimizing friction, 29
shifts in, xxviii, 30–1, 59
standards, 42, 67, 97–100
testing, 16, 67; see also Charnley 
LFA; Stanmore THR
see also speciﬁc materials;  
Appendix 1
MCA see Medicines Control Agency
MDA see Medical Devices Agency
mechanical failures, 63–5, 66
mechanics, 29, 49–50, 51–2, 59, 76
medialized cups, 49, 150
Medical Devices Agency (MDA) (later 
Medicines and Healthcare  
 products Regulatory Agency,  
 MHRA), xxviii–xxix, 37–8,  
 70
Medical Research Council (MRC)
Centre for Rheumatic Diseases, 
Taplow, 33
Early Development of Total Hip Replacement – Index
161
slit sampler, 78
studies on clean air, 76, 77–8, 79
Medicines and Healthcare products 
Regulatory Agency (MHRA) see  
 Medical Devices Agency  
 (MDA)
Medicines Control Agency (MCA), 
xxix
metal materials
alloys, 26–7, 95
mechanical failure, 63–5
standards, 97, 98, 99
toxicity, 43, 45, 56, 57, 72, 73
wear particles, xxviii, 22, 42, 43, 70, 
92
see also cobalt–chromium alloys; 
stainless steel
Metallo Medical, Swindon, 35
metal-on-metal prostheses, xxviii, 59
early development, 7, 10, 21–2, 25
results, 91–2
wear, xxviii, 22, 42, 43, 59, 70, 73
metal-on-plastic prostheses, xxviii, 45
early development, 7, 12, 21
results, 91–2
methylmethacrylate, 22, 25, 57
see also polymethylmethacrylate 
(PMMA)
MHRA see Medical Devices Agency
Middlesex Hospital, London, xxvi, 3, 5
Midland Medical Technologies Ltd, 
56, 106
molybdenum, 99, 100, 101, 153
Moore intramedullary endoprosthesis, 
8, 26, 102
morselized grafting, 86, 150
MRC see Medical Research Council
Müller femoral prosthesis, 60
nail ﬁxation, 30
National Health Service (NHS) 
Purchasing and Supply Agency, 69
National Institute for Clinical 
Excellence (NICE), xxix, 69, 70
National Joint Registry for England 
and Wales (NJR), xxix, 38,  
 69–70, 89
National Research Development 
Corporation (NRDC), 58
NHS see National Health Service
NICE see National Institute for 
Clinical Excellence
NJR see National Joint Registry for 
England and Wales
Norfolk and Norwich Hospital, xxvi, 
24, 47–8, 55
BOA clinical meeting, 25
surgical results, 81, 89, 90
North Hill Plastics, London, 57–8, 88
Norwich, xxvi, 37, 39
Norwich Cathedral, 55
NRDC see National Research 
Development Corporation 
Nufﬁeld Orthopaedic Centre,  
Oxford, 80
nurses, 89
ODEP see Orthopaedic Data 
Evaluation Panel 
Orthopaedic Data Evaluation Panel 
(ODEP), benchmarks, 69
Ortron, 64, 71, 150
Ortron 90, 103
osteolysis, 70, 85, 150
Oxford, 57, 80, 88
patents, 34, 56–8
patient satisfaction, 90
physical activity, 83
physiotherapists, 89
plastics, 27, 96
see also polyethylene; 
polytetraﬂuoroethylene
PMMA see polymethylmethacrylate
162
Early Development of Total Hip Replacement – Index
polyethylene, 27, 28, 96, 150
ultra-high molecular weight see 
ultra-high molecular weight 
polyethylene
wear particles, xxviii, 56, 85, 92
polymethylmethacrylate (PMMA), 8, 
21, 96, 152
see also bone cement; 
methylmethacrylate
polytetraﬂuoroethylene (PTFE; 
Teﬂon®), 96, 150–1
Charnley double cup implant see 
Charnley PTFE double cup  
implant
Charnley sockets, 14, 19, 23, 103
physical properties, 27, 29, 59
wear, 12, 19, 23–4, 72
posterior approach, 46, 48, 53, 54, 55
post-marketing surveillance, 38, 40–1, 
69–70, 93
see also follow-up
Press-Fit cups, Charnley, 14
Protek AG, Switzerland, 106
proximal strain (stress) shielding, 73, 
151
pseudoarthrosis, hip, 6, 24, 86
see also Girdlestone arthroplasty
PTFE see polytetraﬂuoroethylene
quality control, 39–40, 67–8, 97–8
radiation sterilization see gamma-
irradiation
radiolucent/radio-opaque, 85
rasp, 151
rats, 22, 42
reamers, 19, 39, 44, 151
recommended list of implants, 
proposed, 39–41
record keeping, 40, 93
Redhill, xxvi, 7; see also Ring prosthesis
register (registry) of hip implants, 
xxviii, xxix, 38, 41, 70
see also National Joint Registry 
for England and Wales; Trent 
Regional Arthroplasty register; 
Swedish Total Hip Replacement 
Register
regulation, xxviii–xxix, 37–8, 39–40
results, surgical, 64, 75, 89–93
see also follow-up; post-marketing 
surveillance
resurfacing arthroplasty see Imperial 
College London Hospital (ICLH) 
 double cup or resurfacing  
 arthroplasty prosthesis;  
 McMinn Birmingham  
 resurfacing arthroplasty
revision, 83–7, 90
rheumatoid arthritis, 91
juvenile see juvenile chronic arthritis
Ring prosthesis, 7–9, 91–2, 105
Rizzoli Institute, Bologna, 22
RNOH see Royal National 
Orthopaedic Hospital
rose garden, Herbert Seddon’s, 47
Royal College of Surgeons of England, 
London, 6, 36, 62
Royal National Orthopaedic Hospital 
(RNOH), Stanmore, xxvi, 47,  
 62–3, 151
custom-made prostheses, 30, 33
implant testing, 30, 65, 66
patents, 58
Royal Society of Medicine, London, 39
royalty payments, 34, 58–9
Scales–Wilson hip see Stanmore hip
screw ﬁxation, 10, 24
serendipity, 23, 29, 47
Shenton’s line, 53, 152
Simplex bone cement, 57, 96
Early Development of Total Hip Replacement – Index
163
simulators, 21, 30, 66; see also test 
machines
see also testing
ski trips, annual orthopaedic, xxviii, 48
slit samplers, 78, 80, 152
Smith & Nephew, London, 60–1
Smith & Nephew Bromsgrove Ltd, 
56, 106
Smith-Petersen prosthesis, 14, 101
Smith’s Industries, 9
St Bartholomew’s Hospital, London 
(Bart’s), 30, 44, 57
stainless steel, 95
mechanical failure, 63, 64
prostheses using, 10, 12, 26–7, 30
standards, 97, 98, 99
standards of composition and 
manufacturing, xxviii–xxix, 35–7, 
67–70; see also BSI; ISO; 
materials, 42, 67, 97–100
testing for compliance with, 65–6
standing, hip joint force, 84
Stanmore see Royal National 
Orthopaedic Hospital (RNOH), 
Stanmore
Stanmore (Scales) hip, 30, 42, 152
benchmark, 69
ﬁrst, 19
ﬁxation, 30, 31
illustrations, 21, 104
manufacture, 35, 58
results, 75
wear test, 60
Stanmore knee, 41
Staphylococcus, coagulase-negative, 82
Staphylococcus epidermidis, 82–3, 152
steel, corrosion-resisting see stainless 
steel
sterilization
formaldehyde, xxvii, 43
gamma irradiation see gamma-
irradiation
Still’s disease see juvenile chronic 
arthritis
surgical approaches, xxvii, 46, 48, 
54–5
surgical blades, disposable, 61
surgical techniques, 45–6, 48–55, 61
Surgical Trades Association, 41
surveillance
infection rates, 81, 82
post-marketing see post-marketing 
surveillance
survivorship analysis, 90, 152
Swann-Morton, Shefﬁeld, 61
Swedish Total Hip Replacement 
Register, 52, 74, 75
Switzerland, 22, 42, 45, 60, 71
technicians, orthopaedic, 11, 24, 48, 
55
Teﬂon®, 7, 152
see also polytetraﬂuoroethylene
test machines, 16, 30, 65–6, 67
Thackray’s (Charles F Thackray Ltd), 
Leeds, xxvii, 61–2, 103, 152–3
implant sterilization, 43, 45
supply controls, 33
see also DePuy International Ltd
Thompson intramedullary prosthesis, 
22–3, 25, 88, 102, 103
THR see total hip replacement
3-M™ Healthcare, Bracknell, 93
titanium (and alloys), 27, 95, 97, 98, 
99, 153
Tobin trochanteric osteotomy, 53
see also trochanteric osteotomy
total hip arthroplasty (THA) see total 
hip replacement
total hip replacement (THR), xxv–
xxvii, 153
ﬁrst operation, 3, 5–7
numbers of operations, xxv
164
Early Development of Total Hip Replacement – Index
Trent Regional Arthroplasty register, 
38, 85
tribology, 28, 153
triﬁn nail, 8–9
trochanteric osteotomy, 45–6, 48–54, 
61, 153
tumours, 30, 42, 44
Turner Dental School, University of 
Manchester, xxvii, 22
UHMWPE see ultra-high molecular 
weight polyethylene
ulnar nerve palsy, 44
ultra-high molecular weight 
polyethylene (UHMWPE; high- 
 density polyethylene; HDP), 
 96, 153
Charnley cups see under Charnley 
cups
gamma irradiation in air, 21, 43–4, 
56, 67, 71
ICLH double cup, 21
introduction, 14, 16–19, 27, 28, 59
quality control, 67–8
RCH 1000, 14, 86
standards, 99
wear, 70, 71–2
UMIST see University of Manchester
University of Manchester, xxvii, 61–2
uncemented implants, 9, 26, 85, 91–2
United States (US), xxvi, xxviii–xxix, 
20–1, 57–8, 60–1, 84
vacuum-cast implants, 35
vacuum-packing, 45
ventilation systems see clean air ﬂow 
systems
Victoria University of Manchester see 
University of Manchester since  
 2004
Victoria University of Manchester 
Dental School see Turner Dental  
 School, University of  
 Manchester 
Vitallium®, xxvi, 26, 153
walking, hip joint force, 83–4
Watson-Jones approach see 
anterolateral approach
wear, 66–8, 70–2
irradiated UHMWPE, 21, 43
metal-on-metal implants, xxviii, 42, 
43, 59, 70, 73
PTFE cups, 12, 19, 23–4
testing, 16, 30
Wiles’ prosthesis (1938), 6, 30, 101
Wrightington Hospital, near Wigan, 
xxvi, 54, 62
BOA clinical meeting, 25
body exhaust suits, 75, 79
bone cement, 26
clean air enclosure, 75, 79, 80; see 
also greenhouse, Charnley’s
infection rates, 12, 15, 76, 79, 82
laboratory, 50
prosthesis sterilization, 43
PTFE use, 12, 14
results and follow-up, 64, 73, 91
training provision, 33–4, 38, 84
US surgeon at, 58
visitors, 28, 50
see also Charnley low-friction 
arthroplasty
X-rays, 33, 49–50, 85
Zimmer Orthopaedic Ltd, 33, 34–5, 
45, 58, 60, 104
Metallo Medical, 35
Zirconia ceramic (zirconium oxide), 96
Early Development of Total Hip Replacement – Index
165
Amstutz, Harlan, 58
Anderson, Julie, 62
Ansell, Barbara, 32–3
Ansell, Ron, 30
Arden, George, 44, 61, 88
Baker, Frank, 11, 24
Bechtol, Charles, 58
Bloch, Bernard, 35–6
Booth, Sir Christopher, 57, 60,  
62–3, 133
Brittain, H A, 24
Brown, James Tulloch, 84
Buchholz, Hans, 83, 85, 86
Burrows, Harold Jackson, 30, 35,  
47, 133
Chaplin, Simon, 62
Chappell, Alan, 37
Charnley, Lady (Jill), 11, 16, 56, 57, 
134
Charnley, Sir John, xxvii, xxviii, 3, 
7–8, 11, 12–13, 14–19, 21, 22–4, 
25, 26, 27, 28–9, 30, 33–4, 38, 
42, 45–6, 48, 49–51, 53, 56–7, 
58, 59, 61–2, 64, 76, 79, 80, 81, 
82, 83, 84, 86, 103, 134
Charnley, Tristram, 25, 45, 134
Churchill, Rt Hon. Sir Winston, 94
Colton, Chris, 50–1, 54, 134
Craven, Harry, xxvii, 13, 14–16, 26, 
80, 134–5
Crosbie, Andy, 38
Dandy, David J, 90
Darling, Bill, 69
Darrah, Clare, 67, 81, 89, 135
Davidson, Douglas, 35
Deane, Graham, 33, 49–50, 80,  
88, 135
Down, Maurice, 9
Dowson, Duncan, 28–30, 52, 53, 59, 
66, 68, 70, 94, 135
Duff-Barclay, Ian, 30
Dupont, Joe, 58
Edwards, Sheila (née Wilson), 19, 136
Elson, Reg, 79, 80, 82, 83–5, 86,  
87, 136
Faulkner, Alex, 68–9, 136
Frank, Peter, 41
Freeman, Michael, xxviii, 3, 20–2, 25, 
39–40, 41, 42, 43–4, 45, 50, 52, 
56, 57, 59, 60, 66, 67, 70, 71, 
72–3, 74, 76, 77, 80–2, 85, 91, 
93, 106, 136
Furlong, Ronald, 40
George, Walter, 58
Girdlestone, Gathorne Robert, 148–9
Glück, Thermistokles, xxvi
Gregg, Paul, 69
Haboush, Edward, 22, 25
Hampson, Phyllis, 19, 33, 34–5, 36, 
40, 41, 42, 45, 58, 65, 66, 67, 
136–7
Hardinge, Kevin, 22–4, 25, 26, 42, 46, 
53–4, 58, 137
Heath, John, 22
Heywood-Waddington, Mike, 46, 
47–8, 57, 61, 72, 89–90, 137
Hopper, John, 38
Houston, Kirk, 14
Howard, R C, 24
Index: Names  
Biographical notes appear in bold
166
Early Development of Total Hip Replacement – Index
Howorth, F N, 15–16
Hunton, Mr, 24
Jackson Burrows see Burrows, Harold 
Jackson
Jones, Geoffrey Blundell, 35
Judet, Jean, xxvi, 7, 101
Judet, Robert, xxvi, 7, 101
Keith (orthopaedic technician), 48
Kiaer, Sven, 22
King, Geoff, 55, 137
Kirkup, John, 9, 10–11, 25, 61, 137–8
Kunzru, Krishna (Ravi), 3, 44, 61, 138
Law, W Alexander (Scottie), 20–1, 138
Lee, Betty, 24, 138–9
Lee, Clive, xxvi, 105
Lettin, Alan, 3–5, 7, 9, 13, 16, 19, 20, 
22, 26, 28, 30, 31, 32, 33, 34, 37, 
39, 40, 41, 42, 44, 45–6, 48, 49, 
50–1, 52, 53, 54–5, 56, 57–8, 59, 
60, 61, 62–3, 64, 65, 66, 67, 68, 
69, 70–1, 72, 73, 74, 76–7, 78, 
79, 80, 81, 82, 83, 85–6, 87, 88, 
89, 91, 93, 94, 139
Ling, Robin, xxvi, 28, 31–2, 53, 70, 
73–4, 87, 105, 139
Longﬁeld, Michael, 29
Lowbury, E J L (Ted), 77
Ludgate, Susanne, 38
McKee, Ken, xxvi, 3, 7–8, 9, 10–11, 
22, 24, 25, 26, 29, 37, 38, 45, 46, 
47–8, 50, 54, 55, 56, 57, 61, 82, 
84, 89, 90, 102, 139
McMinn, Derek, 20, 56, 106
Moore, Austin T, xxvi, 102, 140
Müller, Maurice, 22, 60, 86
Neary, Francis, xxv–xxix, 3, 61–2, 140
Older, John, 52–3, 64, 76, 93, 140
Partridge, Christopher, 90
Paul, John, 36, 83–4, 140
Philips, Hugh, 88
Pickstone, John, xxv–xxix, 3, 61, 62, 
82, 140–1
Platt, Sir Harry, 49
Poulton, Mr, 15
Read, John, 11, 12–13, 15, 26, 43, 52, 
80, 87, 141
Ring, Peter, xxvi, 3, 7–9, 45, 84, 91–2, 
105, 141
Saemann, F I, 45
Scales, John Tracey, xxvi, 19, 30, 31, 
33, 35, 36, 44, 45, 47, 50, 57, 58, 
59, 65, 93–4, 104, 141–2
Seddon, Sir Herbert, 47, 142
Smallwood, Andy, 69
Smith, Dennis, 22
Smith-Petersen, Marius, xxvi, 48, 101
Somerville, Edgar, 49–50, 142
Stephen, Ian, 31–2, 44, 53, 65, 73, 74, 
87, 142
Swann, Malcolm, 32–3, 44, 61, 88, 
142–3
Swanson, Alan, 21, 22, 26–8, 29, 30, 
42–3, 50, 51–2, 59, 63–4, 65–6, 
68, 71, 95–6, 106, 143
Sweetnam, Sir Rodney, 3, 5–6, 30–1, 
39–40, 41, 51, 60, 66, 73, 74, 77, 
78, 92–3, 143
Taylor, Ian, 47
Terry (orthopaedic technician), 48
Theodorou, B C, 90
Thompson, Frederick, xxvi, 102
Trentani, C, 21–2
Tucker, Keith, 37–8, 39, 43, 54, 55, 
67, 68, 69–70, 82–3, 87, 89,  
91, 143
Early Development of Total Hip Replacement – Index
167
von Bergman, Ernst, xxvi
Watson-Farrar, John, 24, 37, 38,  
47, 55
Watson-Jones, Sir Reginald, 48, 144
Weightman, Barry, 68
Wheble, Victor, 35–6, 37, 42, 65, 
97–8, 144
Wiles, Philip, xxvi, 3, 5–6, 19, 30–1, 
101, 144–5
Willert, Hans, 71, 72
Wilson, James Noel (Ginger), xxvi, 19, 
20, 30, 35, 47, 50, 93, 104, 145
Wilson, Michael, 50, 93–4, 145
Wroblewski, B Michael, 33–4, 41, 43, 
45, 49, 50, 52, 53, 54, 64, 68, 
69–70, 71–2, 73, 74, 76, 77, 81, 
82, 88, 89, 90, 91, 145

Key to cover photographs
Front cover, top to bottom
Mr Alan Lettin (Chair) 
Mr Peter Ring 
Mrs Phyllis Hampson 
Mr Victor Wheble 
Back cover, top to bottom
Sir Rodney Sweetnam 
Lady Charnley, Mr Reg Elson, Mr Tristram Charnley
Professor Michael Freeman 
Professor Alan Swanson 

